cell_line_id,drug_id,response
BC-3C,11222830,1.94023462088946
TC-71,ISOX-bortezomib (250-1 mol-mol),0.4389117295392593
PLC/PRF/5,9866186,1.455978232017785
KMH-2,25126798,3.9705987433413976
PE/CA-PJ15,6252,2.755233482446364
KP-3,6438330,1.362030480673537
AsPC-1,76446078,5.483716778202627
PE/CA-PJ15,9956119,4.212049947291104
GSS,tretinoin-navitoclax (4-1 mol-mol),0.2217678368327082
AsPC-1,135440466,2.1679547773967314
GSS,10410894,2.4619799400555458
NUGC-3,2749,1.9758881841519624
BC-3C,42642645,1.452807214560988
KYSE-510,219104,4.784069254556684
PC-14,11497983,1.5451127638875048
PLC/PRF/5,11152667,1.7058073401634024
PC-14,9903786,1.3474672632704163
TC-71,UNC0638-navitoclax (1-1 mol-mol),4.936257961765979
KMH-2,6918328,-1.001210153531207
KMH-2,9444,2.9030886554096536
BT 112,selumetinib-vorinostat (8-1 mol-mol),2.3775465177087063
IMR-32,1750826,-4.804039609985568
NUGC-3,54618164,3.5634318473860658
IMR-32,11175137,0.9388658200014552
GSS,71466445,1.4608073960696302
PE/CA-PJ15,5329102,2.2036522902454454
HuP-T3,9926054,1.9266750805140576
PE/CA-PJ15,navitoclax-birinapant (1-1 mol-mol),3.0394243463811947
PLC/PRF/5,11612883,3.8925638411617296
SK-MEL-2,piperlongumine-MST-312 (1-1 mol-mol),1.4935345830806257
TC-71,44491742,3.7748114564226407
SK-MEL-2,selumetinib-PLX-4032 (8-1 mol-mol),2.2995519126398336
REC-1,24797083,0.9947998320631116
CML-T1,16038120,0.5708889366464743
D283 Med,44202524,1.228437692555833
BT 112,11238147,2.441031684026273
KYSE-510,46843906,4.090786338136028
KYSE-510,44137675,5.449832828121369
PE/CA-PJ15,400769,-0.9231632206674432
AsPC-1,25183872,-0.8583413037674358
IMR-32,decitabine-navitoclax (2-1 mol-mol),-1.0449082670231582
PE/CA-PJ15,11964036,1.4785290961040634
KMH-2,5470400,-1.131447733049698
AsPC-1,selumetinib-tretinoin (2-1 mol-mol),1.7169571239818917
GSS,136227924,2.0459518542117983
GSS,60750,-4.813514903707047
BT 112,7326481,3.170225390322452
PLC/PRF/5,16038120,2.904407936478441
PC-14,16013152,4.486002154562109
CML-T1,15953870,2.3626237456804025
GSS,24785538,-0.965111989476808
HEC-108,51037431,2.239611554360474
PE/CA-PJ15,252682,6.5374935724785335
IMR-32,42642645,-1.1438472820018184
BC-3C,12001922,2.342706988586835
PLC/PRF/5,25102847,3.721124468986592
AsPC-1,1566236,2.844580785967763
CML-T1,11625818,4.307055863962681
AsPC-1,10184653,1.884059851333118
AsPC-1,16219061,4.6595447221902955
BC-3C,25195348,3.5629849051305227
AsPC-1,409805,5.083096669481897
HEC-108,navitoclax-piperlongumine (1-1 mol-mol),-0.8310694921552283
KYSE-510,25161177,5.577033840224449
CML-T1,4521392,4.044943461780163
TC-71,4521392,4.289191985720217
SK-MEL-2,2729026,2.9654254504210296
GSS,46191454,0.0707062454995161
BC-3C,72193861,0.2761573926255262
PC-14,selumetinib-BRD-A02303741 (4-1 mol-mol),1.6810269495399257
PE/CA-PJ15,5278396,3.6789098748784808
KP-3,25154868,4.324427303858612
PLC/PRF/5,ISOX-bortezomib (250-1 mol-mol),0.363630536844772
HEC-108,3689413,1.021712931431184
KMH-2,sirolimus-bortezomib (250-1 mol-mol),-3.0653636595991203
NUGC-3,71304818,2.3386364661351027
GSS,9826308,0.366176710876113
GSS,docetaxel-tanespimycin (2-1 mol-mol),-6.21332907237171
KP-3,25183872,-0.6521585427488795
AsPC-1,9933475,2.7319135281095908
BT 112,selumetinib-piperlongumine (8-1 mol-mol),3.6452165297650505
PC-14,serdemetan-SCH-529074 (1-1 mol-mol),2.471132541468487
PE/CA-PJ15,navitoclax-PLX-4032 (1-1 mol-mol),3.171250916995731
HuP-T3,7326481,3.4338903427833674
HuP-T3,5746,1.6464242063318688
KP-3,17755052,1.8053835671636087
PLC/PRF/5,54613361,-1.5255580396684505
BT 112,135440466,3.4260770877758207
BT 112,9840324,5.678931191449396
REC-1,24901704,2.3633064511897315
D283 Med,3384730,1.3777916079396086
IMR-32,6914657,-8.885512671402315
PE/CA-PJ15,24748573,2.17566183871997
GSS,selumetinib-vorinostat (8-1 mol-mol),1.884936814348228
PC-14,1716436,3.681033549628276
PE/CA-PJ15,3062316,-1.476141456362071
GSS,5746,-1.9792480264930576
CML-T1,136227924,1.8923919385229255
AsPC-1,31703,0.7807561035178269
AsPC-1,selumetinib-vorinostat (8-1 mol-mol),2.1619817893004805
D283 Med,JQ-1-UNC0638 (2-1 mol-mol),3.413583109357789
HEC-108,6610355,5.333623813086721
CML-T1,11175137,2.223157836501134
HuP-T3,65064,5.168937665689206
CML-T1,6918736,-1.6116924986143133
SK-MEL-2,11717001,1.6786604192843333
HuP-T3,carboplatin-etoposide (40-17 mol-mol),4.278227331004969
AsPC-1,52947716,3.328482082087177
BC-3C,selumetinib-MK-2206 (8-1 mol-mol),2.827500839506983
KYSE-510,6610355,5.233654856875671
NUGC-3,SNX-2112-bortezomib (250-1 mol-mol),-0.9861606497381312
HuP-T3,11485656,3.0565489144797224
PE/CA-PJ15,serdemetan-SCH-529074 (1-1 mol-mol),2.869760401874241
CML-T1,5746,-2.1549173035879803
PE/CA-PJ15,3689413,2.6755130574722767
REC-1,51039095,5.556234972670518
PLC/PRF/5,11707110,5.8269088617366265
BC-3C,5566,3.0593279744022435
IMR-32,56973724,1.5762531066205374
IMR-32,613000,1.9783945793297717
D283 Med,11955716,-2.6841002299683336
KMH-2,25154868,3.095260346153153
KMH-2,135398738,1.012149914013246
BT 112,46199207,1.816162023423103
CML-T1,44819697,-2.8753334506591504
GSS,9911830,2.005456861006021
D283 Med,10127622,5.31032518886127
BC-3C,9935249,3.143232042704622
HEC-108,71304818,2.263440211327266
CML-T1,123631,1.8980514916470088
NUGC-3,54618771,-0.8642995608201182
BT 112,3825829,4.160828844250468
HuP-T3,2858523,3.211348955084378
NUGC-3,3038522,4.279745096390382
BC-3C,6610216,4.163400857926898
BT 112,54596558,3.9811658460437673
REC-1,6918289,4.400712248606405
SK-MEL-2,66577038,3.333852219359522
TC-71,11455910,0.3179864486303165
HuP-T3,16038120,1.51216352382263
PLC/PRF/5,11178236,-2.9823910017753885
BC-3C,24856436,-0.4695822229076069
PC-14,24964624,3.1238694699720626
HuP-T3,25150857,2.779922499061356
CML-T1,36314,-5.131510797683319
BC-3C,252682,6.421105750419417
KYSE-510,2828334,5.89152111148045
AsPC-1,carboplatin-etoposide (40-17 mol-mol),5.367887581807261
BT 112,54618305,3.877432993303292
KMH-2,ISOX-bortezomib (250-1 mol-mol),-0.2001122906253291
BC-3C,11228183,3.2895930272739897
PC-14,navitoclax-sorafenib (1-1 mol-mol),1.3495674721807007
D283 Med,26596,-3.592310964496019
CML-T1,17755052,2.353347963272661
AsPC-1,navitoclax-birinapant (1-1 mol-mol),2.1190799837985597
BT 112,72193861,1.04293508394768
GSS,44137675,2.88816125980243
KMH-2,10074640,2.2394056141087493
KYSE-510,ISOX-bortezomib (250-1 mol-mol),0.8341784419562992
PE/CA-PJ15,decitabine-navitoclax (2-1 mol-mol),3.3125622838929663
KMH-2,selumetinib-vorinostat (8-1 mol-mol),2.389760502831543
D283 Med,4788,3.843501603973715
AsPC-1,54618771,1.0442216511349782
PLC/PRF/5,24964624,3.70653493586393
KP-3,44484440,2.9520563964934565
BC-3C,82146,4.044408785319656
IMR-32,54678924,1.211192770332239
BT 112,168312962,1.7814785578943482
AsPC-1,9840324,5.861158829716173
GSS,119182,-1.2149343584436698
NUGC-3,71466445,2.3864279046881673
KYSE-510,5470400,-1.7132183639530645
HEC-108,68056272,3.6278104442075736
PC-14,73707440,4.422438937843538
BC-3C,11626560,2.479284828278078
TC-71,12003241,0.7010514965491693
KP-3,12001922,1.9624704543542888
PE/CA-PJ15,11707110,3.5465395571368994
D283 Med,67156097,-2.9733455385355803
IMR-32,crizotinib-PLX-4032 (2-1 mol-mol),0.6327639809582529
REC-1,44607531,1.7540961612840025
BT 112,135875424,2.6326015677965087
REC-1,446155,6.051384547880599
GSS,208908,2.0400342847533808
TC-71,446155,1.770257569240382
D283 Med,426756,3.908529404251969
BT 112,6252,1.5654239988674197
SK-MEL-2,25126798,4.248838874551961
KYSE-510,11964036,2.337404068866674
GSS,JQ-1-vorinostat (2-1 mol-mol),0.6919361914926453
GSS,9903786,1.9234294660474929
BT 112,15953870,4.403390528576976
PE/CA-PJ15,navitoclax-MST-312 (1-1 mol-mol),0.989983857271209
SK-MEL-2,crizotinib-PLX-4032 (2-1 mol-mol),3.064457715489462
KYSE-510,448949,2.970947219525978
GSS,JQ-1-carboplatin (1-1 mol-mol),0.1875541485462026
PC-14,969516,2.650113623960972
AsPC-1,126941,-0.909933311518488
HuP-T3,6438330,2.3942211080747837
GSS,12001922,1.6250350563630838
PE/CA-PJ15,49793307,-2.5792921181463617
KYSE-510,25227462,1.603461782703604
REC-1,46907787,4.0420421547178975
PE/CA-PJ15,969516,2.781923448881668
BT 112,135411,-0.6618805280288009
BT 112,selumetinib-JQ-1 (4-1 mol-mol),2.692883041543946
AsPC-1,2746,3.619198032462304
CML-T1,decitabine-carboplatin (1-1 mol-mol),-0.978509690631207
D283 Med,3081361,2.432626618810537
PLC/PRF/5,11222830,1.222868983899977
NUGC-3,66577038,2.999702133731877
KP-3,4259181,-0.2815852402422203
CML-T1,25262965,-1.9815055926190612
IMR-32,49793307,-5.531968071413573
NUGC-3,6852167,3.3889998350800608
GSS,15983966,-4.226142080321806
REC-1,15953870,2.7067445833073407
KYSE-510,5284616,3.059887259402434
PLC/PRF/5,11404337,0.67614932520098
KYSE-510,tanespimycin-bortezomib (250-1 mol-mol),-1.5212875758875433
HuP-T3,9927531,4.952379772704904
PC-14,25262965,-1.0782016960514162
D283 Med,24901704,2.1853171446916257
AsPC-1,3689413,-2.062701377390924
CML-T1,tretinoin-carboplatin (2-1 mol-mol),3.366911214203907
REC-1,11214940,3.3108084395068924
BC-3C,24785538,2.0064484163144303
AsPC-1,126941,-0.909933311518488
REC-1,9956119,4.047976940960665
HEC-108,2113511,5.8682734581201705
HuP-T3,5281321,0.1098786391841839
AsPC-1,135398516,2.7517064972229415
D283 Med,57519531,1.3990443657534628
PLC/PRF/5,375860,-0.0784427755583708
BC-3C,151289,1.3111890606245775
BT 112,676352,1.6174631516365394
PC-14,421610,3.0236503456668697
PE/CA-PJ15,23582824,-0.1031262953747945
REC-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.262800070062549
REC-1,2113511,4.615761097345554
KP-3,66577038,3.7551165367906183
AsPC-1,5328940,1.7821313082315045
AsPC-1,67291369,5.582806392200744
IMR-32,71751553,0.2380209164457374
PLC/PRF/5,9933475,2.1729163341426845
CML-T1,568763,0.104759642693247
TC-71,9927531,4.177938465440418
AsPC-1,9911463,3.4970941612274693
GSS,448949,0.5557874153115744
BC-3C,24772860,0.1904167062107548
BC-3C,5978,-1.0921058186758212
AsPC-1,19582717,4.191920632274723
CML-T1,16115403,-5.689263243746957
TC-71,10113978,1.7471021561496087
KMH-2,carboplatin-UNC0638 (2-1 mol-mol),2.6282435613329405
KYSE-510,alisertib-navitoclax (2-1 mol-mol),0.5478828452247019
PC-14,5281672,4.958845757843883
D283 Med,selumetinib-PLX-4032 (8-1 mol-mol),5.220725051966228
TC-71,15983966,-4.425786271808255
D283 Med,135999136,3.641764348590375
HuP-T3,6914657,-2.995276103152913
TC-71,439501,-2.5028085406649336
AsPC-1,9936388,-0.8199656713038528
HuP-T3,107970,2.2315719384591133
PC-14,2858523,2.9944905399377584
HuP-T3,6918837,-1.8626358392084263
NUGC-3,10410894,2.9371828669992133
HuP-T3,969516,2.913535439683091
REC-1,1242560,4.120560836413046
D283 Med,9903786,1.479416225891386
HEC-108,selumetinib-JQ-1 (4-1 mol-mol),4.622936143310662
PE/CA-PJ15,11485656,1.9220584297940355
KYSE-510,piperlongumine-MST-312 (1-1 mol-mol),2.5201621599478377
GSS,24180719,2.7345917663435975
D283 Med,46398810,1.668520426721307
REC-1,5746,3.861776168634442
D283 Med,9935249,1.011376298828927
AsPC-1,11609586,3.135544943212619
AsPC-1,vorinostat-navitoclax (4-1 mol-mol),0.981904018137164
SK-MEL-2,10231331,1.800532200590708
PC-14,5951923,4.134666638146039
PC-14,71466380,5.576948071004914
IMR-32,969516,2.0761304790104966
KYSE-510,44819697,-0.9231742210002762
GSS,3634881,2.441529952322115
REC-1,6610355,5.258921054567104
BT 112,selumetinib-navitoclax (8-1 mol-mol),3.948164534074535
HuP-T3,219104,4.090562015064086
CML-T1,6450551,-1.1017942434712815
GSS,54618164,3.355805594093071
AsPC-1,11494412,3.580103428724827
PC-14,23635314,-2.371895382371369
PE/CA-PJ15,54596558,4.362404185353882
BT 112,71304818,2.5450175334418987
BT 112,44632017,0.9715199152864828
AsPC-1,11238147,2.0906654911229796
CML-T1,doxorubicin-navitoclax (2-1 mol-mol),-4.289526889070848
REC-1,selumetinib-GDC-0941 (4-1 mol-mol),5.111180510517744
KMH-2,54618771,-0.6611868525273566
KMH-2,51039095,2.0991700648895013
SK-MEL-2,123631,3.616973123734504
AsPC-1,24797083,1.5655308519339004
KMH-2,107985,-4.440693549832868
IMR-32,6918878,1.5583958621376863
BT 112,2871966,-0.611805318298209
GSS,25105715,2.3251299061773505
CML-T1,3011155,1.2837041284349135
GSS,135440466,2.2387831882288354
TC-71,navitoclax-gemcitabine (1-1 mol-mol),-2.881938239750984
TC-71,25126798,3.809241999378844
NUGC-3,6505803,-1.151304908691564
KYSE-510,3062316,3.614219543012608
AsPC-1,salermide-PLX-4032 (12-1 mol-mol),5.331580657961115
PE/CA-PJ15,5951923,6.390550874412015
HEC-108,676352,2.944885570053704
TC-71,11222830,1.762495766937727
BT 112,tanespimycin-bortezomib (250-1 mol-mol),-0.1012397521650829
KP-3,9967941,4.115981052336778
NUGC-3,24785538,3.371294685554557
BC-3C,5280436,2.216528448232833
PC-14,168312962,0.2499622730963001
SK-MEL-2,6918328,0.4245734425761685
TC-71,17755052,1.5318085466577147
KYSE-510,5281321,-1.3491896810483737
PC-14,322968,4.675722029453696
AsPC-1,serdemetan-SCH-529074 (1-1 mol-mol),2.4648978933330232
KMH-2,71680916,4.235623447079222
KYSE-510,navitoclax-MST-312 (1-1 mol-mol),1.2591800601634011
HuP-T3,44566777,1.596285673654969
KP-3,446155,1.1140358835365098
PLC/PRF/5,BRD-A02303741-navitoclax (2-1 mol-mol),3.443176216154077
PLC/PRF/5,57330099,4.158941913895402
CML-T1,984333,-1.4387494949343358
KMH-2,52912189,0.6759981038988053
KYSE-510,BRD-A02303741-navitoclax (2-1 mol-mol),3.8975069186935416
CML-T1,25105715,2.3891517916986684
BC-3C,6184667,1.8382649437115417
HuP-T3,66577038,3.287519898796673
D283 Med,5287969,-2.6386701555560466
CML-T1,11317348,-0.5508465073970409
SK-MEL-2,676352,2.344694612320362
BT 112,3025986,-1.5928563780305742
REC-1,3025944,4.955899940581851
KYSE-510,vorinostat-navitoclax (4-1 mol-mol),2.080072687069866
PLC/PRF/5,168312962,-3.860938529901921
AsPC-1,selumetinib-MK-2206 (8-1 mol-mol),1.6860334273273738
SK-MEL-2,1566236,1.8049776049740816
NUGC-3,5278396,3.6335877730932062
CML-T1,49766530,-2.849769761760908
GSS,10113978,2.163069613164649
KP-3,11238147,2.2063710897494
AsPC-1,11647372,4.7024563360539675
CML-T1,44507138,0.8933545312764144
TC-71,135411,0.5578602362268543
BT 112,135999136,1.34167975240954
PLC/PRF/5,54454,3.425815858271352
AsPC-1,16659841,4.5181069426631
PC-14,11656518,1.9587684942770311
TC-71,135398738,1.6628211751396036
BC-3C,25126798,3.8970148217831464
KYSE-510,11175137,3.8033273559011462
GSS,2749,0.9178208861008688
HEC-108,135398738,5.1700626311097935
PLC/PRF/5,16065773,1.9077509064494416
GSS,52947716,-5.542755351336618
PE/CA-PJ15,JQ-1-navitoclax (2-1 mol-mol),1.969066619122252
IMR-32,25227462,-6.573830800734898
PC-14,4705,-3.029150478382576
D283 Med,54678924,1.845714700786355
KMH-2,73707440,5.915660341573708
D283 Med,46907787,-0.0797634926932206
D283 Med,5351362,0.7934624245547425
TC-71,89928392,1.332332912832931
KMH-2,6917907,-5.658415901866329
CML-T1,selumetinib-piperlongumine (8-1 mol-mol),3.07705446138146
KYSE-510,68056272,4.686757988307578
BT 112,136227924,2.645928432247734
IMR-32,navitoclax-sorafenib (1-1 mol-mol),-0.5251109163009627
TC-71,151289,0.7196413570938871
PE/CA-PJ15,44486219,4.221629533616514
REC-1,73707398,3.9738319614180666
GSS,56946209,-5.05650426892743
REC-1,selumetinib-tretinoin (2-1 mol-mol),6.606807217531799
AsPC-1,9907093,4.363482739155403
PC-14,decitabine-navitoclax (2-1 mol-mol),2.50877904816453
PC-14,selumetinib-MK-2206 (8-1 mol-mol),0.7353160190832573
CML-T1,sirolimus-bortezomib (250-1 mol-mol),-2.349010287951753
GSS,2742550,2.9505623218307298
AsPC-1,54626689,5.229882111208764
REC-1,16741245,3.3248283023586525
D283 Med,2742550,3.5680258108109975
AsPC-1,327653,4.351823995090995
PE/CA-PJ15,10302451,1.647301447843495
NUGC-3,5329102,2.3362385699322803
IMR-32,54618771,0.9755251255632068
PLC/PRF/5,JQ-1-carboplatin (1-1 mol-mol),5.5351057973107505
NUGC-3,11626560,2.505608776596773
HEC-108,6623618,3.02110008293671
AsPC-1,selumetinib-PLX-4032 (8-1 mol-mol),2.574223553479829
IMR-32,erlotinib-PLX-4032 (2-1 mol-mol),3.5712677023534796
PLC/PRF/5,44819697,0.313096788937408
KP-3,448949,1.5067921571071503
KMH-2,5311281,1.6433918392337388
GSS,23725625,3.06660957038394
REC-1,73707386,2.7839275654473243
CML-T1,11640390,3.08306987111381
PLC/PRF/5,11234052,3.958078759188171
NUGC-3,10385095,1.1907439183905275
PE/CA-PJ15,51039095,2.8865821807336545
AsPC-1,462382,1.1756614609859282
HEC-108,selumetinib-navitoclax (8-1 mol-mol),1.4557838229690625
CML-T1,107970,1.8137988275945616
GSS,6917907,-5.651521372982249
GSS,24951314,0.2658208710817306
AsPC-1,613753,3.1774382169580355
D283 Med,decitabine-carboplatin (1-1 mol-mol),-0.1319093330990738
KMH-2,168312962,1.8657992133114711
KYSE-510,54765302,4.325576744279815
SK-MEL-2,44237094,3.084282747734724
PLC/PRF/5,11626560,2.880320774442227
GSS,3062316,1.2789062108027878
AsPC-1,25150857,2.720712035994173
GSS,262093,2.371550442394459
BC-3C,42611257,3.755500580384314
PE/CA-PJ15,4705,2.241412647888812
HEC-108,148198,-2.2464200337513587
NUGC-3,carboplatin-etoposide (40-17 mol-mol),1.7465673544549525
BT 112,selumetinib-PLX-4032 (8-1 mol-mol),4.754861395931308
KP-3,4521392,4.3351469054542
BC-3C,salermide-PLX-4032 (12-1 mol-mol),5.0485806645790205
IMR-32,675434,3.967406414327758
D283 Med,3854666,0.4329488785955893
TC-71,2871966,0.365367168373122
PE/CA-PJ15,selumetinib-vorinostat (8-1 mol-mol),4.124369885528516
CML-T1,445643,3.3065494006722327
KMH-2,656346,0.0409670690742822
PC-14,9826308,0.392936157903732
IMR-32,753704,3.2585074945074233
AsPC-1,135999136,4.3448843965381965
CML-T1,2729026,1.0181320426336582
D283 Med,53495165,-4.057226120074279
AsPC-1,docetaxel-tanespimycin (2-1 mol-mol),-2.3470176928652204
PE/CA-PJ15,11609586,3.1657883491375824
BT 112,262093,1.8523945417932268
IMR-32,44202524,0.850950668804241
KYSE-510,1716436,4.648847836345801
CML-T1,5335621,4.035243944386916
NUGC-3,168313016,5.1272078558334915
BC-3C,16038120,1.738155520417055
PLC/PRF/5,4578,4.9143375126163
PLC/PRF/5,piperlongumine-MST-312 (1-1 mol-mol),1.7796808873366314
KP-3,11404337,-0.3315209931001077
KYSE-510,89928392,2.735824497041842
BC-3C,119607,5.540884545398854
KMH-2,25062766,1.196935006770044
KMH-2,3815108,2.5903945820626006
AsPC-1,selumetinib-JQ-1 (4-1 mol-mol),1.077922067972621
IMR-32,241158,1.87934561893452
IMR-32,selumetinib-GDC-0941 (4-1 mol-mol),2.0130210869415515
PC-14,23725625,5.247138358431667
REC-1,54618771,4.304155025574206
AsPC-1,135984461,3.722049898583642
PC-14,46191454,2.117335177137966
SK-MEL-2,46926350,-3.526858160660795
TC-71,56963564,0.3071275643376286
PE/CA-PJ15,46843906,3.542355715019075
BT 112,11626560,1.4312107958608666
D283 Med,72199292,-0.0739367415470992
NUGC-3,10113978,3.2432102974528947
REC-1,445455,4.440589550189474
PLC/PRF/5,25183872,-1.4493036775008346
SK-MEL-2,148198,-4.089267246303032
CML-T1,10385095,0.9719029483379856
PC-14,25183872,-0.3875173462259941
BT 112,36462,-0.1329200912201302
KYSE-510,46199207,3.753172020849397
KMH-2,375860,-0.9905938635036066
KP-3,4096211,0.4234896505440504
AsPC-1,42611257,3.6284330949745094
GSS,5566,1.869173795327545
BT 112,6918837,-0.2659992739621661
PC-14,11507802,2.9522265346709227
D283 Med,24951314,-0.1478123596184988
AsPC-1,10385095,2.76496705920137
D283 Med,16722836,1.0096131047253871
BC-3C,15547703,3.2001700286255605
HuP-T3,24771867,4.228511460696379
KMH-2,11152667,-1.1792266264119935
D283 Med,2729026,2.489679691216484
KP-3,1714884,3.70641046699709
REC-1,49766530,2.1728933829794395
AsPC-1,5281321,-1.206156098851657
IMR-32,246676,3.267106458420984
TC-71,53232,2.1206553236964556
SK-MEL-2,5282054,4.421155329713266
D283 Med,3025944,3.966000560385046
PC-14,156414,-5.707063313851652
KMH-2,2708,3.3421744997007856
IMR-32,72376,-3.6840357825232863
GSS,2130404,2.800822659952615
HuP-T3,3062316,-3.5835263694309862
HEC-108,24753719,4.945792887212488
SK-MEL-2,9933475,2.361600620643174
CML-T1,10302451,-1.0288409878116755
TC-71,JQ-1-MK-0752 (1-1 mol-mol),1.2503582505355295
D283 Med,2708,2.7389036189058156
PE/CA-PJ15,46398810,3.170934794920483
CML-T1,54618164,3.634689828068523
IMR-32,24964624,2.7013619779223808
AsPC-1,JQ-1-navitoclax (2-1 mol-mol),1.1906328907742711
TC-71,2746,3.085188483378043
HEC-108,44607531,1.840431852580758
CML-T1,9908783,6.154706718384333
GSS,4477,-0.6745922444567984
BC-3C,16722836,2.2207961776722667
KYSE-510,2126,4.70941219623199
HEC-108,107985,-3.7063937347849696
TC-71,241158,3.671280815212322
PC-14,11364421,-4.686558002972056
PE/CA-PJ15,16065773,2.0231988784926123
PLC/PRF/5,73707398,1.7771083987685936
KMH-2,676352,1.6128431160442525
BT 112,252682,6.130098211071154
PC-14,selumetinib-JQ-1 (4-1 mol-mol),0.1857937435498048
HuP-T3,51039095,3.318948357155543
D283 Med,46174525,1.3652890399217403
AsPC-1,12003241,0.1897400127907629
CML-T1,2841722,3.5416474270082796
KYSE-510,44491742,4.7429938042096245
AsPC-1,6914657,-2.819399047423078
SK-MEL-2,54618771,2.1400716929659045
KMH-2,10184653,1.455820590430646
IMR-32,11955716,-2.260468702269608
IMR-32,441298,4.528977514958097
CML-T1,11222830,0.9922056813064216
HEC-108,16725315,4.671671470713106
PE/CA-PJ15,docetaxel-tanespimycin (2-1 mol-mol),-7.588791932673522
PLC/PRF/5,4259181,1.1684219933563562
KP-3,168313047,2.5997698738150072
PE/CA-PJ15,5284616,3.1038537418820424
BT 112,10113978,3.5580397718856496
BC-3C,9884685,2.9353156431975393
PLC/PRF/5,5287620,-2.9036781854316134
NUGC-3,3081361,1.7407523996239211
CML-T1,219104,2.3392357294314055
KYSE-510,31703,-0.8500820879673426
PLC/PRF/5,44137675,5.074736311382347
PLC/PRF/5,3062316,2.7654817877634232
KYSE-510,24771867,2.9455668420955736
IMR-32,11960529,3.2139236071640633
AsPC-1,49793307,-1.0458597957041098
CML-T1,644241,-4.543158274485358
PE/CA-PJ15,445455,4.385473643575934
PE/CA-PJ15,322968,4.812819330141393
PLC/PRF/5,11640390,4.026050039818681
PC-14,656346,0.6979496632306237
NUGC-3,262093,3.0230092898812484
PC-14,11175137,2.2075577694334103
KMH-2,5284616,-5.421998333823896
HEC-108,6438330,3.5129329347136027
NUGC-3,67291369,1.8597014599849688
SK-MEL-2,selumetinib-tretinoin (2-1 mol-mol),2.535897414945112
D283 Med,9826308,-0.3808520436039156
TC-71,445643,3.8565974086988626
IMR-32,UNC0638-navitoclax (1-1 mol-mol),-0.289591590901736
SK-MEL-2,72193861,3.374874194476354
PE/CA-PJ15,24889392,3.817168154957895
TC-71,285033,-4.335711583378416
CML-T1,57330099,4.076691821950742
D283 Med,6918837,-6.563523505293122
D283 Med,BRD-K55473186,4.203896885474867
REC-1,crizotinib-PLX-4032 (2-1 mol-mol),3.524411495353615
BT 112,23635314,-3.8768038728819025
KMH-2,tanespimycin-bortezomib (250-1 mol-mol),-0.7573218655291942
KYSE-510,44489675,3.7222677855122406
D283 Med,44491742,3.738153910971064
SK-MEL-2,24797083,1.36450464232491
D283 Med,409805,5.788391613893814
KYSE-510,25183872,-1.3704539237739704
KMH-2,1750826,-2.4192360478715877
PLC/PRF/5,54619267,3.887834563499544
TC-71,16736978,1.8459401896205945
PLC/PRF/5,241158,3.973842744350964
HuP-T3,10302451,3.3244038223924868
HEC-108,serdemetan-SCH-529074 (1-1 mol-mol),2.423945319779485
BT 112,135398516,1.757671095611884
SK-MEL-2,24821094,4.0114427646580735
PC-14,JQ-1-navitoclax (2-1 mol-mol),0.2990026517861892
AsPC-1,46398810,3.192713565122567
NUGC-3,23582824,2.339817107988292
NUGC-3,5470400,-2.6097310428867964
GSS,55508,0.5466838752127162
KMH-2,4917,2.732041462419925
KYSE-510,3038522,2.2311138116296427
TC-71,6914657,-6.3080462386076945
BC-3C,selumetinib-JQ-1 (4-1 mol-mol),2.3865928246681336
CML-T1,73707440,4.384977554594534
HuP-T3,9866186,1.729562359157257
CML-T1,445091,4.10308804654236
AsPC-1,445091,6.474898015897582
KMH-2,2749,1.5222101236039662
AsPC-1,16720766,4.029008761480653
PLC/PRF/5,25262965,-1.2503212879718717
PLC/PRF/5,11656518,1.9745018977810604
REC-1,9803433,3.0512092518172844
REC-1,selumetinib-vorinostat (8-1 mol-mol),5.79386517083513
AsPC-1,6438330,3.2823568933486196
HEC-108,1750826,1.2012751309541916
GSS,446155,1.4482948295865756
KMH-2,5566,2.7230843575338737
PLC/PRF/5,vorinostat-navitoclax (4-1 mol-mol),1.7032987613361263
AsPC-1,6610216,4.465191830296224
HEC-108,25262965,0.7530764000502068
BC-3C,57519531,4.177086111384941
KMH-2,16725315,3.688730447598931
AsPC-1,135421197,1.8824248695595285
D283 Med,11640390,0.8547144759523356
BC-3C,44566777,0.6929910972078998
TC-71,5284616,3.0629334383975473
GSS,11626560,0.5461644373107777
CML-T1,52947716,-5.195799479557534
PC-14,selumetinib-tretinoin (2-1 mol-mol),2.1541105166477017
REC-1,11427553,3.0944904675195133
HuP-T3,9840324,6.187364891887578
CML-T1,6438330,0.4811462042672619
PE/CA-PJ15,135659046,3.5653102065107176
PE/CA-PJ15,selumetinib-MK-2206 (8-1 mol-mol),1.4968211304792731
CML-T1,11626560,-0.8907703496754931
PLC/PRF/5,51039095,3.746298446982899
NUGC-3,15547703,3.0207395575776967
TC-71,5281321,0.7405109752052328
PLC/PRF/5,44543605,3.6659118638085273
KYSE-510,135875424,3.1467699489442182
PC-14,11977753,1.0998869929301478
KMH-2,638278,2.326730208589123
AsPC-1,5746,2.3674241916356755
KYSE-510,53325874,4.405288748749101
AsPC-1,5329102,1.9734309343360383
PE/CA-PJ15,208908,0.9831396466916148
GSS,1716436,2.886558922325692
NUGC-3,445455,4.201229532647445
KYSE-510,10127622,5.680903160617682
GSS,ISOX-bortezomib (250-1 mol-mol),-1.1241768139975847
PLC/PRF/5,navitoclax-pluripotin (1-1 mol-mol),0.5270372791095314
D283 Med,navitoclax-birinapant (1-1 mol-mol),0.5906558429150628
GSS,71680916,4.384156325288738
CML-T1,24951314,-0.110872768404616
PE/CA-PJ15,9911463,4.11474968197752
GSS,3384730,1.1474950705791862
PC-14,44202524,1.5372693250421796
HuP-T3,5470400,-0.4965810223867313
KYSE-510,9826308,0.2597027427853381
BC-3C,375860,-0.2868729036934795
D283 Med,11625818,3.5261927376586626
GSS,SNX-2112-bortezomib (250-1 mol-mol),-2.5210833382495337
GSS,168312962,-1.0246125778069757
AsPC-1,11228183,2.8237254667802474
GSS,salermide-PLX-4032 (12-1 mol-mol),4.6841598312499855
BT 112,216345,1.4586490487599502
TC-71,11396600,3.405164109661843
KYSE-510,9926054,1.8672783124576204
PLC/PRF/5,448949,1.819458572880246
AsPC-1,46199207,3.695579616421397
KMH-2,24785538,0.2368793011459556
NUGC-3,9936388,-6.309971467031446
BC-3C,11494412,2.054977599436637
IMR-32,tretinoin-navitoclax (4-1 mol-mol),-0.1167947306922327
PLC/PRF/5,12001922,2.4212466115662368
BC-3C,2858523,3.0900467023158567
KYSE-510,sirolimus-bortezomib (250-1 mol-mol),0.7044078807643728
KP-3,5280436,3.7613317976791425
CML-T1,241158,2.0968023336421227
BC-3C,24901704,4.4163964520853805
BT 112,25183872,-1.8103797909861916
GSS,568763,-0.5093320638602902
TC-71,2113511,5.770471757880944
KP-3,5287620,-2.370573295409063
PLC/PRF/5,216468,3.117835212561905
HuP-T3,11455910,1.0919804440303738
IMR-32,2945648,1.7095342073575848
NUGC-3,44202524,1.4553651524358762
CML-T1,20959075,-3.2800173274392983
KP-3,5311,1.5562824681992855
AsPC-1,6852167,3.622461858977091
NUGC-3,49793307,-2.4624005955679316
D283 Med,11167602,1.7563320025634743
HuP-T3,5287969,-2.0305885584054693
BC-3C,5328940,1.5229020385698266
CML-T1,71304818,1.5782846307483736
AsPC-1,25126798,4.196072723195887
IMR-32,5978,-3.045237647024598
CML-T1,9911830,-1.528510322337235
BT 112,448949,1.863535813652351
KMH-2,9866186,-0.3606868682849701
PLC/PRF/5,3385,6.107653459973532
AsPC-1,44202524,5.110549363526631
PC-14,375860,-0.4543940661648492
SK-MEL-2,7251185,3.090040795487297
SK-MEL-2,262093,3.2801506390546225
NUGC-3,46843906,2.8878078445031052
CML-T1,702558,3.0833664933254235
KMH-2,66577038,2.1103594166698483
AsPC-1,9933475,2.7319135281095908
KMH-2,JQ-1-navitoclax (2-1 mol-mol),0.3677156255237743
KMH-2,2828334,5.602104318797055
AsPC-1,24772860,0.3605797719579043
HEC-108,10385095,1.228149017066595
KMH-2,2841722,5.090397309151612
AsPC-1,24901704,4.152315193440913
NUGC-3,51037431,5.202516756892299
PLC/PRF/5,6918878,3.7165774660165023
SK-MEL-2,44566777,1.1693923855033086
GSS,10427712,3.697999165054243
AsPC-1,10296883,4.32215490848641
NUGC-3,selumetinib-BRD-A02303741 (4-1 mol-mol),6.647283967483016
BC-3C,216239,1.867815006623664
IMR-32,selumetinib-tretinoin (2-1 mol-mol),3.623951247347857
D283 Med,54619267,3.614000477543864
NUGC-3,241158,4.199647797705153
SK-MEL-2,51039095,3.9609708573660254
BT 112,44185566,2.3471539577419835
NUGC-3,56963564,0.7969993684000385
NUGC-3,navitoclax-piperlongumine (1-1 mol-mol),2.047655849663459
BT 112,decitabine-navitoclax (2-1 mol-mol),5.309394661219557
KMH-2,vorinostat-carboplatin (1-1 mol-mol),1.58568108614195
GSS,675434,3.954967904904104
PC-14,119182,-2.1067175342920925
PC-14,9967941,4.035370880169342
IMR-32,46398810,1.744942055136264
PC-14,carboplatin-etoposide (40-17 mol-mol),3.6148280985374193
PLC/PRF/5,11955716,-2.1974947878153146
BT 112,387447,-5.550366096650992
SK-MEL-2,3634881,3.4291754860690866
NUGC-3,25183872,-1.0817418808194064
PE/CA-PJ15,56963564,0.3057615147183591
NUGC-3,322968,3.8530153072800855
HEC-108,11175137,3.357797200724247
TC-71,25195348,3.239287869489777
IMR-32,4477,0.65093547041199
PC-14,4261,1.859443898930513
PE/CA-PJ15,10074640,3.294429044375617
TC-71,navitoclax-birinapant (1-1 mol-mol),1.407706418712655
IMR-32,23635314,-6.370110019296166
CML-T1,5738263,2.8352523784169525
HuP-T3,JQ-1-vorinostat (2-1 mol-mol),0.3185506624165122
HEC-108,654092,0.6558774071347439
TC-71,135440466,1.4028530025263657
REC-1,67291369,4.7132158410784335
KYSE-510,11178236,-2.37576544899856
BC-3C,5351362,1.2214820356422638
HuP-T3,BRD-A02303741-navitoclax (2-1 mol-mol),4.136817383870447
TC-71,salermide-PLX-4032 (12-1 mol-mol),5.438165089220917
CML-T1,9840324,5.6593047828259495
KYSE-510,2708,4.949325553929874
KP-3,vorinostat-carboplatin (1-1 mol-mol),4.061540115833001
PLC/PRF/5,446155,1.3842369105164714
KYSE-510,24775005,4.208183150740286
HuP-T3,25183872,-1.5149537087973208
NUGC-3,11497983,4.403536655740841
AsPC-1,969516,2.9281765712067447
PE/CA-PJ15,285033,-2.5479033681234258
PE/CA-PJ15,135875424,3.5762101924458585
CML-T1,9936388,-6.3994005254305995
BC-3C,67291369,6.085070970208458
AsPC-1,51039095,3.058915175873227
KYSE-510,24856436,1.579191955678064
KP-3,3025986,-0.2402974624298327
KYSE-510,65064,5.781452779579058
CML-T1,6918878,-0.7643857619236708
D283 Med,JQ-1-carboplatin (1-1 mol-mol),3.772418054249175
TC-71,4788,3.855302893625856
BT 112,44607531,0.6377481559529096
BC-3C,5470400,5.901198207811197
PLC/PRF/5,151289,1.433153813655942
NUGC-3,219104,4.066719314482466
D283 Med,tanespimycin-gemcitabine (1-1 mol-mol),-4.72619951673043
KYSE-510,11427553,3.768822907052048
BC-3C,285033,-3.4039827877287756
PE/CA-PJ15,50905018,5.401121647936095
GSS,9866186,0.3766521276573631
NUGC-3,23635314,-2.075682950311756
PE/CA-PJ15,5566,3.0835355928329395
HEC-108,5282054,4.01625624429958
KMH-2,9935249,3.3935783727628426
BT 112,42642645,0.6970367427086502
AsPC-1,71304818,2.27524368423619
REC-1,6450551,3.361583238713797
CML-T1,JQ-1-UNC0638 (2-1 mol-mol),0.1970824478028413
CML-T1,44543605,3.785822858271075
CML-T1,89183176,3.024950752568636
AsPC-1,12001922,2.2862775547931675
KP-3,12003241,-0.3092638329597765
HuP-T3,262093,3.018266583248783
KYSE-510,9887053,4.757989021138123
KYSE-510,25150857,3.987568988377749
HEC-108,44620216,4.0504389741939635
TC-71,7251185,3.0201536010805334
PC-14,10231331,0.5461377223152567
AsPC-1,322968,4.827920048367381
PLC/PRF/5,12003241,0.8244509806325866
AsPC-1,11238147,2.0906654911229796
AsPC-1,568763,2.040921390287386
BC-3C,2126,4.812461440359688
KYSE-510,49793307,0.4281536807005762
IMR-32,vorinostat-navitoclax (4-1 mol-mol),-1.4498537602059711
AsPC-1,135875424,4.124114476494282
KYSE-510,11238147,4.511708704127056
PE/CA-PJ15,73707398,0.9467877501744384
NUGC-3,89183176,4.138880829261935
PE/CA-PJ15,71751553,4.310591125974167
D283 Med,126941,-4.12717690100812
KYSE-510,45279963,4.003876039547263
AsPC-1,135421197,1.8824248695595285
GSS,5282054,3.147086617125536
KP-3,JQ-1-vorinostat (2-1 mol-mol),1.5663032703740083
TC-71,9956119,3.998275978065295
PC-14,54618164,4.181975842638425
HuP-T3,5311,2.274555641774389
IMR-32,375860,-2.054219262250898
AsPC-1,148198,-3.729188282050714
CML-T1,25126798,3.796147395391691
BC-3C,31703,1.0531871666088966
CML-T1,9956119,2.073633266475815
CML-T1,5329102,0.8946748960608596
PC-14,vorinostat-carboplatin (1-1 mol-mol),2.3386153603186517
AsPC-1,56946209,-4.100794030874608
AsPC-1,44137675,4.002233175780649
TC-71,322968,4.479083613321321
HuP-T3,71304818,3.5647709327393287
AsPC-1,9935249,3.639166614114404
AsPC-1,navitoclax-pluripotin (1-1 mol-mol),0.1867529421630529
KYSE-510,6918837,-0.6488492574479466
REC-1,3689413,1.860618150322578
NUGC-3,409805,4.126577550423276
HuP-T3,9933475,3.0776536859408807
CML-T1,168313047,1.9633067789473095
TC-71,31703,-1.6789713944802074
CML-T1,72734382,3.1811123479261276
PC-14,36314,-5.605050726088523
KP-3,49766530,-2.4187443119050904
BC-3C,89928392,3.068450270772866
KYSE-510,selumetinib-GDC-0941 (4-1 mol-mol),1.3541576401803423
REC-1,9887053,4.003103851529854
TC-71,122327,5.601666051446012
KMH-2,11178236,-2.554107614991997
NUGC-3,3689413,0.9569280148265664
NUGC-3,53392493,2.54845348231856
HuP-T3,3689413,-1.422602865458103
CML-T1,216345,1.8584843601432488
KYSE-510,216239,1.800001299703895
KYSE-510,54618795,3.7136664764316127
AsPC-1,3854666,3.565227366628202
PLC/PRF/5,15547703,3.081119751403267
CML-T1,135421197,0.9317392273651705
AsPC-1,10074640,3.638861482782184
BT 112,89928392,0.5920656256018224
BT 112,11222830,1.5105140978241234
IMR-32,4788,4.830021067218355
BT 112,selumetinib-UNC0638 (4-1 mol-mol),4.250486145990314
AsPC-1,11656518,2.0782041289904845
BC-3C,135875424,4.794032428578798
AsPC-1,11707110,-3.3734075653106506
CML-T1,3815108,1.7472513397157303
TC-71,44486219,4.324113584159778
BT 112,25102847,2.5247869657619395
SK-MEL-2,168313200,3.8202183973722144
KMH-2,9825149,2.2749474319771648
BT 112,9907093,5.482705363653191
PLC/PRF/5,11396600,2.8035721911913645
AsPC-1,25062766,3.1635616497742283
PE/CA-PJ15,tanespimycin-gemcitabine (1-1 mol-mol),-2.5021526295064356
AsPC-1,9840324,5.861158829716173
SK-MEL-2,4378219,3.1510075145048644
PE/CA-PJ15,5281321,-0.9819012025134504
PLC/PRF/5,10322450,3.983384699735352
KYSE-510,9866186,0.6465909128042013
CML-T1,11964036,0.6626338262041811
PE/CA-PJ15,selumetinib-PLX-4032 (8-1 mol-mol),3.579969697697414
PE/CA-PJ15,2945648,3.047957601160832
PC-14,5566,3.0914991862540333
NUGC-3,4788,5.824969392569313
HEC-108,16722836,2.6260322097351447
PE/CA-PJ15,126941,-4.198683985585476
D283 Med,15983966,-4.384389226245483
PC-14,selumetinib-vorinostat (8-1 mol-mol),1.2532439157087734
KYSE-510,54618164,5.681734700355768
CML-T1,vorinostat-navitoclax (4-1 mol-mol),0.0862805898320609
KYSE-510,4578,4.554613045268205
SK-MEL-2,navitoclax-pluripotin (1-1 mol-mol),0.1902174859900846
IMR-32,tanespimycin-gemcitabine (1-1 mol-mol),-4.8655579808353835
KYSE-510,7326481,3.0936043842813485
AsPC-1,53232,3.925663364010775
PLC/PRF/5,selumetinib-tretinoin (2-1 mol-mol),6.995372412821593
NUGC-3,387447,-2.9848094100296283
KMH-2,208908,1.5627974363378532
D283 Med,5291,3.8993292084473814
KMH-2,JQ-1-vorinostat (2-1 mol-mol),0.2759899908588843
D283 Med,6918328,-4.962430098316081
GSS,11497983,1.538927772575629
KP-3,1641662,3.91303788853309
KP-3,44589607,3.759468778414478
GSS,46398810,1.7712487939531856
PLC/PRF/5,252682,6.946748419277584
HEC-108,216345,4.4823048447920755
PE/CA-PJ15,241158,3.6544935074881586
AsPC-1,56973724,5.500241353025212
PC-14,6917907,-7.815617224147094
PE/CA-PJ15,selumetinib-GDC-0941 (4-1 mol-mol),-0.1113612810066529
PC-14,selumetinib-decitabine (4-1 mol-mol),1.378488741424842
IMR-32,5311281,0.8394278615563535
PLC/PRF/5,11364421,-3.990513021072169
PE/CA-PJ15,11178236,-3.3152218482507867
TC-71,168312962,-1.006241963036675
BC-3C,docetaxel-tanespimycin (2-1 mol-mol),0.937456814485436
BC-3C,10184653,1.8423660317885069
SK-MEL-2,448949,1.9137656912654937
AsPC-1,374536,-1.7506249493921369
AsPC-1,9907093,4.363482739155403
KMH-2,159324,1.5423120810193625
KYSE-510,246676,4.677306022279273
PC-14,9927531,4.079128694018213
BC-3C,11175137,2.6274322047570307
HEC-108,3543504,4.706207337036549
KYSE-510,10184653,2.23177858509392
IMR-32,11213558,1.0218437510968257
D283 Med,11964036,0.8770173052283631
KP-3,54649381,3.7166707762390385
PE/CA-PJ15,65628,4.3455180568825025
HuP-T3,navitoclax-gemcitabine (1-1 mol-mol),2.4880623143443965
D283 Med,52947716,0.9658281246971616
AsPC-1,11719255,5.644609733763846
AsPC-1,44566777,0.4941234322675649
PE/CA-PJ15,5280436,2.1166954192920677
GSS,24964624,1.2664902184830518
IMR-32,3384730,1.043970126546716
AsPC-1,5311,1.9705564216623497
AsPC-1,24951314,2.0738112971970275
SK-MEL-2,24856436,0.8500320632837244
KP-3,2113511,5.813704134045976
HEC-108,89928392,1.8334971858898483
GSS,9929138,2.058801232137709
GSS,16725315,3.472607349009777
PC-14,49850262,4.082010069589332
TC-71,11175137,1.9918759437235851
PE/CA-PJ15,24775005,3.768261378939309
KMH-2,5978,-1.6147166653692522
NUGC-3,168313047,2.211649946318512
GSS,11717001,4.298067990238408
HuP-T3,4788,5.894927949545096
BT 112,46174525,4.318783265075236
PE/CA-PJ15,72734382,6.1223876525140914
BC-3C,9915743,1.1334859275806484
BC-3C,16659841,3.888281429771044
HEC-108,445455,5.031008976461082
CML-T1,3503,1.2439697949752524
BC-3C,4917,3.0321571740464117
BC-3C,25105715,3.736683888359909
AsPC-1,637858,2.8111542457272605
IMR-32,46191454,-0.7065529533745926
KP-3,15953870,3.990399169996875
NUGC-3,selumetinib-GDC-0941 (4-1 mol-mol),1.725630389990751
D283 Med,216239,2.1724575702857
D283 Med,9927531,3.2144716566788745
BC-3C,44491742,3.863176048034213
SK-MEL-2,60750,5.399063219277862
KMH-2,135411,0.0392364050134285
IMR-32,702558,3.03620954549747
TC-71,9933475,2.3904291637713
D283 Med,448949,1.5195328538607995
IMR-32,3038522,1.601494990114808
GSS,439501,-2.3619517329640782
CML-T1,16725315,3.685793664289718
KMH-2,10113978,1.9769897773276333
AsPC-1,107970,2.236934549480267
HEC-108,54618771,2.78064765565191
BT 112,53495165,-3.2644950718857255
GSS,5280436,3.581985900917063
PLC/PRF/5,9935249,3.446956558470987
PE/CA-PJ15,65064,5.660757119379924
PE/CA-PJ15,3038522,3.112992871822826
GSS,71466380,3.195482829886122
AsPC-1,42642645,1.2436203489585118
PLC/PRF/5,49793307,-1.2494059838705176
HuP-T3,vorinostat-carboplatin (1-1 mol-mol),4.326832101925159
BT 112,637858,1.3708104354326625
SK-MEL-2,25183872,-1.7332559783932406
BC-3C,3081361,2.1919829055875346
CML-T1,11167602,0.5863351465273275
PLC/PRF/5,23725625,4.071749460097811
GSS,23635314,-1.4897897951669024
PLC/PRF/5,44486219,4.4704442969329
TC-71,107985,-3.2735823603491987
KP-3,5291,3.900265250367686
CML-T1,24753719,1.910679313408318
KMH-2,5113032,5.224680794267088
HuP-T3,60750,3.212181181151216
KMH-2,navitoclax-MST-312 (1-1 mol-mol),1.0941690336919907
TC-71,navitoclax-MST-312 (1-1 mol-mol),2.4036180623797385
CML-T1,6918837,-4.73728443815153
KYSE-510,10302451,5.138407368996928
NUGC-3,5287620,-2.5010032932640933
CML-T1,9903786,2.526700219209825
KYSE-510,44185566,3.076765215314321
CML-T1,49850262,2.3003389318393404
PE/CA-PJ15,11152667,-0.7034244137409247
PLC/PRF/5,5470400,-0.2064372952544378
PE/CA-PJ15,1239801,3.8964030609370446
PE/CA-PJ15,11427553,3.0001109261894983
KYSE-510,51037431,1.874705558116675
PC-14,navitoclax-piperlongumine (1-1 mol-mol),1.8502903613096509
CML-T1,ISOX-bortezomib (250-1 mol-mol),-0.7676441178316211
HEC-108,5746,2.057736968957512
IMR-32,426756,1.487905565263738
GSS,6252,-0.6783759496152978
KP-3,5311281,4.894081294772208
PC-14,55508,2.800196673961477
KP-3,2749,5.709851837562526
PE/CA-PJ15,44607531,0.9744795313801364
KYSE-510,445643,4.2930648359891785
REC-1,3062316,3.031590043339633
HuP-T3,tretinoin-navitoclax (4-1 mol-mol),4.772875046445671
IMR-32,135421197,0.1202799185207932
PE/CA-PJ15,navitoclax-sorafenib (1-1 mol-mol),3.0607110817671885
HuP-T3,5328940,2.3682781464336147
CML-T1,11234052,1.4016611587884042
PC-14,10113978,1.875995802268999
KMH-2,6505803,-1.1271558599433815
PE/CA-PJ15,5282054,4.554221037529222
AsPC-1,23725625,6.32859301599116
D283 Med,135875424,3.0041212409823053
CML-T1,11656518,-0.3565307280161567
BC-3C,navitoclax-sorafenib (1-1 mol-mol),1.214401011814799
AsPC-1,24964624,2.5492070232527424
IMR-32,216239,1.7675164480853849
KYSE-510,5329102,3.506015893473117
GSS,3552672,3.482100422552061
PE/CA-PJ15,3634881,3.545664118415659
SK-MEL-2,10184653,1.840677228292894
REC-1,16722836,1.7227474141732009
PE/CA-PJ15,11364421,-5.742721831490082
AsPC-1,613753,3.1774382169580355
IMR-32,26596,-3.972445110403932
BT 112,11485656,1.9046121738712176
PC-14,126941,-2.146825063130458
BC-3C,25183872,-0.1234485282606677
NUGC-3,5460769,1.9333841225118369
IMR-32,JQ-1-MK-0752 (1-1 mol-mol),0.34348071798695
D283 Med,135398738,4.108910630376311
HEC-108,54613361,0.1609074083651108
HEC-108,piperlongumine-MST-312 (1-1 mol-mol),1.556813220853092
CML-T1,9907093,3.685523679081733
PC-14,10410894,3.112460950624989
BT 112,44489675,3.682584405613984
D283 Med,135398516,0.8377293343644862
BC-3C,11719255,3.525023530055355
PC-14,72376,-2.4231616771308047
BC-3C,tretinoin-navitoclax (4-1 mol-mol),3.9057385314373647
D283 Med,tanespimycin-bortezomib (250-1 mol-mol),-0.3446270457541043
PC-14,2708,4.06004152790413
HEC-108,2708,6.110657664739327
PLC/PRF/5,107985,-2.4767035195687304
KYSE-510,25105715,3.736006589183936
BT 112,JQ-1-navitoclax (2-1 mol-mol),4.422337220171912
AsPC-1,crizotinib-PLX-4032 (2-1 mol-mol),1.9702112350407297
AsPC-1,44493528,4.313387127964929
CML-T1,6610216,3.6071739537574863
NUGC-3,56946209,-4.377885836795028
CML-T1,navitoclax-birinapant (1-1 mol-mol),0.167080687914587
AsPC-1,4261,2.35820288641389
PC-14,445091,5.963684061014051
AsPC-1,53325874,4.506725704395743
KYSE-510,9884685,1.452172872973614
BT 112,BRD-A02303741-navitoclax (2-1 mol-mol),4.211528826599794
PC-14,54618771,1.2873092129984136
TC-71,11364421,-5.9201938141651675
CML-T1,16741245,3.55536863016822
BC-3C,5329102,2.065688125302431
KYSE-510,5738263,3.796434617535653
GSS,25154868,3.2349416355243865
KYSE-510,6184667,2.7549263728466076
PC-14,6450551,1.723712317687973
PLC/PRF/5,135398516,2.0536550313444115
CML-T1,11609586,-0.1617986940719625
TC-71,SNX-2112-bortezomib (250-1 mol-mol),-2.109028735278536
HEC-108,969516,3.1177295269090664
KMH-2,6918878,1.3262621039986062
IMR-32,4096211,1.198413533077926
AsPC-1,49793307,-1.0458597957041098
TC-71,6450551,1.358788910777725
SK-MEL-2,387447,-4.977672858008192
BT 112,navitoclax-piperlongumine (1-1 mol-mol),3.2143536144775084
SK-MEL-2,5281321,-2.884396164754634
IMR-32,JQ-1-carboplatin (1-1 mol-mol),0.0356823782644729
KYSE-510,11455910,0.588334409452975
PE/CA-PJ15,5460769,-0.4178373813349113
D283 Med,445455,1.4902396217257328
HuP-T3,5738263,4.055810266621769
HEC-108,1641662,3.2650548064529237
BT 112,46215462,1.7689414169857487
TC-71,11427553,1.6172562595840143
HEC-108,135398516,2.4406871230924385
IMR-32,2113511,4.951640128540397
IMR-32,25150857,1.03956288088766
PE/CA-PJ15,5978,-6.95712328026761
PE/CA-PJ15,1242560,3.1315569486629315
PE/CA-PJ15,613753,3.2873816903354083
SK-MEL-2,135440466,3.518713620628013
PE/CA-PJ15,16013152,4.170385211383189
REC-1,5335621,5.583215213785345
BT 112,5328940,1.9807564403861109
REC-1,5278396,3.353742403077532
KYSE-510,54618771,0.5023256188939713
PC-14,6918837,-4.156310961446877
KMH-2,46191454,0.7646488495082653
AsPC-1,11640390,5.159931420709134
BC-3C,44185566,3.2238554830097517
HEC-108,24978538,-0.9824677506425258
HEC-108,10302451,3.916028655528669
PE/CA-PJ15,53392493,2.944433696457154
PC-14,selumetinib-UNC0638 (4-1 mol-mol),2.495606970321077
CML-T1,387447,-5.712019248069361
PC-14,3503,2.6027668022878134
AsPC-1,2749,1.937127114514975
D283 Med,6918878,0.6524959368526162
NUGC-3,72734382,4.564427334987343
BT 112,9933475,1.5933394130611254
PLC/PRF/5,16736978,1.9877100266718313
TC-71,6252,0.6507643358566317
BT 112,73707398,0.9645515230778364
AsPC-1,selumetinib-piperlongumine (8-1 mol-mol),2.3106029653407276
HuP-T3,2828334,6.159425491986346
PLC/PRF/5,selumetinib-piperlongumine (8-1 mol-mol),4.6011425455067405
PC-14,26596,-1.584314299248499
D283 Med,10113978,2.100289947071623
GSS,10302451,2.0776350865742623
HEC-108,5278396,3.63044129466019
TC-71,3854666,1.5564077538227652
AsPC-1,446155,5.1652347554602995
KP-3,123631,2.348787876732731
AsPC-1,16659841,4.5181069426631
PLC/PRF/5,66577038,3.08567157605167
PE/CA-PJ15,11396600,3.3444318017760986
D283 Med,11647372,0.822685670820016
PE/CA-PJ15,5470400,-0.0617904370996869
PLC/PRF/5,4788,5.088915656736264
KYSE-510,2733526,3.372399595723863
AsPC-1,44202524,5.110549363526631
PLC/PRF/5,44607531,2.230602664594125
KP-3,9903786,3.3194843074548843
IMR-32,1566236,1.2008370083057098
AsPC-1,1242560,3.922175022537436
D283 Med,11152667,-1.23900039901842
KMH-2,11364421,-4.893528283668471
KP-3,4917,3.138622063765874
KP-3,216239,2.374250027754081
D283 Med,9823820,3.71007725808951
KYSE-510,4705,3.5266968051066856
D283 Med,selumetinib-navitoclax (8-1 mol-mol),1.217940754144839
GSS,638278,3.026573609399736
PC-14,124202324,1.9145516901942
NUGC-3,3385,3.8284060465456062
GSS,3854666,0.8019328802169965
AsPC-1,tanespimycin-gemcitabine (1-1 mol-mol),0.4479893231727763
KYSE-510,10427712,5.645374533963565
PE/CA-PJ15,375860,-0.3600146700827705
IMR-32,46907787,-0.8465098966903165
BT 112,4261,1.960966237703145
IMR-32,322968,1.8551733212144244
HuP-T3,40482356,5.071639396405957
SK-MEL-2,11152667,-0.6797547387468098
HEC-108,tanespimycin-bortezomib (250-1 mol-mol),0.6287218196429517
CML-T1,135928012,3.921778036516406
KP-3,SNX-2112-bortezomib (250-1 mol-mol),-2.18950982339932
PE/CA-PJ15,1716436,3.7079819536891554
GSS,6918837,-4.54080628702949
D283 Med,6252,-2.3531201064109526
PC-14,17759555,1.6519344508674516
AsPC-1,11656518,2.0782041289904845
BT 112,10296883,3.9999728699442607
KYSE-510,54678924,3.4324962907495964
GSS,JQ-1-MK-0752 (1-1 mol-mol),-1.5123687798012648
BC-3C,66577038,3.123738397831446
HEC-108,15983966,2.2350760521339024
HuP-T3,2945648,2.5475895191101197
TC-71,piperlongumine-MST-312 (1-1 mol-mol),2.528521680159404
HEC-108,11625818,4.313201084341855
TC-71,24180125,3.7432821305045545
SK-MEL-2,72376,-0.3175424925605319
GSS,16741245,2.5988612558116375
BC-3C,23635314,-4.057242995028073
PE/CA-PJ15,136227331,4.888188791536357
HuP-T3,54618164,3.3933985234085755
KP-3,11717001,4.714706744036414
HEC-108,31703,-0.7744900613716049
PE/CA-PJ15,9823820,4.4065530992073
KMH-2,10302451,3.711688985022062
AsPC-1,9911463,3.4970941612274693
CML-T1,675434,3.803383794807122
CML-T1,71466578,2.784294880886227
IMR-32,5311,-0.9820670104921884
KP-3,676352,2.8106194565981877
KYSE-510,11222830,1.972185906682253
HuP-T3,73707398,1.153693297692098
PLC/PRF/5,9956119,4.197215444771073
REC-1,docetaxel-tanespimycin (2-1 mol-mol),6.128904719375764
REC-1,11175137,3.868048003377553
TC-71,11977753,-3.300916447963325
BC-3C,10322450,3.9889152923020537
AsPC-1,11609586,3.135544943212619
PLC/PRF/5,72376,0.0698046634317744
KYSE-510,49766530,3.99865541167158
AsPC-1,3503,2.1995832473977157
REC-1,613000,4.883255539354151
BT 112,5311281,1.2927719080632414
GSS,44491742,4.082096433494501
TC-71,24901704,2.6637342155064685
REC-1,72193861,3.839467453811461
CML-T1,selumetinib-GDC-0941 (4-1 mol-mol),2.3571897890829323
BT 112,5281321,0.9074041531401555
REC-1,25105715,4.2910669876148875
BT 112,25227462,0.01299535421097
BC-3C,51039095,2.5958584996124956
CML-T1,crizotinib-PLX-4032 (2-1 mol-mol),-0.082010794969092
PLC/PRF/5,10385095,1.1350857797892653
KYSE-510,selumetinib-MK-2206 (8-1 mol-mol),3.89161945323662
GSS,alisertib-navitoclax (2-1 mol-mol),-3.7584210736342674
KYSE-510,tanespimycin-gemcitabine (1-1 mol-mol),-1.555673981075483
GSS,16115403,-5.770215516266121
SK-MEL-2,46191454,2.150362505084453
REC-1,613753,5.013136988520993
BC-3C,374536,2.8246931045554473
D283 Med,11234052,3.767459494315311
GSS,25150857,1.6292254621650744
BT 112,10074640,3.3091637914687073
PE/CA-PJ15,42642645,1.5086089624743753
GSS,11612883,1.697379770642959
BC-3C,5284373,3.4422730345980814
TC-71,448949,1.5764874729915268
BC-3C,216345,4.386146842644508
TC-71,JQ-1-UNC0638 (2-1 mol-mol),2.8562026221796635
KYSE-510,12001922,2.4168763157889597
SK-MEL-2,54619267,4.064435085283967
KMH-2,241158,3.3374557271517
KYSE-510,11404337,0.4094464488051804
KMH-2,24772860,-2.338344331022242
AsPC-1,216345,4.477392842458871
TC-71,carboplatin-etoposide (40-17 mol-mol),1.0711420168776016
HEC-108,4788,5.901110925385162
BT 112,135421197,2.023572470173789
CML-T1,2828334,5.888296080725352
NUGC-3,11485656,2.456489968727232
KMH-2,53232,2.4238633478627976
NUGC-3,9444,4.28438078042175
KP-3,selumetinib-GDC-0941 (4-1 mol-mol),1.1487168771210745
AsPC-1,25126798,4.196072723195887
KMH-2,89928392,0.3434587206066553
HEC-108,3025944,5.148490920496766
AsPC-1,16725315,5.210607806565737
NUGC-3,tanespimycin-gemcitabine (1-1 mol-mol),-0.3110991656880211
KMH-2,11175137,2.314084253176101
HEC-108,409805,5.771065107307232
PLC/PRF/5,selumetinib-UNC0638 (4-1 mol-mol),4.8017407635433305
TC-71,753704,4.484790267591646
PLC/PRF/5,54618771,1.111508720136614
AsPC-1,11647372,4.7024563360539675
HEC-108,sirolimus-bortezomib (250-1 mol-mol),0.3537850835558722
KYSE-510,637858,3.0396411206635516
NUGC-3,6918837,-1.9489805586763604
NUGC-3,17759555,2.4110082673089748
KYSE-510,selumetinib-vorinostat (8-1 mol-mol),3.1641046161129376
TC-71,6610355,3.639698123960083
REC-1,9908783,5.154056177198126
AsPC-1,1716436,2.9196038383716205
KP-3,44607531,1.6245069102773584
TC-71,25154868,4.936836961802446
PLC/PRF/5,24771867,3.823478811331514
HuP-T3,1716436,3.1901993610711092
KP-3,tanespimycin-gemcitabine (1-1 mol-mol),-0.1354720492622221
SK-MEL-2,navitoclax-PLX-4032 (1-1 mol-mol),3.4942967527041313
PC-14,2949965,3.1436858143877533
KYSE-510,2949965,3.40229991983247
PLC/PRF/5,135411,0.9422586029913752
CML-T1,51037431,4.458839280310569
BT 112,3025944,4.482277488188436
AsPC-1,serdemetan-SCH-529074 (1-1 mol-mol),2.4648978933330232
PC-14,54143018,-1.3029373778236335
GSS,51037431,1.7202547933547585
D283 Med,serdemetan-SCH-529074 (1-1 mol-mol),1.078221364588871
TC-71,135659046,3.771711324789507
NUGC-3,5280436,3.845598360212427
KMH-2,9967941,3.413814046598107
BC-3C,9927531,5.131139518306293
HuP-T3,11717001,4.25253085122872
KP-3,10385095,2.538896937216095
KYSE-510,168312962,-1.76294861905608
AsPC-1,24821094,4.10595231639086
CML-T1,1641662,2.8295390269831464
AsPC-1,9952709,5.897814669584309
KMH-2,11507802,-0.0005253325323591
BT 112,148198,-3.0030353997640074
AsPC-1,81146,4.947223766743442
TC-71,selumetinib-GDC-0941 (4-1 mol-mol),2.572877726139947
D283 Med,400769,-1.1931139995593163
REC-1,6852167,4.364510532165473
AsPC-1,1750826,-1.5700020776253725
BT 112,ISOX-bortezomib (250-1 mol-mol),-0.0253360091538834
IMR-32,alisertib-navitoclax (2-1 mol-mol),-4.507240752220432
GSS,148198,-4.278267230656994
HEC-108,46199207,3.6826733270490646
GSS,12003241,-1.231369265985878
AsPC-1,6918837,-2.7365580441764155
PC-14,2749,1.485867030410151
AsPC-1,3634881,3.56845743908184
KYSE-510,11364421,-3.694039597230251
KYSE-510,10113978,5.808683268152186
HuP-T3,409805,5.703463345532586
AsPC-1,76446078,5.483716778202627
AsPC-1,45279963,4.120012544363151
NUGC-3,53495165,0.516838657942775
PC-14,51039095,2.567022032708071
BC-3C,54618164,4.2924903991284395
PE/CA-PJ15,ISOX-bortezomib (250-1 mol-mol),0.1914462809002973
TC-71,135398516,1.410725034028912
AsPC-1,doxorubicin-navitoclax (2-1 mol-mol),0.4165226995067387
D283 Med,65628,4.590969471061447
REC-1,9549297,1.1033414943534166
TC-71,2126,3.8920568327142497
BC-3C,241158,4.191862782565103
BC-3C,637858,3.302055844369792
BT 112,doxorubicin-navitoclax (2-1 mol-mol),-3.3405934698905555
SK-MEL-2,54454,3.4564157344921296
KMH-2,25195348,3.2079117056805755
TC-71,8515,3.820519321601544
PC-14,11213558,0.2378242160835004
HuP-T3,49793307,-5.3581383477853555
TC-71,10296883,3.4863812877107176
CML-T1,navitoclax-pluripotin (1-1 mol-mol),-4.409543307902375
KMH-2,60750,-4.113460548744094
PC-14,2874250,4.751781896690002
GSS,24856436,-0.9308959794576592
TC-71,6438330,2.717075021751112
PC-14,387447,-3.812338595624124
IMR-32,31703,-4.371309273328438
HuP-T3,erlotinib-PLX-4032 (2-1 mol-mol),4.371591161861475
TC-71,11238147,2.1410321878630905
BT 112,5394,4.526138920769001
BC-3C,11640390,3.0662581213626674
BC-3C,55283,4.203383716181661
HEC-108,56963564,0.296809560260297
KMH-2,docetaxel-tanespimycin (2-1 mol-mol),-4.953459019568371
KMH-2,107970,2.222246268833958
PE/CA-PJ15,53232,2.5776765826269528
PC-14,11152667,-3.213893550122198
IMR-32,445455,3.7416341175321746
TC-71,11404337,-2.7316229346528145
TC-71,10322450,2.6904194400167207
REC-1,8515,2.9172768808189096
CML-T1,44489367,4.494553632990814
PLC/PRF/5,3136844,4.290735112780334
PC-14,alisertib-navitoclax (2-1 mol-mol),-1.0906231063902465
TC-71,119607,5.713901067114308
GSS,31703,-2.517622672173304
NUGC-3,9911463,3.217932170312211
HuP-T3,9935249,3.692881062494191
PE/CA-PJ15,5479543,3.83954766911358
HEC-108,637858,2.449708151119433
GSS,5113032,4.768655166491295
TC-71,11955716,-2.326736792256835
KYSE-510,6252,0.4388197195078833
HEC-108,BRD-A02303741-navitoclax (2-1 mol-mol),1.0152806773342118
TC-71,24753719,4.206568050184285
BC-3C,16219061,3.4762181811015815
D283 Med,6914657,-8.666743136315109
SK-MEL-2,54618164,3.880613274058296
TC-71,3136844,3.85086680688821
CML-T1,322968,2.5082577681036473
NUGC-3,24951314,0.8366303080404784
KYSE-510,11612883,3.606018144278483
KYSE-510,vorinostat-carboplatin (1-1 mol-mol),3.255124328405866
TC-71,100016,6.681443396825605
IMR-32,6917907,-5.81623632053924
HEC-108,16038120,2.2224846611744957
KYSE-510,3081361,3.714302526809718
GSS,151289,0.3152471574412673
HuP-T3,16722836,1.72068374216493
TC-71,11152667,-0.90552312132183
NUGC-3,3025944,4.110215734430488
KP-3,5460769,4.226589336768475
KYSE-510,10322450,3.90855044095945
PE/CA-PJ15,24797083,1.5613893197381916
PE/CA-PJ15,11625818,4.212335485082237
CML-T1,5351362,1.0869507822739353
HEC-108,216468,0.5077016894807419
TC-71,serdemetan-SCH-529074 (1-1 mol-mol),2.8499678436944285
CML-T1,44259,0.1754844857900887
IMR-32,55508,1.4490788326398434
REC-1,216345,2.7910779135508967
REC-1,1716436,3.388391652618184
HuP-T3,11612883,3.639610964764467
BC-3C,10296883,3.936118595707102
SK-MEL-2,11494412,4.029789291760362
NUGC-3,46174525,4.934564355387081
SK-MEL-2,3136844,4.246241998610311
KYSE-510,9907093,5.118339887324728
KP-3,4261,1.3326527073710714
AsPC-1,11364421,-1.021042778985214
D283 Med,613753,3.0929826878056135
HEC-108,9911463,4.37199271437254
D283 Med,168313016,4.168522701530026
BT 112,2945648,1.3917420344498488
KP-3,72193861,-0.2586612801583873
BT 112,3062316,2.6021941524202674
KMH-2,4788,3.979356944296041
NUGC-3,3025986,-0.4571639510324569
KMH-2,carboplatin-etoposide (40-17 mol-mol),0.7571954359380428
REC-1,1750826,2.208787286180855
TC-71,262093,3.008445971803391
PC-14,11626927,1.825278064370036
BC-3C,11977753,-3.323592343676236
IMR-32,11656518,1.1863889584189269
KMH-2,135440466,2.7627804900872266
NUGC-3,2746,2.5957810637319625
BC-3C,5291,4.048899787640436
D283 Med,60750,-5.2447634258495155
HuP-T3,SNX-2112-bortezomib (250-1 mol-mol),0.0780901353743998
REC-1,5284616,3.779450255031602
D283 Med,11214940,-0.7958287739094837
REC-1,9936388,3.0128299108104306
IMR-32,6918328,-2.563540464533447
BT 112,3854666,0.1986005618410543
PC-14,17755052,2.3851104377198995
HuP-T3,2746,4.662800576379415
PE/CA-PJ15,11494412,-0.2051245265419709
REC-1,46398810,4.241593479202957
IMR-32,9887053,1.6349533965413043
HuP-T3,3552672,1.4793505278318
CML-T1,3081361,0.8904525598046117
HEC-108,36314,3.0566190608483015
CML-T1,216239,1.5759445467703133
PC-14,navitoclax-gemcitabine (1-1 mol-mol),0.487794635289785
HEC-108,5280436,4.260553189863144
BT 112,57519531,1.0837379770359268
AsPC-1,176870,5.289710540069244
KYSE-510,salermide-PLX-4032 (12-1 mol-mol),4.880806253004285
CML-T1,135440466,1.4712310181015782
BT 112,2858523,2.609953955894282
PLC/PRF/5,selumetinib-GDC-0941 (4-1 mol-mol),2.3628622666013683
GSS,17755052,0.971243204633715
CML-T1,24785538,1.8797614633691848
HuP-T3,148198,-3.5090934063696153
PLC/PRF/5,6184667,1.7464147598315043
D283 Med,3062316,1.834992436946839
HuP-T3,6917907,-1.7519392074642692
KMH-2,5278396,2.550508189743561
CML-T1,25062766,1.440222571379222
KYSE-510,erlotinib-PLX-4032 (2-1 mol-mol),3.67790622709582
PE/CA-PJ15,262093,3.193957949465754
PC-14,11396600,4.745127634228124
IMR-32,6505803,0.9080588170181416
BC-3C,5278396,3.729729139306519
BT 112,selumetinib-tretinoin (2-1 mol-mol),5.260723410115697
D283 Med,sirolimus-bortezomib (250-1 mol-mol),0.1311503224086672
PC-14,3385,4.025433343560732
AsPC-1,10074640,3.638861482782184
BT 112,11640390,4.0217292152504
AsPC-1,15953870,5.362858272792295
HEC-108,11427553,3.7826747165213086
KYSE-510,135421197,2.241265348212864
CML-T1,3025986,-2.237853890359125
HuP-T3,462382,0.4397112913332706
SK-MEL-2,11238147,3.719914867098992
D283 Med,53245473,4.5476493386622625
PLC/PRF/5,45279963,3.757521856111735
BT 112,5113032,4.617227577008262
GSS,409805,3.734629262000393
TC-71,54618771,1.220599365734416
TC-71,4261,1.4573540513016077
PE/CA-PJ15,151289,0.6596724768960354
BC-3C,navitoclax-PLX-4032 (1-1 mol-mol),2.5760778365514785
GSS,15953870,2.249610266987025
PE/CA-PJ15,6918638,0.9363103788474072
IMR-32,5278396,3.356655857212658
PE/CA-PJ15,15983966,-4.408426759241299
IMR-32,65064,5.443607579901783
HEC-108,25150857,3.0835964658841246
SK-MEL-2,10302451,4.273835624093029
CML-T1,31703,-3.375342626899218
TC-71,3825829,4.097679921403836
TC-71,71466445,3.509629418813805
PE/CA-PJ15,navitoclax-pluripotin (1-1 mol-mol),-1.160938191480762
TC-71,16065773,3.3687508255977594
GSS,969516,2.3232998651568977
KP-3,107970,2.4048716428801677
REC-1,73707438,4.744631332095545
AsPC-1,5746,2.3674241916356755
PC-14,219104,4.7491354511551345
KP-3,135440466,2.589306452051924
REC-1,3825829,3.4040065823648877
BT 112,24797083,1.2381958000259223
TC-71,9911830,2.32382211110597
TC-71,tanespimycin-bortezomib (250-1 mol-mol),0.107717273209992
KYSE-510,25126798,3.99511895853666
KMH-2,5460769,1.5529919827376786
KYSE-510,285033,-1.833426029356953
BC-3C,16725315,5.3177180390506225
NUGC-3,36462,0.7786329645465295
KYSE-510,216468,3.461908605752232
PC-14,5311,0.5745844674676404
D283 Med,984333,-2.902754645088125
BC-3C,JQ-1-navitoclax (2-1 mol-mol),0.6028645544836561
TC-71,24785538,-1.2946892854803618
AsPC-1,24772860,0.3605797719579043
BC-3C,5738263,2.5075252261663223
PE/CA-PJ15,53481919,3.924471054520181
KP-3,969516,2.9201293282085894
BT 112,56946209,-5.137911214748189
AsPC-1,285033,-0.5419823336362324
CML-T1,56973724,1.0958106846759064
AsPC-1,168312962,4.080126214508297
REC-1,44486219,4.077321087019859
IMR-32,11609586,1.932345905136295
IMR-32,400769,-0.845917918323077
NUGC-3,36314,1.6974718387373755
BT 112,25150857,1.6816948486973082
NUGC-3,5566,2.898854593220752
NUGC-3,4261,1.7943665056610378
IMR-32,11647372,0.9819689139689508
PLC/PRF/5,675434,3.985001403964064
AsPC-1,16722836,2.2980478994816425
PLC/PRF/5,2113511,4.273374285792885
BC-3C,322968,4.761796307382421
D283 Med,2126,1.5971545854650095
PC-14,16720766,2.9696351581057825
PLC/PRF/5,16013152,3.911408074975365
TC-71,637858,2.1337665442095664
HuP-T3,selumetinib-navitoclax (8-1 mol-mol),3.027921751084016
IMR-32,11485656,1.530549227150807
TC-71,5287969,-2.365235328819383
KYSE-510,119607,5.899787280801418
PLC/PRF/5,72193861,1.5966332574965283
PLC/PRF/5,3503,1.5745959384185868
AsPC-1,9967941,3.911764573168509
CML-T1,11427553,0.3447104584156399
PE/CA-PJ15,168312962,3.379697023370571
KP-3,135984461,4.664901942241971
D283 Med,11717001,4.89268752114943
D283 Med,1242560,3.0255302054486797
GSS,327653,2.9951374094188172
CML-T1,10127622,3.755726914771393
HEC-108,selumetinib-BRD-A02303741 (4-1 mol-mol),6.22303090572745
AsPC-1,56973724,5.500241353025212
PE/CA-PJ15,44237094,3.080316075944741
PE/CA-PJ15,6505803,-4.077813218319251
PE/CA-PJ15,11507802,0.9199677226332336
HuP-T3,16725315,3.145396972494799
HuP-T3,2749,2.009482044490881
PLC/PRF/5,24951314,2.4864266106347355
PC-14,44507138,1.924622634318641
AsPC-1,4259181,1.083384461798112
KYSE-510,9936388,-2.6451183198904373
AsPC-1,selumetinib-JQ-1 (4-1 mol-mol),1.077922067972621
BC-3C,tanespimycin-bortezomib (250-1 mol-mol),1.3285525848592783
KYSE-510,11656518,3.762048066755811
AsPC-1,11707110,-3.3734075653106506
TC-71,9840324,5.772136521602821
KMH-2,44486219,3.638973589174113
KP-3,5281672,6.097432852037508
GSS,9825149,0.334890897536332
AsPC-1,60700,1.1964352024151823
TC-71,123631,3.628635852792541
KP-3,5278396,4.221246896581015
TC-71,BRD-K55473186,4.299596183563138
HuP-T3,216239,2.9976543037230665
D283 Med,252682,6.563125255029891
CML-T1,navitoclax-MST-312 (1-1 mol-mol),0.6606923209980897
REC-1,BRD-K99584050,5.492819834675278
GSS,54639665,4.407333409116942
PE/CA-PJ15,3854666,0.5733431717297748
GSS,11228183,-0.1181553909713114
BC-3C,53495165,0.2260583255687451
NUGC-3,446155,4.069036816042921
TC-71,JQ-1-navitoclax (2-1 mol-mol),3.3340692272346835
AsPC-1,tretinoin-carboplatin (2-1 mol-mol),4.763060903699729
NUGC-3,11404337,-0.7682490419788565
HEC-108,9866186,0.8605945036267506
BT 112,navitoclax-pluripotin (1-1 mol-mol),-0.5614812394120877
PC-14,25154868,4.52292180363284
TC-71,26596,-3.193308290167961
GSS,57519531,1.6724134664806338
AsPC-1,46191454,4.573546152494067
HuP-T3,1750826,-1.878047057258104
KP-3,2708,5.865062247079506
PE/CA-PJ15,16659841,4.664105426478433
CML-T1,73707398,-0.0310412376393591
NUGC-3,4096211,1.5698453837692168
PE/CA-PJ15,10322450,4.3579745096101075
SK-MEL-2,ISOX-bortezomib (250-1 mol-mol),0.2286395369927496
D283 Med,17755052,0.4087785710021853
KYSE-510,46174525,5.43336097338414
KYSE-510,568763,1.5750727912429554
GSS,5460769,0.9437954326098514
HuP-T3,107985,-4.90392348596967
TC-71,JQ-1-vorinostat (2-1 mol-mol),-0.1519328708015374
AsPC-1,219104,4.54762024266609
AsPC-1,5479543,3.7451312348556582
TC-71,selumetinib-PLX-4032 (8-1 mol-mol),4.854238475753168
BT 112,11609586,3.092948816829803
PE/CA-PJ15,374536,3.161408900699119
D283 Med,119607,5.46522088170326
IMR-32,navitoclax-gemcitabine (1-1 mol-mol),-4.761465860153877
CML-T1,11404337,-1.4571467715346416
HuP-T3,11152667,0.3145958176635
GSS,71466578,3.176321594811436
BT 112,46926350,-4.347811941752451
GSS,73707398,1.0095081490958464
CML-T1,24978538,-0.5146505107576096
AsPC-1,11222830,1.755039918901926
D283 Med,5281321,-4.405439498584387
PE/CA-PJ15,24964624,2.39277886308643
AsPC-1,46843906,4.099754684530221
NUGC-3,6918328,-0.3853574314367468
TC-71,2828334,5.786709865848735
PLC/PRF/5,3025944,4.465017787261757
IMR-32,24978538,-1.5677474222494736
GSS,5328940,1.3407707030464449
D283 Med,9967941,4.476390135887204
CML-T1,alisertib-navitoclax (2-1 mol-mol),-1.6309921665617133
HuP-T3,3503,2.6961085729175465
HEC-108,11640390,4.025636872827305
D283 Med,216468,1.9230482030211824
GSS,46174525,3.1849523273188636
HuP-T3,136227924,2.888640375816574
BC-3C,25150857,2.8136199812217764
CML-T1,navitoclax-sorafenib (1-1 mol-mol),0.8856526530243491
BC-3C,9911463,4.117920402638588
TC-71,73707398,0.9570811163223728
PC-14,4917,3.2092171400843457
HEC-108,3815108,3.3299414273071273
NUGC-3,1750826,0.3276101927459922
PE/CA-PJ15,10427712,4.366561552625221
TC-71,46398810,3.018096109784033
REC-1,5328940,3.0740483869601993
PC-14,67156097,-2.5306538286794003
CML-T1,119182,-4.6073645657146285
AsPC-1,984333,1.2969820633088274
KYSE-510,9956119,4.068397002065963
BC-3C,navitoclax-birinapant (1-1 mol-mol),2.8505195571855046
BT 112,11396600,2.640188999201151
KP-3,3543504,4.20808934410366
IMR-32,6852167,1.9156173636084908
AsPC-1,4917,3.701934006694463
GSS,51039095,1.408305693545926
PLC/PRF/5,9911830,2.188550604148889
KYSE-510,1750826,2.6372284212424955
BC-3C,navitoclax-piperlongumine (1-1 mol-mol),2.778275737504269
HEC-108,124202324,3.003291050730973
KMH-2,72193861,-0.7870275994854161
AsPC-1,10127622,2.6030187662085384
GSS,20959075,-3.1514136658737635
BT 112,71680916,4.277413325515947
BT 112,5329102,1.915457190932002
GSS,11507802,1.0877384860804078
PLC/PRF/5,31703,-1.0309426859759032
PLC/PRF/5,tanespimycin-bortezomib (250-1 mol-mol),-0.763786349552494
BC-3C,24821094,2.5913185802786325
CML-T1,676352,1.5222388602604249
PLC/PRF/5,6610216,3.842648408877997
PLC/PRF/5,2874250,4.2887282832865194
REC-1,25150857,4.137412786869543
PE/CA-PJ15,2746,3.741230111498992
PE/CA-PJ15,36314,-7.581588008180118
CML-T1,71466445,2.0221424049362033
TC-71,11609586,3.251789491444927
KYSE-510,216345,4.470837381739231
PLC/PRF/5,9803433,4.351238846775036
REC-1,322968,2.0364678189821865
D283 Med,11977753,-2.8972996135138565
BC-3C,107970,3.022957216824654
HEC-108,4259181,0.4931043474853455
AsPC-1,53392493,3.5744228182767164
NUGC-3,216468,1.1899233629806203
HuP-T3,168313200,4.289513738947004
IMR-32,60700,-4.992143928815151
KP-3,5351362,0.7719002325908333
PLC/PRF/5,44185566,3.035209627780528
NUGC-3,10427712,4.493040945003225
TC-71,66577038,3.1970186390368114
NUGC-3,44607530,1.5406465512819376
BT 112,16038120,1.1181319044078708
IMR-32,8515,1.8895636486981031
PE/CA-PJ15,11404337,-2.320439466084731
KMH-2,9903786,1.3660293069385576
REC-1,16065773,3.4063601854764647
GSS,5738263,2.5126387327358337
KP-3,107985,-4.13659757249414
KMH-2,24964624,2.0132989934839536
GSS,6852167,1.3969716760302158
TC-71,969516,2.575805931339847
TC-71,9926054,1.5758673536433587
TC-71,107970,2.798539733238077
IMR-32,24748573,0.5645013941406656
KP-3,54618305,4.754928976610576
KYSE-510,374536,3.4543675814774795
HuP-T3,46843906,1.6260119885378777
AsPC-1,24797083,1.5655308519339004
PLC/PRF/5,44566777,1.1340588240403455
AsPC-1,selumetinib-BRD-A02303741 (4-1 mol-mol),2.3046725635070757
PE/CA-PJ15,5426,4.953040449368789
PC-14,9911830,1.0701556722840508
CML-T1,1750826,-4.284831191139796
BC-3C,3676137,4.071835044257108
BT 112,67156097,-1.0460495753019483
HEC-108,11364421,2.372411654135638
NUGC-3,9967941,4.15619579121294
BC-3C,3384730,3.4103506494880595
PLC/PRF/5,148198,-2.947936464140587
REC-1,9911463,3.153332853315619
PLC/PRF/5,1242560,3.776078980505744
REC-1,107970,3.403139793728704
D283 Med,vorinostat-carboplatin (1-1 mol-mol),1.5123175007523422
SK-MEL-2,1750826,2.708131758438896
HuP-T3,135440466,1.565116417651368
D283 Med,5311,-0.2786348864571751
CML-T1,11396600,3.3654395371867425
CML-T1,100016,5.302267949835527
AsPC-1,104842,0.0602967281328717
CML-T1,19582717,1.9595186711365948
CML-T1,446155,3.2304119453056632
REC-1,9823820,2.978079708899726
BT 112,6918328,1.0363276408883513
PE/CA-PJ15,23635314,-3.571358850473721
KP-3,5566,2.9181335458321427
TC-71,5284329,3.792877837942985
KMH-2,3038522,4.4632233034848845
AsPC-1,44607531,1.5574724897590664
KMH-2,JQ-1-UNC0638 (2-1 mol-mol),1.1907602496556098
KYSE-510,selumetinib-UNC0638 (4-1 mol-mol),4.924682893676594
BC-3C,crizotinib-PLX-4032 (2-1 mol-mol),1.706108160081081
BT 112,11152667,1.095866512531577
NUGC-3,44486219,3.900978630969632
PC-14,73707398,2.0324483303809666
PE/CA-PJ15,25195348,3.4311636975468165
REC-1,702558,7.790217698913398
GSS,10322450,2.8723971217143824
KMH-2,2945648,2.630958732295752
PE/CA-PJ15,12001922,2.3409617701087577
KMH-2,5746,-1.6439308977847142
IMR-32,151289,-0.4127478685653054
NUGC-3,6610355,4.893041435827952
D283 Med,5329102,2.0804491951462323
SK-MEL-2,462382,0.8673901408354348
AsPC-1,44462760,4.701078704400346
PE/CA-PJ15,57330099,4.4384780408522815
KYSE-510,navitoclax-piperlongumine (1-1 mol-mol),3.2224883081815134
CML-T1,9825149,1.6129799202532635
PE/CA-PJ15,17755052,1.5124868987767677
GSS,JQ-1-navitoclax (2-1 mol-mol),-0.9749199575570726
TC-71,53495165,-1.5110206403590818
PC-14,654092,0.4321002454947655
CML-T1,11364421,-5.082505847469849
HuP-T3,44607531,1.7591062122540748
REC-1,5291,2.78520070098662
BT 112,24821094,1.850576537519091
BC-3C,selumetinib-UNC0638 (4-1 mol-mol),4.540645553469682
IMR-32,135411,-1.4785586518887983
IMR-32,9823820,2.332919827428616
PE/CA-PJ15,4788,5.865158053674836
AsPC-1,5311,1.9705564216623497
PE/CA-PJ15,2828334,6.208466277594022
D283 Med,285033,-3.580408991915884
KP-3,65064,4.409027805588154
BT 112,462382,-0.8334021028816797
NUGC-3,285033,-1.834970806624124
AsPC-1,66577038,3.0978373542257973
PC-14,navitoclax-MST-312 (1-1 mol-mol),1.8324518221045003
TC-71,6918638,-0.2365825415632411
HuP-T3,15547703,4.355520728687953
REC-1,selumetinib-piperlongumine (8-1 mol-mol),4.826033479915962
GSS,400769,-1.353671895728273
HuP-T3,4259181,1.3598984416642497
BC-3C,JQ-1-vorinostat (2-1 mol-mol),1.4595380748290387
KP-3,selumetinib-vorinostat (8-1 mol-mol),2.7675803183632155
BC-3C,5287620,-1.6355886819404404
IMR-32,451668,-0.533247559485573
AsPC-1,36462,3.6552458214160506
GSS,11964036,0.1293048809874563
KP-3,89928392,1.4992284192645884
PE/CA-PJ15,tanespimycin-bortezomib (250-1 mol-mol),-3.0373663834156943
D283 Med,carboplatin-etoposide (40-17 mol-mol),0.662788733652507
CML-T1,BRD-A02303741-navitoclax (2-1 mol-mol),1.3394174355089614
KP-3,54618771,0.4281141975114925
GSS,9868037,1.8794585438915803
NUGC-3,5282054,3.5096130206390157
IMR-32,44607530,0.8863308713136792
D283 Med,451668,-1.57029447939279
D283 Med,JQ-1-navitoclax (2-1 mol-mol),-0.3504935844901085
PLC/PRF/5,2733526,4.858031662341783
PE/CA-PJ15,25150857,2.430682281615116
GSS,11609586,2.3914024463338053
IMR-32,44589607,0.9924085640703696
BC-3C,navitoclax-gemcitabine (1-1 mol-mol),0.7314354741311846
AsPC-1,selumetinib-BRD-A02303741 (4-1 mol-mol),2.3046725635070757
SK-MEL-2,12001922,1.5880296179795197
KMH-2,71466578,4.074256853134251
IMR-32,10302451,3.1192672729398407
PE/CA-PJ15,168313200,2.967546559162406
AsPC-1,3689413,-2.062701377390924
TC-71,67156097,-2.6476936851120163
CML-T1,25154868,3.739287072403725
KMH-2,selumetinib-JQ-1 (4-1 mol-mol),-2.0810705685207265
CML-T1,60700,-4.046906202956944
KYSE-510,11719255,3.625649920889949
CML-T1,65628,2.7154825762494057
NUGC-3,25126798,3.907441402500329
AsPC-1,568763,2.040921390287386
AsPC-1,216239,1.707935704723652
GSS,selumetinib-GDC-0941 (4-1 mol-mol),0.7443695681674949
CML-T1,969516,2.44416602520126
NUGC-3,119182,-2.3458838456973017
D283 Med,9907093,3.62208828367571
AsPC-1,107970,2.236934549480267
BC-3C,4477,1.1789698735341652
AsPC-1,11178236,-3.0731642515052098
BC-3C,9952709,4.463947306968215
KYSE-510,BRD9876-MK-1775 (4-1 mol-mol),3.05404489643946
KYSE-510,15547703,4.331037881708386
BC-3C,135440466,1.833865068058189
IMR-32,9884685,-1.1306444874275756
HEC-108,60700,1.732447929158594
NUGC-3,6918736,-3.353656707031916
HEC-108,387447,-5.079207916782074
BC-3C,148124,-4.411439012775604
PE/CA-PJ15,JQ-1-vorinostat (2-1 mol-mol),0.8852221304814516
KP-3,17759555,4.298399189301517
BT 112,24856436,0.5972809342094648
PE/CA-PJ15,doxorubicin-navitoclax (2-1 mol-mol),-2.601929873995627
HuP-T3,31703,0.4675615226322689
HEC-108,25183872,-1.8518137093604925
AsPC-1,73707398,2.3690176063372888
PLC/PRF/5,56649450,4.35024844141295
PE/CA-PJ15,9911830,3.3068944538526672
KP-3,10231331,4.79345932538097
HuP-T3,4378219,2.0668857590794767
CML-T1,55283,-0.0221984323925449
KMH-2,42642645,0.908731492566517
REC-1,6184667,4.234456857670769
PC-14,16038120,0.0190258428468705
KMH-2,9868037,1.8367202409128176
D283 Med,12003241,-3.4539176227720794
BC-3C,44202524,1.849442934129631
AsPC-1,66577038,3.0978373542257973
KP-3,11485656,2.673409024797461
NUGC-3,1242560,3.4266512661366746
KMH-2,10385095,1.3020469045256973
KYSE-510,9911830,3.344308722430599
PE/CA-PJ15,25161177,5.4130558978250845
GSS,carboplatin-UNC0638 (2-1 mol-mol),1.9349633699433515
CML-T1,15983966,-4.817800919639036
PE/CA-PJ15,3025986,-1.5068920069952254
NUGC-3,11507802,1.4281674308136507
GSS,4096211,1.5541996249841517
AsPC-1,9911830,2.936776162598985
IMR-32,5287620,-1.4953063851884132
KP-3,6914657,-5.860460007512633
KYSE-510,24821094,3.818188441093623
KYSE-510,6918638,1.620078603816946
GSS,24753719,2.4096224758736895
NUGC-3,327653,3.534710126050335
D283 Med,BRD-A02303741-navitoclax (2-1 mol-mol),4.100647340597535
AsPC-1,45279963,4.120012544363151
REC-1,2841722,5.360306310676448
KP-3,44137675,4.427212794850303
AsPC-1,piperlongumine-MST-312 (1-1 mol-mol),2.821737440312523
KYSE-510,12003241,-0.1961434673469709
D283 Med,salermide-PLX-4032 (12-1 mol-mol),4.644943358179887
PC-14,54454,0.5388288870311388
PE/CA-PJ15,676352,1.7969794327090745
KMH-2,9929138,5.036636108742583
GSS,2729026,0.973159646767844
PE/CA-PJ15,16722836,2.3675136645426886
AsPC-1,123631,3.3144447888973048
HuP-T3,400769,-0.02490432142157
HEC-108,3825829,3.356859835270974
SK-MEL-2,6450551,4.058466448990368
KP-3,441298,2.7597429791451553
PLC/PRF/5,crizotinib-PLX-4032 (2-1 mol-mol),2.5393412161931783
CML-T1,4259181,-0.9247208790621684
BT 112,753704,3.3999292862808077
CML-T1,9911463,2.5893115421622737
D283 Med,11404337,-0.900512184015852
PE/CA-PJ15,44491742,3.9025986426144934
HEC-108,2729026,3.096957715125247
PC-14,16065773,3.2165423601217347
HuP-T3,navitoclax-piperlongumine (1-1 mol-mol),2.1493116178026157
BT 112,5460769,1.283415330936559
AsPC-1,11964036,1.5618628535664978
KYSE-510,5351362,1.2623948906658475
GSS,25183872,-1.963181641244228
HEC-108,6610216,4.664785359409005
AsPC-1,17755052,1.5687054045124371
CML-T1,17759555,3.491613035913433
TC-71,3385,1.568387487770316
BC-3C,46191454,2.097345398248227
IMR-32,9549297,1.1470577167587233
GSS,navitoclax-pluripotin (1-1 mol-mol),-1.243360778407297
PLC/PRF/5,46215462,2.875415716219954
PE/CA-PJ15,54618305,4.31153259720802
HuP-T3,11640390,3.629059315953643
D283 Med,11494412,-0.6782080211757803
BC-3C,135398516,2.0615627329886665
TC-71,selumetinib-JQ-1 (4-1 mol-mol),4.262945722459713
CML-T1,55508,2.709114480954857
IMR-32,selumetinib-navitoclax (8-1 mol-mol),0.7053426054110573
KMH-2,11427553,1.2431761665882468
GSS,11178236,-3.6474508664317566
HuP-T3,11214940,1.8541641961456377
AsPC-1,387447,-4.291846387154746
CML-T1,135411,-2.1332231058037796
HEC-108,44241473,4.4856951268247585
IMR-32,9927531,3.188320479836116
REC-1,11625818,5.343350600184494
PC-14,16725315,3.2048847799835665
CML-T1,8515,3.304453494146528
PC-14,24771867,-2.59629099527772
AsPC-1,3503,2.1995832473977157
HEC-108,11228183,1.0147252747004392
IMR-32,11497983,-5.434053629981828
HEC-108,135421197,3.884784600125324
IMR-32,15547703,3.1483634471925765
PE/CA-PJ15,568763,0.8807153121588625
TC-71,25105715,3.651402549890334
TC-71,400769,-1.489711840099049
KMH-2,409805,3.8048240258679256
BC-3C,9903786,3.0556905946174537
TC-71,25150857,3.1808232088264976
CML-T1,135999136,1.353337094400064
KP-3,374536,-3.681172393088042
KP-3,11626560,1.7887274459041371
AsPC-1,46174525,4.390753346499015
GSS,44507138,1.1541274283405591
PE/CA-PJ15,25183872,-1.443697759883257
D283 Med,4578,4.258576085653485
GSS,241158,4.1367730610069975
REC-1,11640390,2.967274756453034
HuP-T3,135875424,4.261865095251217
D283 Med,73707438,3.9956281889573697
PE/CA-PJ15,6610355,4.832793826513437
REC-1,9911830,2.634781008938807
AsPC-1,11396600,3.3240147605355506
PE/CA-PJ15,4378219,3.8751704694952753
BC-3C,49793307,-2.339426263536596
NUGC-3,400769,-1.6186872440140136
HuP-T3,9903786,4.0743016574038915
PE/CA-PJ15,56946209,-4.557496180443621
HuP-T3,56973724,4.820716068374067
CML-T1,25102847,0.4234360383549997
D283 Med,5278396,2.633233418079239
KP-3,serdemetan-SCH-529074 (1-1 mol-mol),2.3920415747472537
AsPC-1,8515,4.986545700595871
PE/CA-PJ15,54678924,1.6746192512900708
KMH-2,54143018,-1.242880212456163
BC-3C,25227462,2.027620460683823
HEC-108,11612883,3.04097878516087
REC-1,3543504,2.61004000705113
BC-3C,16013152,4.130260089787398
HuP-T3,123631,3.4682236131630213
AsPC-1,4578,5.074011683523406
HEC-108,56946209,-3.633344479104151
BT 112,285033,-2.2130720086668836
BC-3C,1750826,4.104442670228249
HuP-T3,25154868,5.141210696949765
D283 Med,6450551,2.1323753590226686
D283 Med,selumetinib-JQ-1 (4-1 mol-mol),1.653180962560337
KYSE-510,25154868,3.173665221180196
PLC/PRF/5,11977753,-0.8768594331005037
PE/CA-PJ15,66577038,3.151084486401523
PE/CA-PJ15,2113511,6.213528533816965
KP-3,176870,3.779573670811729
PC-14,11427553,1.8046600537431947
KMH-2,3025986,-0.257740003575554
PE/CA-PJ15,2733526,4.109828603744543
PC-14,5746,1.1464831809049938
KMH-2,67291369,1.5421170432429974
PLC/PRF/5,219104,4.740235940317164
NUGC-3,60700,-1.0864447637146128
CML-T1,452548,-3.528686830959828
PE/CA-PJ15,216239,2.7008177821497124
GSS,387447,-5.1490583646059855
KYSE-510,3825829,3.4984079576895843
BT 112,1242560,3.547587200922832
HEC-108,JQ-1-navitoclax (2-1 mol-mol),1.4144543388665205
GSS,vorinostat-carboplatin (1-1 mol-mol),1.0541407481710998
KYSE-510,16722836,1.900624390036885
PLC/PRF/5,54626689,4.565474707676091
HEC-108,vorinostat-carboplatin (1-1 mol-mol),3.8874971320983143
BT 112,10410894,4.183510098776423
BT 112,navitoclax-sorafenib (1-1 mol-mol),1.1762931149119242
GSS,445455,4.266056042600774
BC-3C,11455910,1.805675194715763
AsPC-1,carboplatin-etoposide (40-17 mol-mol),5.367887581807261
GSS,selumetinib-UNC0638 (4-1 mol-mol),3.5254187911555066
KYSE-510,9952709,2.930976759418399
PE/CA-PJ15,11612883,3.8104677239271223
AsPC-1,11964036,1.5618628535664978
TC-71,23725625,2.787758104842475
NUGC-3,11175137,2.5197528002032414
AsPC-1,10302451,4.160835682979353
PLC/PRF/5,5738263,3.4010785704174102
CML-T1,carboplatin-UNC0638 (2-1 mol-mol),2.1290435317203023
KP-3,15547703,3.502054897992746
BT 112,selumetinib-MK-2206 (8-1 mol-mol),3.149156895525344
TC-71,12001922,1.6128279763162578
AsPC-1,56649450,2.958633157592254
REC-1,9926054,3.5400616992055847
KMH-2,637858,0.9367437449814346
PE/CA-PJ15,9884685,0.3729589706560922
PC-14,11964036,1.9982884581849667
BC-3C,24771867,3.611120049755405
GSS,246676,4.2642843593675765
PE/CA-PJ15,119182,-1.3122958755203809
AsPC-1,216345,4.477392842458871
KYSE-510,10385095,1.814777248632933
KMH-2,3689413,-1.7619354335242607
KP-3,46199207,2.723843900853901
HuP-T3,10385095,0.7178899916931367
KMH-2,25183872,-2.094788836829873
REC-1,piperlongumine-MST-312 (1-1 mol-mol),4.394420056876291
AsPC-1,6918638,0.7071735542476161
KP-3,44486219,4.292467007303418
IMR-32,36462,-1.733502190713641
KMH-2,11485656,1.7580590050514375
D283 Med,444795,-3.2845998018022775
GSS,3038522,2.5198573341470425
KYSE-510,46215462,3.288669587883855
PLC/PRF/5,19582717,3.9912957848121704
GSS,9936388,-5.73118994601309
BT 112,9911463,2.5169416957375015
HEC-108,675434,4.085694536082024
BC-3C,tanespimycin-gemcitabine (1-1 mol-mol),1.1729206538741082
AsPC-1,24821094,4.10595231639086
KP-3,46191454,2.2158866738690493
IMR-32,24901704,1.9067094769005688
BT 112,11175137,1.5585592210455712
SK-MEL-2,11707110,-2.099269246419877
NUGC-3,24772860,-2.0289992156764147
IMR-32,11494412,-1.4286694328738665
KP-3,638278,4.144592396497575
KP-3,124202324,2.4407993053685413
BC-3C,46926350,-4.115294296697457
IMR-32,vorinostat-carboplatin (1-1 mol-mol),0.8832189817530558
KYSE-510,6917907,-5.97871988269504
AsPC-1,72734382,6.119259394736332
SK-MEL-2,25150857,2.7623433272086575
NUGC-3,168312962,0.8696720856170315
KYSE-510,24753719,4.343319490515707
CML-T1,6918328,-2.287128701752201
HEC-108,400769,-0.3836243025224323
HEC-108,decitabine-navitoclax (2-1 mol-mol),0.2916022830293501
HuP-T3,135421197,1.625440100707307
PE/CA-PJ15,5287969,-2.03511955746643
D283 Med,56946209,-6.610135638072429
REC-1,208908,3.069929195687628
AsPC-1,409805,5.083096669481897
D283 Med,462382,-0.0438075540116339
KYSE-510,3503,1.7000411538582143
GSS,9444,4.281538050192459
PLC/PRF/5,24785538,3.3508626584365433
PC-14,53495165,1.0663117810977292
BT 112,11625818,4.486916503071115
PLC/PRF/5,15953870,3.9476910695044767
PLC/PRF/5,613753,3.3358981369111675
SK-MEL-2,6610355,5.831541242380359
GSS,25262965,-2.1452700847853676
PE/CA-PJ15,3136844,3.987949830303945
KMH-2,44589607,2.1056689776685404
TC-71,65628,3.786909553172794
BT 112,65064,5.244324782512833
KMH-2,16038120,-0.0384022722184617
TC-71,23635314,-4.137086753012752
IMR-32,44137675,2.9562929137787712
GSS,piperlongumine-MST-312 (1-1 mol-mol),1.515605936569976
SK-MEL-2,31703,0.7114191518361959
NUGC-3,135398516,2.2230322771661313
D283 Med,6918638,-2.490498776882626
KP-3,51039095,3.0052998284349317
PC-14,446155,-0.7424552052477895
BC-3C,1641662,3.853562919265672
PLC/PRF/5,11494412,2.4031877451972754
GSS,54686904,4.302214119748775
PE/CA-PJ15,462382,0.9369549231727788
PLC/PRF/5,JQ-1-navitoclax (2-1 mol-mol),4.09396881874311
D283 Med,322968,2.541378119684702
PLC/PRF/5,46199207,3.6962856213642112
CML-T1,2126,4.385584292912835
REC-1,6918328,3.6052842783231993
TC-71,42642645,0.3664127835845306
PLC/PRF/5,6918837,-1.555128390132324
KP-3,387447,-4.22311088168715
TC-71,25262965,-2.287782836634246
HuP-T3,10410894,4.484643398072658
D283 Med,15953870,2.787040507745561
BC-3C,445643,3.7151941654998897
TC-71,navitoclax-PLX-4032 (1-1 mol-mol),3.0650514798949997
PLC/PRF/5,135421197,1.8500736721187756
BT 112,6450551,1.6386256333107696
KMH-2,11626560,1.1417294335260535
GSS,5351362,1.0956228855479284
PE/CA-PJ15,5311,2.929642766626198
AsPC-1,11640390,5.159931420709134
PE/CA-PJ15,25105715,3.675314900908473
SK-MEL-2,sirolimus-bortezomib (250-1 mol-mol),0.4660061968632925
HEC-108,104842,-0.6030222866662514
KYSE-510,15983966,-2.785553407760656
PLC/PRF/5,71466445,4.409191653894859
PC-14,400769,-2.2191284270813516
PE/CA-PJ15,vorinostat-navitoclax (4-1 mol-mol),2.4853954630897053
REC-1,654092,1.1648734902582711
KMH-2,23635314,-3.793708760952174
CML-T1,selumetinib-tretinoin (2-1 mol-mol),2.254120654073675
SK-MEL-2,vorinostat-carboplatin (1-1 mol-mol),3.8126311679317366
TC-71,11234052,2.410276418697339
CML-T1,10322450,3.1347292789416934
PE/CA-PJ15,9915743,-1.4704662389348668
AsPC-1,31703,0.7807561035178269
BC-3C,54678924,1.885433331985395
BT 112,1566236,1.551499234243426
GSS,451668,2.643427205827407
REC-1,9927531,3.800278065681949
HEC-108,2858523,3.032487777915684
IMR-32,5291,3.123850209832584
PC-14,9444,3.6058045572239146
PC-14,25195348,1.7826194825719548
HuP-T3,10296883,4.266239948990751
HuP-T3,6450551,3.7588607556856006
PLC/PRF/5,36314,-2.7940360499226906
KP-3,navitoclax-gemcitabine (1-1 mol-mol),0.6027161328228624
AsPC-1,tanespimycin-bortezomib (250-1 mol-mol),-2.405972862542407
PE/CA-PJ15,12003241,-2.2005242909151668
KMH-2,6914657,-7.533849846968669
PLC/PRF/5,10074640,3.273887585809614
KP-3,11427553,2.9595504593835127
PC-14,168313047,3.256575471584884
BC-3C,16736978,0.9698938814714056
AsPC-1,44491742,4.429887143828186
CML-T1,4261,-0.2906672064872484
HEC-108,123631,2.3972749886256266
IMR-32,9826308,-0.1892043635440729
HEC-108,159324,3.617209831238773
KMH-2,3634881,2.883123455365029
BC-3C,462382,0.8810418617518906
KYSE-510,4917,3.426544358275519
PE/CA-PJ15,10296883,4.07189179930938
KYSE-510,6438330,2.6871158986784884
IMR-32,3689413,-3.464498060379514
KMH-2,216468,1.6482750667767774
NUGC-3,375860,-0.2148572525752654
HuP-T3,10113978,4.191114511390656
KP-3,262093,2.764663205540099
HEC-108,168313047,3.5343278963000033
KMH-2,49766530,-1.67617119568669
PC-14,2828334,6.799287199401149
GSS,4261,-0.6488560152703174
BT 112,322968,2.3735338663741192
HuP-T3,2126,5.715410620657667
TC-71,2749,2.0642491714459723
KP-3,6917907,-5.628880878854727
GSS,42642645,0.9983353320399786
GSS,67156097,-1.6555264738223374
KYSE-510,6852167,3.606040413694624
REC-1,54639665,4.455967355102018
BC-3C,52947716,2.926903504573943
BC-3C,122327,4.142533358423347
PE/CA-PJ15,6918328,0.6587015663992094
PLC/PRF/5,3689413,0.4443196233363375
KP-3,119607,5.5453154352771445
PLC/PRF/5,126941,-4.591060997089375
KYSE-510,5311281,5.540102542505399
KMH-2,65628,3.890017095144683
AsPC-1,11234052,4.540853045838434
PLC/PRF/5,24856436,0.5107833646252546
SK-MEL-2,3081361,3.50261592652662
AsPC-1,2871966,-0.1237405253519755
HEC-108,3384730,3.335460233588695
PC-14,53232,0.6703608287087818
PC-14,JQ-1-vorinostat (2-1 mol-mol),1.088268810915832
BC-3C,168312962,2.82389694381846
HEC-108,54649381,3.8371593577221255
CML-T1,11152667,-2.6898641024331584
BC-3C,26596,-0.2711171382512473
BC-3C,53325874,4.311265347777945
NUGC-3,10231331,2.721945968034159
KYSE-510,selumetinib-navitoclax (8-1 mol-mol),4.078827889732385
KMH-2,3062316,2.1798230916808055
PE/CA-PJ15,675434,4.368434014356364
D283 Med,46926350,-5.859080576387131
REC-1,9866186,2.788920837091142
NUGC-3,100016,7.160996607387645
KMH-2,72376,-2.9516442192946313
KMH-2,148198,-4.1260923744300015
PC-14,11640390,3.3680946545298096
AsPC-1,2749,1.937127114514975
AsPC-1,16038120,0.5677006157285766
REC-1,4788,5.882204624871407
HuP-T3,52912189,2.4400429797195065
D283 Med,49793307,-5.548587928279458
REC-1,53232,6.664382272072013
GSS,5281321,-2.320326728661935
IMR-32,285033,-4.134977712668135
NUGC-3,54613361,-0.1287400833795678
BT 112,56649450,3.981227494013605
HEC-108,54618305,5.558551802909847
TC-71,54678924,1.685300098778463
HEC-108,3385,6.041983945648764
IMR-32,navitoclax-piperlongumine (1-1 mol-mol),-1.1776357049676387
IMR-32,439501,-2.4799025778743884
PLC/PRF/5,6918328,0.8083871234456194
KYSE-510,SNX-2112-bortezomib (250-1 mol-mol),-2.1600738960361294
GSS,3689413,-0.0459197992618788
CML-T1,6918289,0.3823031541189219
GSS,3385,3.0513990945584313
PLC/PRF/5,216345,4.529148549895513
BT 112,11178236,-4.407924823586387
BC-3C,navitoclax-MST-312 (1-1 mol-mol),0.8594952201110262
D283 Med,16038120,-1.2659800311805858
D283 Med,25161177,4.21580762062299
PLC/PRF/5,SNX-2112-bortezomib (250-1 mol-mol),-1.948435641512707
PLC/PRF/5,10184653,1.6428250482784534
IMR-32,carboplatin-etoposide (40-17 mol-mol),-0.8341002728008562
AsPC-1,7251185,2.99432826291256
KMH-2,decitabine-navitoclax (2-1 mol-mol),-0.6649345371848503
PLC/PRF/5,10302451,4.036530527642544
PE/CA-PJ15,tretinoin-navitoclax (4-1 mol-mol),4.408695223285738
PC-14,selumetinib-navitoclax (8-1 mol-mol),0.9559974576764104
KMH-2,6623618,1.9063060401204115
D283 Med,4521392,4.070852610455029
AsPC-1,24901704,4.152315193440913
D283 Med,168313200,1.8321011656642825
KYSE-510,navitoclax-birinapant (1-1 mol-mol),3.0363792900657005
CML-T1,44486219,3.9826752825954306
PLC/PRF/5,123631,2.636024232570981
D283 Med,tretinoin-navitoclax (4-1 mol-mol),6.584931144825414
NUGC-3,135984461,5.20039455882723
CML-T1,54143018,-0.824314936779772
CML-T1,262093,1.3151134240668207
BT 112,613753,3.334694062247594
D283 Med,JQ-1-MK-0752 (1-1 mol-mol),0.6628276308701311
IMR-32,25262965,-3.922457664113769
KP-3,6918878,4.298092310764335
CML-T1,104842,-6.467154894462458
GSS,19582717,3.4816890717872924
PE/CA-PJ15,54765302,4.797362382600232
PC-14,2841722,4.26384457063064
D283 Med,9803433,2.2263192458664767
BC-3C,219104,5.016392640243932
PE/CA-PJ15,5738263,2.6152875419037898
TC-71,10410894,3.3047285408666007
GSS,753704,6.0092696995558645
AsPC-1,11626560,2.2683411612930637
HuP-T3,322968,2.6241189840020787
BT 112,3689413,-2.4519950955667764
TC-71,36462,0.2309996783752871
PLC/PRF/5,navitoclax-birinapant (1-1 mol-mol),1.727330149088276
BT 112,4477,0.3430018022640513
AsPC-1,7251185,2.99432826291256
PC-14,25062766,2.6228137259530326
D283 Med,11612883,1.593543211602983
PC-14,selumetinib-PLX-4032 (8-1 mol-mol),1.9609187733259617
CML-T1,10113978,1.6264516706818362
NUGC-3,24797083,1.1880624941925266
SK-MEL-2,24785538,3.271955441237361
BC-3C,11485656,2.025268186046356
CML-T1,2858523,2.0919777443937715
AsPC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.9679789776412068
AsPC-1,vorinostat-navitoclax (4-1 mol-mol),0.981904018137164
GSS,654092,-0.7320945436383166
PE/CA-PJ15,5328940,-0.0830733334700748
SK-MEL-2,3025986,0.1982340345845162
BC-3C,11507802,1.360910437675902
TC-71,9825149,0.878438786360008
AsPC-1,5281672,6.419333790815674
GSS,702558,3.1842169687807487
SK-MEL-2,6918638,1.2677051834629418
CML-T1,51039095,1.5406670560339248
BC-3C,9933475,1.9147989807585633
SK-MEL-2,439501,1.1166422747690987
KYSE-510,136227924,3.267869272747249
CML-T1,54613361,-1.4794949633252166
CML-T1,SNX-2112-bortezomib (250-1 mol-mol),-2.787489120690278
SK-MEL-2,44197249,4.981669333138379
PE/CA-PJ15,6610216,4.602296752882169
TC-71,10074640,2.9370071359566294
PE/CA-PJ15,56649450,2.4864234790550306
PE/CA-PJ15,2742550,4.3930090361473155
PE/CA-PJ15,9927531,4.562949408871821
IMR-32,11152667,-1.250307023414486
HEC-108,23635314,-2.542270451290658
PLC/PRF/5,16659841,4.216320849597769
KP-3,9907093,4.849472171367946
CML-T1,2708,2.830885116766648
D283 Med,3634881,2.480961702066835
PC-14,5291,4.296849144403432
REC-1,119607,3.5916178398125065
BT 112,25195348,3.9880227699607262
PLC/PRF/5,JQ-1-vorinostat (2-1 mol-mol),1.648602449125795
KP-3,135411,0.6280074036773945
KP-3,navitoclax-piperlongumine (1-1 mol-mol),1.4843522372680005
HuP-T3,54454,3.567661200928428
HuP-T3,11175137,3.603877049706456
D283 Med,71680916,4.275278855129835
KP-3,73707398,1.3853432761584183
TC-71,5951923,3.84129696725162
TC-71,702558,4.620481533511871
NUGC-3,2708,4.650156734517159
PC-14,5287620,-3.1191762505389113
BC-3C,65064,5.150136996547595
BC-3C,44607531,1.7571673467015438
GSS,46907787,-0.800523617648134
CML-T1,5284616,-2.6047133462283276
REC-1,10385095,3.1459726814165205
PE/CA-PJ15,15953870,3.815080099518923
SK-MEL-2,67291369,5.211406139033099
PLC/PRF/5,5311037,3.781363104556152
CML-T1,serdemetan-SCH-529074 (1-1 mol-mol),0.193373711840136
IMR-32,17755052,0.9241650367949554
KYSE-510,6918328,0.4168922188169522
PC-14,135423438,1.1691167584744715
HuP-T3,54619267,3.893027602521098
CML-T1,2113511,4.359369559056824
D283 Med,SNX-2112-bortezomib (250-1 mol-mol),-3.2108691902220317
CML-T1,44202524,1.467740802576286
GSS,11214940,2.1700811486284235
REC-1,42642645,2.0902609204351537
KYSE-510,119182,-1.1085639013268027
PLC/PRF/5,44241473,3.926194550962254
PE/CA-PJ15,11238147,1.9368815843555724
BT 112,24951314,0.7149145611857288
KYSE-510,148198,-4.124050195334788
KYSE-510,24951314,2.063142392632271
CML-T1,carboplatin-etoposide (40-17 mol-mol),-0.8203492199596885
AsPC-1,49766530,-1.5554439905221051
KYSE-510,4788,5.836611645706231
PLC/PRF/5,25105715,3.7741972774207535
REC-1,19582717,5.6127552511190295
REC-1,9825149,3.2738180165412487
GSS,56963564,-0.3427605826111028
AsPC-1,5278396,3.912005463923024
IMR-32,71466445,2.852327940242344
GSS,637858,1.823205693461285
KMH-2,selumetinib-UNC0638 (4-1 mol-mol),4.467214050459532
KYSE-510,5280436,3.692320132329106
CML-T1,5282054,3.0197566265123754
KYSE-510,11152667,1.4867272406888024
PE/CA-PJ15,alisertib-navitoclax (2-1 mol-mol),0.3645623597579537
KYSE-510,11485656,2.507694679939137
PE/CA-PJ15,11626560,2.4485271299143503
SK-MEL-2,56946209,-1.8475786839882544
SK-MEL-2,11214940,4.164104783521612
AsPC-1,3062316,2.757974416117501
KYSE-510,56649450,3.819118131212465
PC-14,ISOX-bortezomib (250-1 mol-mol),1.1155914488339396
HuP-T3,216345,4.480282764347718
PC-14,navitoclax-PLX-4032 (1-1 mol-mol),2.008859248665764
KP-3,3038522,3.8887419194513537
PE/CA-PJ15,4477,0.4659263473677219
PLC/PRF/5,54596558,4.434650821095265
AsPC-1,448949,1.7535133746232512
AsPC-1,439501,-1.6009280184427317
NUGC-3,72193861,1.6416447606578408
KYSE-510,135440466,3.006373435124255
KYSE-510,BRD-K55473186,3.763525185643664
BT 112,53392493,1.8363086740890933
AsPC-1,11497983,4.51017072011312
AsPC-1,446155,5.1652347554602995
HuP-T3,11964036,1.9148977928601396
AsPC-1,11626560,2.2683411612930637
D283 Med,9936388,-6.8022099816120605
BC-3C,64971,2.0204049912705595
PC-14,71304818,2.390926518141532
BC-3C,5284616,3.5182454459280916
TC-71,1242560,4.298451841868074
AsPC-1,6918328,0.3822733035015269
IMR-32,168312962,1.0654628792125465
NUGC-3,3825829,3.787352426707947
PE/CA-PJ15,135984461,4.416241968173964
CML-T1,tanespimycin-bortezomib (250-1 mol-mol),-0.4350289295501254
BC-3C,6438330,3.191176807159749
HEC-108,44197249,3.927114018352238
BC-3C,56973724,4.387057336049977
KP-3,46907787,2.5590188315760956
PE/CA-PJ15,72376,-1.337193116518152
PC-14,24753719,5.07098831205633
TC-71,tanespimycin-gemcitabine (1-1 mol-mol),-2.3448316851784874
AsPC-1,24785538,0.8298650260870277
BC-3C,107985,-3.218950986835144
NUGC-3,675434,4.36791966318275
KMH-2,19582717,3.4526761436377296
CML-T1,piperlongumine-MST-312 (1-1 mol-mol),1.169857653831876
PE/CA-PJ15,31703,-2.4270645825749857
PE/CA-PJ15,135440466,2.775498035074722
PE/CA-PJ15,46191454,1.902127423052216
PE/CA-PJ15,25262965,-2.0925054008893285
PE/CA-PJ15,11497983,5.527040483901927
CML-T1,5566,2.203374574789853
PC-14,24785538,0.8050188267583898
TC-71,375860,-0.373501612035207
IMR-32,54613361,-2.079088449750026
HEC-108,2841722,7.354178437919021
AsPC-1,11612883,5.278069767960674
PE/CA-PJ15,4578,4.29753811382301
TC-71,46907787,1.352087076315588
KYSE-510,24772860,-2.0467548586209947
TC-71,3062316,3.678210107980008
BT 112,31703,-2.420524319729687
TC-71,44819697,-3.250792165147415
BT 112,107970,1.504371825071881
REC-1,89928392,5.908663272108372
NUGC-3,1716436,1.962970882075595
KYSE-510,9825149,3.2278837086001557
KYSE-510,9868037,3.781080992935668
IMR-32,5281321,-4.911853025981361
KP-3,19582717,4.675110092223906
PLC/PRF/5,4096211,2.22960107179648
KP-3,135875424,4.114191182933948
CML-T1,654092,-1.9909155078044125
KMH-2,4259181,-1.7257445215614664
TC-71,11612883,1.13554113865764
TC-71,104842,-6.906124331293704
AsPC-1,5291,4.446798964395248
KMH-2,17759555,3.503053967041157
SK-MEL-2,5351362,3.093189377228118
KMH-2,60700,-0.8567336285722738
PLC/PRF/5,1239801,3.683167254525033
HuP-T3,5351362,1.4959503226370765
HuP-T3,374536,4.193584653265312
KYSE-510,2858523,3.0899792491564875
PE/CA-PJ15,24180125,3.914289437715523
HEC-108,67156097,-0.2232306565612508
D283 Med,5470400,-0.4295186800488584
PLC/PRF/5,25154868,3.091050864951689
PLC/PRF/5,4521392,4.181507186870224
NUGC-3,54649381,3.869271637490854
BT 112,3136844,3.8258170991022222
KMH-2,219104,2.851565320163975
AsPC-1,4521392,4.0696198883268275
D283 Med,969516,2.332007147829158
HEC-108,10127622,5.316186973162969
PLC/PRF/5,42642645,1.69070755210191
IMR-32,9866186,-1.3076350315507412
GSS,46901937,4.918776253856149
NUGC-3,176870,1.478392228624827
BT 112,26596,-1.3919420546275056
HuP-T3,89928392,1.747135585577409
BC-3C,selumetinib-PLX-4032 (8-1 mol-mol),4.06585356026774
CML-T1,44493528,3.9716542826771297
HuP-T3,54626689,4.821166418142214
REC-1,44607530,5.591472436740001
HuP-T3,3081361,3.872954779649628
GSS,100016,3.718199006522657
GSS,57330099,4.073348744531585
KYSE-510,46907787,4.415386026929367
PE/CA-PJ15,25227462,0.6142202816013134
NUGC-3,selumetinib-UNC0638 (4-1 mol-mol),3.072216273282764
IMR-32,53495165,-4.6828682787731895
KP-3,327653,2.831253990169757
CML-T1,salermide-PLX-4032 (12-1 mol-mol),4.618653772046038
HuP-T3,serdemetan-SCH-529074 (1-1 mol-mol),2.447475280373413
GSS,navitoclax-birinapant (1-1 mol-mol),-2.0502223529544965
D283 Med,5335621,3.872227054379363
TC-71,docetaxel-tanespimycin (2-1 mol-mol),-7.798553920474523
PLC/PRF/5,6438330,2.6682434478706454
NUGC-3,123631,-1.0844801861344486
AsPC-1,5328940,1.7821313082315045
D283 Med,4259181,-0.2806940214967063
PC-14,136227924,3.162840410264972
AsPC-1,262093,3.2992304028365926
NUGC-3,11396600,3.780901195469807
NUGC-3,17755052,1.369633473015012
PC-14,52912189,3.471072781641098
CML-T1,46191454,-1.3100798451488396
KMH-2,selumetinib-BRD-A02303741 (4-1 mol-mol),5.760290198732975
BT 112,6852167,2.8502822773493315
KP-3,54619267,4.412752492905837
REC-1,11656518,-0.6835179208047504
HuP-T3,19582717,-4.617931701404403
NUGC-3,24753719,4.191075133336168
SK-MEL-2,54626689,4.994958580964683
GSS,107970,2.2178092034727954
PC-14,119607,4.988479520693017
TC-71,6918328,-0.6321990094734333
BT 112,44607530,0.8844189369301123
NUGC-3,135875424,3.4631977650642396
GSS,9926054,1.4316065343869406
D283 Med,151289,0.5549046196657793
PC-14,72734382,4.364446921513513
REC-1,selumetinib-PLX-4032 (8-1 mol-mol),5.072809874857802
HuP-T3,54618771,0.8132197250487964
BT 112,54618771,1.3381626551406447
CML-T1,2742550,2.9758871773228366
BC-3C,54613361,-0.2062835134283783
PLC/PRF/5,441298,1.078664619920883
D283 Med,46215462,1.5827854676989337
PLC/PRF/5,135659046,3.5172360380546084
AsPC-1,11404337,0.3809720735493328
AsPC-1,10127622,2.6030187662085384
TC-71,16725315,5.201320291674229
AsPC-1,24748573,4.519934140177759
D283 Med,135659046,3.420100505846104
HuP-T3,24753719,4.122061219367772
AsPC-1,46398810,3.192713565122567
CML-T1,44185566,0.9347798856606148
AsPC-1,44185566,2.682305355629655
CML-T1,5281321,-0.1268784610637486
KYSE-510,613753,4.8331313799666225
KMH-2,445643,6.18756328874756
REC-1,23635314,3.6368440694006585
PC-14,24797083,1.8906553904066348
PLC/PRF/5,9903786,4.947267974127204
D283 Med,navitoclax-gemcitabine (1-1 mol-mol),-5.0092480687610035
TC-71,selumetinib-piperlongumine (8-1 mol-mol),2.8497578566095054
HuP-T3,44589607,2.433680498088492
HuP-T3,49766530,1.2218451996302029
AsPC-1,676352,1.9564823338284063
IMR-32,56963564,-1.6811865894881788
BC-3C,46199207,3.844058410424992
AsPC-1,135398516,2.7517064972229415
D283 Med,16736978,0.404071171344105
PE/CA-PJ15,104842,-3.638454647557915
KP-3,3689413,-2.21572351958202
PC-14,2113511,4.109768785138769
REC-1,11485656,4.187438515257482
BT 112,23725625,2.6047701146720774
TC-71,11485656,1.8010543407786783
D283 Med,72193861,-0.1483015304434956
BT 112,100016,6.504213631006025
PE/CA-PJ15,25154868,5.138759833329878
KMH-2,168313047,1.8405045282737191
KMH-2,24856436,-0.2017498878738879
PE/CA-PJ15,1641662,3.2691272545520884
CML-T1,46224516,0.9570028124056976
NUGC-3,65064,3.6467113453363456
D283 Med,5280436,0.4701684330621582
PLC/PRF/5,carboplatin-UNC0638 (2-1 mol-mol),4.20389648540839
IMR-32,10231331,3.825760806014001
KYSE-510,42642645,1.5790175631495278
BT 112,10184653,1.1503631618042085
HEC-108,984333,1.245430533507037
TC-71,11494412,0.2670168299570634
KP-3,24901704,2.7837543484136305
AsPC-1,SNX-2112-bortezomib (250-1 mol-mol),0.1734990544717531
IMR-32,selumetinib-MK-2206 (8-1 mol-mol),4.062397023599035
KMH-2,44493528,4.009016955634305
KMH-2,54649381,3.605505301942369
PE/CA-PJ15,49867926,3.939583945337153
GSS,54613361,-1.5716349878143452
GSS,44620216,4.750751690808709
KP-3,72376,-2.1111556340636843
AsPC-1,1641662,3.9838157290035
KP-3,104842,1.565525323326621
PE/CA-PJ15,44137675,2.851716707756922
AsPC-1,11485656,3.206693439346989
D283 Med,3385,1.9589527474544168
CML-T1,637858,1.454745710944211
AsPC-1,11625818,4.311821961769238
IMR-32,11977753,-3.1483042344786933
AsPC-1,tanespimycin-bortezomib (250-1 mol-mol),-2.405972862542407
HuP-T3,JQ-1-UNC0638 (2-1 mol-mol),1.1921000919454006
AsPC-1,54618164,4.187549957668634
KYSE-510,445455,6.319297264173732
IMR-32,327653,2.318153172774913
PE/CA-PJ15,11214940,4.68728018963696
CML-T1,67156097,-2.1928175380469477
HuP-T3,637858,1.096014734488476
PC-14,20959075,-3.579939594206626
TC-71,erlotinib-PLX-4032 (2-1 mol-mol),3.520302003510197
GSS,44543605,4.181665787826431
BT 112,9926054,1.759668872476805
PE/CA-PJ15,26596,-1.1054075726167758
AsPC-1,6914657,-2.819399047423078
KMH-2,4261,0.8972500118962282
GSS,11175137,1.1365534608594052
REC-1,44185566,3.2511381919617044
KMH-2,44202524,1.0243970058234346
NUGC-3,637858,1.9360146170624208
CML-T1,52912189,1.3905308136477008
AsPC-1,navitoclax-piperlongumine (1-1 mol-mol),1.083172716520978
BT 112,11612883,3.767323531047295
AsPC-1,72734382,6.119259394736332
PC-14,vorinostat-navitoclax (4-1 mol-mol),0.6440039915346073
BC-3C,46215462,1.5469449173567815
REC-1,6918837,4.296635576829373
HEC-108,702558,5.741783323073097
AsPC-1,25154868,4.981069474579037
KMH-2,11497983,1.3232117971910344
HuP-T3,445643,4.0158423100173986
PC-14,53481919,3.604196886603432
KP-3,52912189,-0.591071616638485
PLC/PRF/5,24180125,4.178076837557003
BT 112,11364421,2.5919971436685816
REC-1,3136844,3.938412595022709
IMR-32,100016,6.43791059275997
IMR-32,73707398,0.5521746080508468
KYSE-510,42611257,3.573329234613239
HuP-T3,46191454,1.9484889201022677
PE/CA-PJ15,4261,3.0667647360084227
IMR-32,16736978,0.4956684827629452
PC-14,31703,0.324790882634775
PE/CA-PJ15,3081361,0.74058948354625
KYSE-510,51039095,3.766368744765704
SK-MEL-2,1716436,3.9824529155827655
SK-MEL-2,15953870,4.259716832213739
NUGC-3,tretinoin-carboplatin (2-1 mol-mol),6.432371370772898
KYSE-510,73707398,1.7707709875360005
PE/CA-PJ15,6852167,2.545538398770599
D283 Med,25262965,-4.463192676637634
GSS,6610355,3.4725760410424273
TC-71,65064,5.194008909773804
BC-3C,71304818,2.97705765963707
KYSE-510,9967941,3.9974946583295807
KP-3,10113978,4.36466045727124
KMH-2,135398516,1.5003320435026537
HEC-108,15547703,3.396555621710324
HEC-108,11152667,0.9436637108805932
KYSE-510,126941,-3.0179245546113576
HuP-T3,24821094,3.9398095537443023
PC-14,439501,-2.395737625467809
GSS,54619238,4.678074692740671
TC-71,11497983,3.973922021191196
KMH-2,441298,0.9682769144706788
GSS,104842,-3.439026370475527
CML-T1,375860,-0.8039918924580166
AsPC-1,4261,2.35820288641389
D283 Med,68056272,-6.774567480474886
BC-3C,327653,4.094698905019423
GSS,54454,1.6937807836180017
D283 Med,24856436,-0.0403728829049674
KP-3,9868037,3.7824186326212494
IMR-32,9956119,2.5209366494044096
TC-71,2945648,0.887791343198155
PC-14,122327,4.862590373540679
HuP-T3,23582824,1.5911146583975455
HuP-T3,16659841,4.694527425679891
PLC/PRF/5,24753719,3.8725658441506368
GSS,72376,-3.4699256195728556
AsPC-1,tanespimycin-gemcitabine (1-1 mol-mol),0.4479893231727763
BT 112,JQ-1-UNC0638 (2-1 mol-mol),2.705069065658094
AsPC-1,alisertib-navitoclax (2-1 mol-mol),1.2084192852647102
TC-71,1566236,1.8045860018031188
CML-T1,107985,-4.139753917879256
CML-T1,decitabine-navitoclax (2-1 mol-mol),-1.9117963719087396
TC-71,25062766,1.3194651942334497
AsPC-1,25154868,4.981069474579037
BT 112,71751553,4.665557673334606
SK-MEL-2,3854666,3.3106573281169664
KMH-2,3384730,0.3270351946480155
GSS,44819697,-2.951729561034057
AsPC-1,44185566,2.682305355629655
CML-T1,JQ-1-carboplatin (1-1 mol-mol),0.6334590834009667
AsPC-1,445643,4.30663769172778
HuP-T3,6918638,1.0959798369911515
BT 112,BRD-K55473186,3.914494657267586
PC-14,3825829,3.604955593937337
CML-T1,135984461,1.8956927240773784
AsPC-1,5479543,3.7451312348556582
PE/CA-PJ15,44632017,0.8360374067438779
PLC/PRF/5,16725315,4.723612959725885
PE/CA-PJ15,3465537,1.6564118127840195
AsPC-1,25227462,2.9060868065293195
BT 112,12001922,0.29456942425987
TC-71,119182,-0.9142333728843396
PE/CA-PJ15,25102847,1.6675486463652875
HEC-108,5329102,3.413313733369096
PE/CA-PJ15,53325874,4.420861887362008
BT 112,2746,3.687274706255036
KYSE-510,53393127,3.838453918606616
SK-MEL-2,5328940,3.274148741678988
REC-1,3815108,4.528116845485933
GSS,10074640,2.274075175890361
PLC/PRF/5,selumetinib-BRD-A02303741 (4-1 mol-mol),6.433067058708403
IMR-32,2871966,-2.361624071150029
TC-71,9903786,2.1601140442915736
HEC-108,5566,3.7962472662927143
IMR-32,11238147,0.9881360490145906
PLC/PRF/5,9967941,1.9357368486222144
PE/CA-PJ15,119607,5.887802205779473
BT 112,5287620,-2.7532847329497883
AsPC-1,4788,5.925917601642537
SK-MEL-2,6852167,4.028362425471942
TC-71,60700,-2.786505539773197
D283 Med,5746,-2.9158663455035434
BT 112,5335621,3.6179814635651377
PLC/PRF/5,11507802,1.1325154026531083
GSS,4788,4.082449872744708
PC-14,3025986,-0.7418591282491218
PC-14,10385095,2.2928310628241455
IMR-32,24856436,-0.9573500127398432
HEC-108,24964624,3.1655733599312126
HEC-108,11238147,3.83834503247448
BC-3C,36314,-6.209626792126011
PC-14,44589607,3.5378384136887377
PLC/PRF/5,2126,3.557931433411604
GSS,25126798,3.788287062432602
PE/CA-PJ15,9840324,5.741799311729206
D283 Med,24964624,0.6925287192814263
AsPC-1,5281321,-1.206156098851657
KMH-2,44489675,3.7804388029972738
IMR-32,219104,2.2072244040254123
PLC/PRF/5,53392493,1.820631679013277
BT 112,400769,-1.0288775980123002
AsPC-1,67291369,5.582806392200744
GSS,17759555,3.2309913459688997
TC-71,5278396,3.79453410616762
KYSE-510,10410894,2.7178950129841435
SK-MEL-2,44202524,4.211687473295859
BC-3C,5702613,3.4048868453025163
D283 Med,BRD-A02303741-carboplatin (1-1 mol-mol),4.587928026591079
CML-T1,44589607,0.9502853682806348
AsPC-1,2708,5.587707055847425
PE/CA-PJ15,selumetinib-JQ-1 (4-1 mol-mol),2.840123680248533
PE/CA-PJ15,156414,0.0244775870569668
D283 Med,3825829,1.8555624568055975
HuP-T3,piperlongumine-MST-312 (1-1 mol-mol),1.4346079723069378
AsPC-1,25062766,3.1635616497742283
CML-T1,2733526,2.616681149896765
BT 112,15547703,3.043535770474186
KP-3,151289,0.8654353651458653
BC-3C,9907093,4.348531311208054
GSS,1750826,-0.9325556547078584
PLC/PRF/5,49766530,1.3653713216930163
TC-71,216345,4.518618182669627
KYSE-510,46926350,-3.440649021989863
KYSE-510,387447,-4.55671268851583
BT 112,51039095,3.5175679175043437
NUGC-3,208908,0.9006291067006931
PC-14,135398516,2.1549851018652393
NUGC-3,148198,-1.9201503205114672
BC-3C,10385095,2.7598083039620764
KP-3,11152667,-0.1171632623198148
PC-14,216239,2.3822524941299617
TC-71,5329102,1.5847789313122642
GSS,49850262,3.0382678313203404
TC-71,72193861,0.1171262095330942
HuP-T3,387447,-4.787053098216054
KP-3,6610355,3.647818431996112
PLC/PRF/5,5746,1.7131835455559226
CML-T1,9887053,1.7753443459725933
PLC/PRF/5,637858,2.297656828654134
BC-3C,11317348,4.341878826868443
KYSE-510,4259181,-1.303373724971253
PC-14,637858,2.799364880868444
NUGC-3,46199207,2.298961869566232
BT 112,156414,0.8059624645319847
KMH-2,46398810,2.11078357421812
REC-1,44202524,3.930220827110828
IMR-32,11719255,1.0612984191716195
KYSE-510,9935249,3.150721090572469
CML-T1,7326481,2.1414014754107735
KP-3,selumetinib-PLX-4032 (8-1 mol-mol),5.060633129291673
PLC/PRF/5,984333,1.397091425685376
TC-71,675434,4.563926787252539
PLC/PRF/5,docetaxel-tanespimycin (2-1 mol-mol),-4.468597977998593
CML-T1,6610355,4.414519429527798
HEC-108,5287620,-1.2592050187487678
HuP-T3,568763,0.3762081962980199
NUGC-3,5311281,3.331405084897055
HEC-108,44185566,2.966044024818036
REC-1,6918878,4.654279043966399
AsPC-1,135984461,3.722049898583642
KMH-2,124202324,0.6842828421146526
HuP-T3,25262965,3.989652761156405
AsPC-1,3062316,2.757974416117501
D283 Med,46191454,0.4881415464041219
CML-T1,60168763,3.1201048573104395
D283 Med,71466380,4.234415328805577
BC-3C,24978538,2.520705996569634
IMR-32,445643,2.4517361452368087
TC-71,52912189,3.2729530143525887
HuP-T3,5282054,2.779269170716028
CML-T1,25183872,-2.27655686726873
KMH-2,selumetinib-tretinoin (2-1 mol-mol),4.525741477760766
CML-T1,54619267,3.062776009775362
D283 Med,73707398,0.757498039182734
NUGC-3,26596,-0.5443807488000636
BT 112,54143018,0.6919547440728372
TC-71,2858523,3.0552333661291606
CML-T1,docetaxel-tanespimycin (2-1 mol-mol),-5.351471523499181
TC-71,6852167,2.7255120299816684
PE/CA-PJ15,6917907,-5.814677187736003
GSS,2126,3.9401020125114976
BC-3C,126941,0.5965803483373604
KMH-2,72734382,3.9996380799295497
TC-71,6917907,-4.972763787850012
HuP-T3,56946209,-4.563482636842077
BT 112,44566777,0.6331747644646614
TC-71,72376,-2.05776427230036
AsPC-1,navitoclax-gemcitabine (1-1 mol-mol),1.0785149117899562
GSS,7326481,1.6820638265297014
AsPC-1,52947716,3.328482082087177
GSS,56973724,0.8578806883222132
BT 112,54619267,3.469133833703133
BT 112,10231331,5.608675026595674
KYSE-510,409805,5.991865357716927
IMR-32,tretinoin-carboplatin (2-1 mol-mol),3.3587712115879125
IMR-32,445091,2.4599404391801905
HuP-T3,selumetinib-BRD-A02303741 (4-1 mol-mol),4.443167910893738
IMR-32,12003241,0.5902035807991148
PC-14,1641662,3.170530164943573
PLC/PRF/5,16722836,3.213139894359902
IMR-32,44185566,1.1420453798550203
SK-MEL-2,984333,1.156848706202566
AsPC-1,11955716,-2.13511164723979
CML-T1,11717001,4.07494523492724
BC-3C,168313200,2.4495117116245786
KYSE-510,JQ-1-vorinostat (2-1 mol-mol),1.7192923981826973
PC-14,46843906,3.8082460843083825
KMH-2,selumetinib-navitoclax (8-1 mol-mol),5.9412533496878
GSS,216345,3.2341310071558564
KP-3,11214940,1.020152445144494
HEC-108,selumetinib-vorinostat (8-1 mol-mol),3.960684910603258
CML-T1,5460769,1.000954417912476
GSS,9935249,2.9109339589908374
KMH-2,5281672,4.5141329255176705
BC-3C,5460769,2.335900284678582
BC-3C,56649450,1.638421551071453
PE/CA-PJ15,4521392,3.3811867857617575
KYSE-510,446155,3.8948944231694504
PE/CA-PJ15,123631,2.5337035997034416
REC-1,17755052,3.936834362379093
D283 Med,3689413,-5.066385831563446
IMR-32,JQ-1-UNC0638 (2-1 mol-mol),-0.4447482395606248
PC-14,135875424,3.4913396696572523
PE/CA-PJ15,carboplatin-UNC0638 (2-1 mol-mol),4.28959354666425
PC-14,BRD-A02303741-navitoclax (2-1 mol-mol),2.254377627302129
PC-14,15953870,2.774112835405703
KP-3,46398810,2.326486242571873
TC-71,5287620,-0.8767838826288041
AsPC-1,sirolimus-bortezomib (250-1 mol-mol),0.6140845395504789
D283 Med,4096211,0.7263346692990906
IMR-32,448949,1.621015235329902
CML-T1,135398738,1.6792363237461696
BC-3C,72376,-1.3442346366006723
PE/CA-PJ15,1750826,2.974208117628124
PLC/PRF/5,6917907,-5.5458096708626865
PLC/PRF/5,46907787,4.590488786856309
PLC/PRF/5,5328940,2.094772371360336
TC-71,52947716,3.387720745792808
PE/CA-PJ15,135421197,1.0415253026449975
AsPC-1,445643,4.30663769172778
BC-3C,24964624,1.9385976348562668
PLC/PRF/5,5281672,4.48325980597267
PLC/PRF/5,24180719,4.127629216534508
IMR-32,navitoclax-MST-312 (1-1 mol-mol),-0.9722048125363189
TC-71,49793307,-5.136436244022803
TC-71,7326481,2.7100445020049615
TC-71,4259181,-1.3693696367229935
AsPC-1,SNX-2112-bortezomib (250-1 mol-mol),0.1734990544717531
BT 112,4578,5.535818023647584
BT 112,409805,3.8696760433856774
BC-3C,6505803,1.2910533343434352
PLC/PRF/5,11175137,3.788564460905007
D283 Med,439501,-4.70695325279779
KP-3,3503,1.914788616217679
PC-14,285033,-0.2516082958086743
GSS,375860,-0.7667011218707456
CML-T1,168312962,-0.7219792388324245
D283 Med,6438330,1.0407570094657193
BT 112,11455910,0.2027348347828513
BT 112,1641662,3.733134142495612
IMR-32,10385095,0.2389491055401895
TC-71,1750826,-1.352701584369015
KYSE-510,53495165,1.6518681330938645
PLC/PRF/5,2749,1.5607350957647046
PC-14,10074640,3.427227628615904
AsPC-1,JQ-1-vorinostat (2-1 mol-mol),1.708029438891557
KMH-2,3025944,3.4959476689889266
REC-1,969516,3.1998096166078915
BT 112,11955716,-2.698255200036422
BT 112,104842,-6.929937328010905
TC-71,44566777,0.8822851174146784
NUGC-3,9956119,4.203668139637336
BC-3C,11396600,2.927390282149192
HEC-108,3503,1.40407452628706
BT 112,10427712,3.9873037991521594
REC-1,4477,3.586856374933584
GSS,36314,-6.4893212309123784
BT 112,44197249,1.805481072961874
CML-T1,5113032,5.118103556540756
GSS,44493528,3.3523152661805526
TC-71,11657048,6.095956564705127
PLC/PRF/5,9926054,1.9278694567430317
SK-MEL-2,9911830,2.439526960003118
CML-T1,3634881,2.472630922180769
PC-14,53392493,3.0751770373287894
KMH-2,16741245,3.840749402657228
HuP-T3,4917,3.663340719397695
AsPC-1,4259181,1.083384461798112
KMH-2,322968,1.9273620383949697
IMR-32,46843906,1.39027528579442
D283 Med,24978538,0.887710634714784
SK-MEL-2,5329102,3.2571933996041778
GSS,crizotinib-PLX-4032 (2-1 mol-mol),1.0904657823737454
CML-T1,71680916,4.411758468982172
KP-3,637858,2.0723058540314945
D283 Med,9952709,1.9575920153591797
GSS,6918878,-0.6581972049472502
REC-1,2742550,3.767979931246989
GSS,JQ-1-UNC0638 (2-1 mol-mol),0.1184072695888955
BC-3C,10074640,3.4102018191524883
D283 Med,219104,2.423967848276844
AsPC-1,9911830,2.936776162598985
BC-3C,24775005,3.086821540542589
SK-MEL-2,5278396,4.053684378742761
GSS,656346,-0.1635009430971385
PE/CA-PJ15,89183176,5.853169928784385
CML-T1,navitoclax-piperlongumine (1-1 mol-mol),0.6324311645871261
GSS,2708,3.514621167476827
GSS,11234052,2.5498052611877906
KMH-2,327653,2.6435192789338724
KMH-2,6852167,2.5301856007997348
IMR-32,60750,-5.157709658605212
HEC-108,126941,-2.7817702272816267
BC-3C,ISOX-bortezomib (250-1 mol-mol),0.1562903558969083
TC-71,1716436,2.8333127798173012
D283 Med,70680404,3.701093742955501
SK-MEL-2,16720766,0.6122666828133897
IMR-32,65628,1.73184881776237
D283 Med,selumetinib-tretinoin (2-1 mol-mol),-0.135437445848875
BT 112,24964624,1.8320643006347463
BC-3C,4261,2.447745177613448
KP-3,9823820,5.493613069708307
BT 112,675434,4.248539137201915
PLC/PRF/5,9884685,0.8097728854232519
TC-71,11317348,1.6794127862493595
D283 Med,11497983,0.3282977330400873
SK-MEL-2,241158,4.163944752728283
KP-3,11222830,1.836638607658496
TC-71,67291369,1.697365024153772
AsPC-1,4578,5.074011683523406
AsPC-1,374536,-1.7506249493921369
KMH-2,6252,-0.7158420980115995
HuP-T3,5566,3.0002994658008935
NUGC-3,6623618,1.8044254730456488
PC-14,tanespimycin-bortezomib (250-1 mol-mol),-0.4303356181915626
GSS,selumetinib-piperlongumine (8-1 mol-mol),3.746309794071323
AsPC-1,11178236,-3.0731642515052098
CML-T1,JQ-1-vorinostat (2-1 mol-mol),-0.0778878507242399
GSS,107985,-3.999302317591999
D283 Med,2858523,2.945286331512549
HEC-108,23725625,5.683398539557035
NUGC-3,44607531,1.4059463096216085
PE/CA-PJ15,16038120,1.6620887407602336
KMH-2,11612883,2.5035978942287653
IMR-32,decitabine-carboplatin (1-1 mol-mol),1.155790499448351
IMR-32,135984461,1.157056096731398
CML-T1,439501,-2.361432010025089
BT 112,16736978,2.096742119081054
AsPC-1,54618164,4.187549957668634
PLC/PRF/5,9952709,2.132159484028921
PLC/PRF/5,285033,-1.0245356570651007
BT 112,sirolimus-bortezomib (250-1 mol-mol),0.0905666857071608
NUGC-3,navitoclax-pluripotin (1-1 mol-mol),-0.2528035767410677
TC-71,135421197,1.432077175902578
PLC/PRF/5,168313200,3.731927316813972
KYSE-510,crizotinib-PLX-4032 (2-1 mol-mol),2.704942913210382
BC-3C,4705,2.713954554956948
BC-3C,2828334,6.256938950085984
BT 112,168313200,1.7991755506997456
GSS,44489127,4.490877550009559
PE/CA-PJ15,navitoclax-gemcitabine (1-1 mol-mol),-2.7969832915442487
BC-3C,135659046,3.4176936154501845
HuP-T3,2729026,2.9922624267509317
NUGC-3,135411,0.6658905713792896
HEC-108,4477,-0.1758732099665472
BC-3C,erlotinib-PLX-4032 (2-1 mol-mol),2.009717450680508
GSS,24180125,2.5429718088865503
TC-71,doxorubicin-navitoclax (2-1 mol-mol),-1.896927642929895
GSS,5311,0.0285054167810616
D283 Med,45279963,2.3359358447892093
HuP-T3,12001922,2.3367896101102907
HEC-108,26596,-0.981636576627464
NUGC-3,6610216,4.213897022791766
KYSE-510,5494449,3.907368158385813
D283 Med,16659841,2.7868909453303337
SK-MEL-2,11175137,3.892112171552428
KYSE-510,5328940,1.913248190471614
D283 Med,54454,3.694221793159312
PC-14,3136844,4.323237919355452
BT 112,44202524,1.0325728707890818
BC-3C,2113511,7.83254417625961
D283 Med,89183176,3.347036918603312
PC-14,10127622,1.2028917526414225
KYSE-510,9911463,4.240688148771923
HuP-T3,salermide-PLX-4032 (12-1 mol-mol),5.718732466752557
PC-14,3854666,0.2934048653754776
GSS,54143018,-0.6822032956389418
IMR-32,148198,-7.685974048863974
NUGC-3,46191454,1.0095217895959832
SK-MEL-2,444795,5.015543431579257
PLC/PRF/5,409805,5.993816683766392
TC-71,44202524,1.078096145491692
PLC/PRF/5,4917,3.571946876542999
PE/CA-PJ15,4917,3.7625286971373457
KP-3,3062316,0.7965701280540384
D283 Med,54613361,-0.9633976035183264
IMR-32,135928012,1.2971235582262872
PLC/PRF/5,23582824,0.2161179164080368
REC-1,9967941,4.301773121348624
BC-3C,46907787,1.9222116024183311
BC-3C,2733526,4.323673420326108
KP-3,675434,4.282223019896807
KYSE-510,71466578,5.581240730051074
BC-3C,11656518,2.6271018455392787
KP-3,16725315,3.7411302570306457
PE/CA-PJ15,426756,4.910865073915536
PLC/PRF/5,7251185,2.990034392288682
HuP-T3,JQ-1-MK-0752 (1-1 mol-mol),1.9324342474715044
PLC/PRF/5,tanespimycin-gemcitabine (1-1 mol-mol),-1.839909044942684
KYSE-510,16725315,5.159408584110691
CML-T1,135398516,1.062716502546658
KMH-2,selumetinib-GDC-0941 (4-1 mol-mol),1.8839311590073071
REC-1,123631,3.5036781589715296
D283 Med,44137675,1.6630116690363648
KMH-2,44607531,1.2258651488337708
PE/CA-PJ15,6438330,2.858510803754111
GSS,10184653,-1.0733784273060956
KP-3,25262965,-0.5859350687588153
BT 112,45279963,3.846989137571412
REC-1,10296883,4.285765558435674
AsPC-1,4917,3.701934006694463
PC-14,2742550,4.050636111371891
PC-14,3384730,1.2394493376738462
KYSE-510,10296883,4.094303304653805
IMR-32,119182,-1.1542405671304483
BT 112,9911830,1.5924575123512974
TC-71,219104,2.1982331607961423
IMR-32,44607531,1.008428819946378
PC-14,9956119,3.2961236861869363
AsPC-1,2742550,5.133078791264603
GSS,67291369,-1.6191946974724234
KYSE-510,11717001,5.441706570133951
NUGC-3,65628,4.4498634773511725
D283 Med,5282054,2.5822291305993064
SK-MEL-2,42642645,1.9027852819088145
SK-MEL-2,9866186,1.79871033508337
BC-3C,5311,2.3431611865568436
GSS,49836020,4.0402801556040036
AsPC-1,702558,5.7476960936684565
NUGC-3,16736978,1.1572175924019654
KMH-2,44259,0.757260384175628
PLC/PRF/5,71304818,1.407670612460023
HuP-T3,285033,-3.1273004056463916
AsPC-1,16720766,4.029008761480653
PC-14,24821094,-1.655897912694663
AsPC-1,5281672,6.419333790815674
NUGC-3,selumetinib-vorinostat (8-1 mol-mol),2.91278989567709
PE/CA-PJ15,carboplatin-etoposide (40-17 mol-mol),2.099370260607421
KMH-2,73707438,4.106138783340211
CML-T1,selumetinib-vorinostat (8-1 mol-mol),2.04753807538672
BC-3C,5281321,-2.4136717111914394
HuP-T3,10231331,2.6811135289001236
CML-T1,11497983,1.5281324652658594
BT 112,tanespimycin-gemcitabine (1-1 mol-mol),-1.366722683150895
KYSE-510,2749,2.997707455196536
CML-T1,2130404,3.1458672398900425
AsPC-1,5287620,-2.2438477065180233
D283 Med,3503,1.294693501027344
PLC/PRF/5,107970,2.9757983230893092
AsPC-1,doxorubicin-navitoclax (2-1 mol-mol),0.4165226995067387
AsPC-1,12001922,2.2862775547931675
NUGC-3,12001922,1.850764543497205
CML-T1,5311,-0.0657355385312412
PC-14,5335621,2.4579899492998223
NUGC-3,45100481,6.363194065049644
NUGC-3,439501,-0.8687930764506365
PE/CA-PJ15,4259181,0.664963818132981
PLC/PRF/5,60700,2.1257360260206255
BT 112,4378219,2.0035787751838057
KYSE-510,135411,0.4893840258787899
PC-14,675434,4.614829643257481
SK-MEL-2,25062766,3.5768693362394126
IMR-32,BRD-A02303741-navitoclax (2-1 mol-mol),-0.3067922241751981
SK-MEL-2,2945648,3.473513810202376
HEC-108,crizotinib-PLX-4032 (2-1 mol-mol),2.8622947616000984
AsPC-1,72193861,3.428817244246792
AsPC-1,676352,1.9564823338284063
TC-71,216239,1.733394307916732
AsPC-1,81146,4.947223766743442
PC-14,60700,-1.2251472186443342
KMH-2,6438330,1.5352425056894736
TC-71,46199207,3.520234926566718
CML-T1,10077130,2.746402588915116
IMR-32,49766530,-2.845366137118504
KYSE-510,5394,4.807780138159589
PC-14,568763,1.308843380200126
PC-14,5281321,2.005542943561995
BC-3C,9866186,2.6073675876290614
TC-71,BRD-A02303741-navitoclax (2-1 mol-mol),3.5378360655704655
HEC-108,6918837,-1.8871962922774617
KYSE-510,969516,3.458410952028274
SK-MEL-2,44185566,3.0051699870646176
KYSE-510,5278396,3.947084750607045
HuP-T3,sirolimus-bortezomib (250-1 mol-mol),0.6074306873304286
AsPC-1,23725625,6.32859301599116
PLC/PRF/5,11485656,2.5978340800355544
TC-71,5281672,4.896432719022209
HuP-T3,23725625,5.187021863055133
BC-3C,carboplatin-UNC0638 (2-1 mol-mol),3.8903770573402023
PLC/PRF/5,1750826,0.448797616081414
KMH-2,73707386,2.2684707650817453
PC-14,11719255,2.8273442583778072
D283 Med,23635314,-3.5786484067215545
KMH-2,31703,-2.071418108926546
NUGC-3,6918878,0.8478164423084844
IMR-32,5287969,-2.3612460649135856
NUGC-3,selumetinib-navitoclax (8-1 mol-mol),3.4523021838001693
D283 Med,44632017,0.7172381887934464
AsPC-1,4788,5.925917601642537
AsPC-1,5738263,4.8764899816054905
TC-71,44607530,1.2887336878833424
GSS,4917,1.973946077381158
PLC/PRF/5,2871966,1.1678355664702484
NUGC-3,4259181,-1.671238825802355
KP-3,71466578,6.197300139241283
BC-3C,53481919,4.140054830194117
GSS,216239,2.0047159141488393
CML-T1,JQ-1-navitoclax (2-1 mol-mol),-0.3838204075177596
KYSE-510,3689413,3.0228627584183565
KMH-2,71304818,1.835622422813945
AsPC-1,25105715,4.199758530142014
PLC/PRF/5,53232,2.3507678066528146
SK-MEL-2,11612883,4.120849200953437
HCC33,54143018,-0.7766554454051989
PC-14,5978,-3.445347134539419
KMH-2,54613361,-1.5882427638951675
HuP-T3,6610216,4.722811341582641
HuP-T3,11222830,1.7699584455080513
PLC/PRF/5,445643,4.098978273092887
BT 112,6918736,-3.569526346741858
KYSE-510,navitoclax-sorafenib (1-1 mol-mol),1.987742032635523
AsPC-1,136227924,3.2025742465891938
KP-3,54618164,4.648325993327064
GSS,5278396,2.9715685706298753
D283 Med,docetaxel-tanespimycin (2-1 mol-mol),-4.966560181844395
CML-T1,4096211,0.5897034084412636
PLC/PRF/5,439501,-1.8160204684239925
KMH-2,119607,3.775698687409495
HEC-108,5281321,-0.2460018354270553
SK-MEL-2,5280436,1.683380720570961
NUGC-3,24964624,2.816089993053737
REC-1,24748573,5.040628139289987
BC-3C,19582717,4.645606711005002
KP-3,navitoclax-birinapant (1-1 mol-mol),4.867400539565304
IMR-32,5738263,2.202256609757131
D283 Med,216345,1.9831386358290584
HEC-108,11507802,1.3993540262685686
KP-3,11640390,3.558251661617552
KP-3,568763,-0.0803294122123086
TC-71,156414,1.5752060003210238
TC-71,168313200,3.674389674642696
BT 112,16722836,2.2677202044282976
PE/CA-PJ15,650361,5.890408316913619
SK-MEL-2,6914657,-2.613888672277605
D283 Med,6917907,-6.043720587150759
KP-3,24785538,0.9837076258398504
TC-71,4705,3.1245427089592757
PC-14,24779724,4.4167236388652364
HuP-T3,702558,5.633624519144866
NUGC-3,9840324,5.607421553210407
CML-T1,208908,1.88775844056814
D283 Med,53392493,1.8196798066611335
PLC/PRF/5,10127622,5.822104425847518
PC-14,9868037,2.5861209247826644
HEC-108,2945648,2.8918279332914074
KYSE-510,24748573,1.7819793206160368
BT 112,60750,-4.243293157722899
TC-71,3543504,2.453768749400788
REC-1,1566236,3.018034053127421
PC-14,24889392,3.614733856805847
CML-T1,168313016,4.15358640853123
TC-71,10077130,3.9992521611924383
PLC/PRF/5,54618164,4.054681529600222
HuP-T3,327653,2.4979616286385573
SK-MEL-2,446155,1.2117234530094174
AsPC-1,71680916,4.418583351869457
PE/CA-PJ15,2729026,3.0133380592288073
HuP-T3,46199207,3.4499209547515433
AsPC-1,9825149,2.485133390345911
AsPC-1,24964624,2.5492070232527424
TC-71,24772860,-2.359845249946639
SK-MEL-2,3503,1.8293327091202949
PLC/PRF/5,9823820,4.33597490165482
HEC-108,3854666,0.9548518440486092
AsPC-1,24785538,0.8298650260870277
KMH-2,11964036,1.4191519849589271
KMH-2,44137675,5.057620935637761
AsPC-1,piperlongumine-MST-312 (1-1 mol-mol),2.821737440312523
CML-T1,navitoclax-gemcitabine (1-1 mol-mol),-3.0033720863451467
KMH-2,2858523,2.563233361065934
NUGC-3,104842,-3.630941012104842
KMH-2,9907093,3.572106113899987
PC-14,65064,5.646584439038967
HuP-T3,9911463,3.677427040789425
NUGC-3,11238147,1.6979806907659976
GSS,676352,1.6077485317167353
PLC/PRF/5,46174525,4.37489170875269
NUGC-3,piperlongumine-MST-312 (1-1 mol-mol),2.129303431734592
KMH-2,11960529,4.291330287455724
HuP-T3,72193861,3.3106720937076233
KP-3,100016,6.07483479536675
NUGC-3,31703,-2.4505540295286066
BT 112,carboplatin-etoposide (40-17 mol-mol),1.4555391384046878
TC-71,11178236,-6.303441880706198
PLC/PRF/5,135999136,4.161588438871366
NUGC-3,2729026,2.522310882878487
PLC/PRF/5,5566,3.2576830455909827
IMR-32,135875424,2.969458523828033
PE/CA-PJ15,11228183,2.954707650998396
PE/CA-PJ15,5746,0.107893092080109
IMR-32,44632017,0.117048778259507
KMH-2,9911463,2.975818602931934
PC-14,2126,3.655976740297496
BC-3C,6450551,3.704028205237641
NUGC-3,11178236,-3.011820251485286
PC-14,25102847,1.7676592344294957
HuP-T3,3634881,3.0028113890745707
NUGC-3,11455910,1.6597314376827883
GSS,135398738,2.9294910568684513
NUGC-3,sirolimus-bortezomib (250-1 mol-mol),0.5062722406192697
TC-71,25102847,1.6599052740629052
TC-71,24821094,3.5076565350362907
AsPC-1,57519531,4.317220146110072
BC-3C,46398810,2.835137840237641
D283 Med,44566777,0.6704743507952735
IMR-32,selumetinib-JQ-1 (4-1 mol-mol),0.7090363184607439
NUGC-3,5281672,4.639634852676749
CML-T1,selumetinib-UNC0638 (4-1 mol-mol),2.45517668205048
KYSE-510,selumetinib-PLX-4032 (8-1 mol-mol),4.94534641943281
PE/CA-PJ15,9903786,2.2611792207171484
NUGC-3,159324,2.9089691628310845
PE/CA-PJ15,72193861,0.6686129421450179
AsPC-1,54613361,2.957295670472447
IMR-32,15953870,3.6691189890833416
KYSE-510,702558,5.70033932722313
BT 112,5291,3.7853178637094262
BC-3C,10410894,2.9989321251620495
BC-3C,15953870,3.424334340589905
PE/CA-PJ15,11656518,0.2985068958700391
HuP-T3,11427553,3.1840600229712037
BT 112,5351362,1.3510507237988774
NUGC-3,9915743,-0.9717204559547163
AsPC-1,168313200,3.2842521999758523
CML-T1,9884685,1.1136090650670494
HuP-T3,3025986,0.0333046209415895
KYSE-510,151289,1.5856860037874574
D283 Med,2871966,-1.8966862089774792
D283 Med,2749,1.8420962714891145
PE/CA-PJ15,sirolimus-bortezomib (250-1 mol-mol),0.416438105686926
IMR-32,45279963,1.9636724308157116
KYSE-510,57330099,3.1601645044578195
NUGC-3,10302451,1.9926087789716964
AsPC-1,6505803,-1.959385905579291
HEC-108,46907787,5.113191551513952
HuP-T3,selumetinib-MK-2206 (8-1 mol-mol),2.743935040601299
PLC/PRF/5,serdemetan-SCH-529074 (1-1 mol-mol),2.9725391299577
HuP-T3,10074640,3.8159838645365807
REC-1,24951314,4.225069599426471
AsPC-1,25161177,4.641147259380914
HuP-T3,16013152,4.473149012747972
CML-T1,26596,-2.14043660837674
PC-14,44137675,3.2204053533427284
PLC/PRF/5,44589607,3.41392046791236
IMR-32,16659841,1.6878401136159278
HEC-108,11964036,3.068027447156284
AsPC-1,ISOX-bortezomib (250-1 mol-mol),1.1160066277256155
HuP-T3,11178236,-4.0067645508863174
TC-71,1641662,2.9529882792726205
KMH-2,doxorubicin-navitoclax (2-1 mol-mol),-2.698351404926901
AsPC-1,285033,-0.5419823336362324
TC-71,4477,0.8459863190768653
D283 Med,71466578,4.625574960038893
BT 112,54678924,1.7826120968253354
CML-T1,5284329,2.20205002414717
NUGC-3,16720766,-0.6930949908471143
KMH-2,452548,-2.285409678805446
SK-MEL-2,24901704,4.250191014208499
KP-3,1716436,2.492121125287185
PLC/PRF/5,462382,0.8054265083741808
SK-MEL-2,24180125,4.1729350383120485
KP-3,2841722,4.276365961207118
BC-3C,60700,1.733011793798261
PC-14,11626560,1.2085096706261982
D283 Med,3136844,3.2984572039507274
GSS,44632017,0.6868266407507463
CML-T1,656346,-0.3506831167953311
AsPC-1,65064,5.237570806440869
CML-T1,89928392,0.2335848320544615
HuP-T3,135411,0.8125735513868637
AsPC-1,71304818,2.27524368423619
TC-71,19582717,3.708349835068161
GSS,4259181,-2.284174243977743
D283 Med,24821094,1.9076821647913431
PC-14,46907787,2.390406251773133
HuP-T3,5278396,4.193223405360703
KYSE-510,148124,-5.076093364813466
BT 112,56963564,-0.0795668388707357
AsPC-1,4705,5.582464580618905
BT 112,11964036,2.3781270120302556
TC-71,56649450,1.7925910769763338
TC-71,3689413,0.4216372127873143
KMH-2,54619267,4.781349834096086
CML-T1,9444,4.326131103147221
PLC/PRF/5,2746,3.4483774015176447
REC-1,44137675,4.048277998263935
PE/CA-PJ15,44493528,4.269836707696998
D283 Med,9911463,2.6227366888943986
BC-3C,9840324,5.257795197767218
BT 112,46843906,3.5145309028016953
PE/CA-PJ15,5394,5.238681648406455
PE/CA-PJ15,71680916,4.353383537079945
PE/CA-PJ15,salermide-PLX-4032 (12-1 mol-mol),5.176983203845215
BC-3C,439501,-3.6854661122428896
SK-MEL-2,selumetinib-UNC0638 (4-1 mol-mol),2.1798950072084393
HEC-108,5738263,3.298542747172543
BC-3C,5282054,4.4712672073103805
GSS,5978,-3.583716812635495
CML-T1,54454,4.932328921432074
D283 Med,5287620,-0.8821442485679016
KMH-2,54454,2.1726847492597097
TC-71,9826308,0.5352405871605554
BC-3C,1566236,3.5939971161988367
REC-1,24779724,3.0011490046538407
D283 Med,54765302,3.826457537496404
KMH-2,JQ-1-carboplatin (1-1 mol-mol),1.5982474569998335
SK-MEL-2,16065773,2.2843829100739206
IMR-32,66577038,3.174978939657769
NUGC-3,11152667,-0.5905276129747937
CML-T1,25150857,1.621602747179882
AsPC-1,46843906,4.099754684530221
GSS,89928392,1.323969596834067
IMR-32,3854666,-0.9157783750736912
PC-14,5280436,5.041517753496301
SK-MEL-2,285033,0.8066514843785048
GSS,11222830,1.6810668480668536
NUGC-3,25262965,-2.3767281092529773
CML-T1,135875424,3.5304182343940935
D283 Med,ISOX-bortezomib (250-1 mol-mol),-0.293421488526388
SK-MEL-2,6438330,2.47559376570888
KMH-2,26596,-2.508510760962814
AsPC-1,16725315,5.210607806565737
IMR-32,1716436,2.9168233069343272
BC-3C,7326481,3.094137059612246
CML-T1,5281672,4.316508820409711
NUGC-3,135440466,3.320457627404024
REC-1,46174525,6.333082683836244
CML-T1,44632017,0.7838820876699769
KYSE-510,11626560,2.5788548170322905
KYSE-510,44607530,3.014462869267947
KMH-2,56963564,-1.1450506350043832
GSS,613753,3.1264488438314877
SK-MEL-2,409805,5.943118564665864
TC-71,10127622,6.299855507310025
PLC/PRF/5,selumetinib-navitoclax (8-1 mol-mol),2.073125407442445
KP-3,23725625,6.634630648563009
D283 Med,675434,4.226898122057941
PC-14,44819697,2.88284620615727
AsPC-1,104842,0.0602967281328717
KP-3,44185566,2.190069985543879
KMH-2,11455910,1.2516447842889498
PE/CA-PJ15,448949,2.1767399240328063
BT 112,1750826,-2.206420752683485
PC-14,72193861,0.0281288419645521
D283 Med,107985,-4.659724680199273
PE/CA-PJ15,JQ-1-UNC0638 (2-1 mol-mol),2.4300148232580647
BC-3C,119182,3.231501407326556
AsPC-1,25183872,-0.8583413037674358
D283 Med,46843906,0.2520687270302775
AsPC-1,42611257,3.6284330949745094
CML-T1,10410894,3.3337757256136245
AsPC-1,1641662,3.9838157290035
SK-MEL-2,46398810,3.573271637439445
AsPC-1,57519531,4.317220146110072
REC-1,2858523,2.1850862642442603
IMR-32,57519531,1.1506946442344708
NUGC-3,24856436,0.82961608148075
IMR-32,11427553,-1.123365595093854
KP-3,5746,2.3079316144145037
D283 Med,9825149,0.299021869301145
HEC-108,5351362,1.2308965787917867
PLC/PRF/5,navitoclax-sorafenib (1-1 mol-mol),1.4056184494382928
PE/CA-PJ15,3503,2.508358326972826
SK-MEL-2,16722836,3.274518367444452
AsPC-1,46191454,4.573546152494067
AsPC-1,53232,3.925663364010775
KYSE-510,23582824,1.1574751631008686
D283 Med,107970,1.5899675113879286
GSS,6438330,1.6048881304001728
KYSE-510,44507138,2.660176958241633
D283 Med,51037431,2.0998452060410484
AsPC-1,salermide-PLX-4032 (12-1 mol-mol),5.331580657961115
IMR-32,67156097,-3.749657984615806
GSS,176870,2.4404167131145087
NUGC-3,9866186,0.7503234239606524
TC-71,57519531,1.8808488069633584
GSS,984333,-2.1917176410313557
AsPC-1,462382,1.1756614609859282
NUGC-3,119607,5.354752865889699
D283 Med,9866186,-1.70229195873881
TC-71,24951314,0.8492609067118003
AsPC-1,10385095,2.76496705920137
PE/CA-PJ15,67156097,-1.715044152720716
KYSE-510,6610216,4.6142103505031375
HuP-T3,15953870,4.533958601099395
IMR-32,5460769,-1.03513215878617
KP-3,10302451,2.012637643935689
PC-14,676352,2.34047579855133
BT 112,erlotinib-PLX-4032 (2-1 mol-mol),5.222233695296922
GSS,1641662,2.8890851820433916
AsPC-1,11175137,3.2351214827225956
TC-71,148198,-5.123045083168725
PE/CA-PJ15,107985,-2.5858433218961108
NUGC-3,135999136,4.702707449703542
KP-3,5284373,-1.257942285034982
HuP-T3,119607,5.841541098284191
GSS,serdemetan-SCH-529074 (1-1 mol-mol),-0.5162771297799539
AsPC-1,11625818,4.311821961769238
KMH-2,613753,3.3587916695976845
KMH-2,6918736,-4.379337096779674
PLC/PRF/5,2729026,3.0680044306331853
IMR-32,46943432,1.660440908421779
IMR-32,67291369,-0.7641939320697528
BC-3C,2742550,3.812502027917897
TC-71,46191454,0.0065418059845309
SK-MEL-2,15547703,2.9186281854193545
PLC/PRF/5,selumetinib-JQ-1 (4-1 mol-mol),3.8128877630515614
KP-3,16722836,1.35953951460932
HuP-T3,25126798,3.926602492728053
HuP-T3,selumetinib-PLX-4032 (8-1 mol-mol),4.085577653340594
AsPC-1,56946209,-4.100794030874608
PE/CA-PJ15,9933475,1.484249502746553
HEC-108,135875424,4.07561778301408
CML-T1,54618771,0.285641515878807
SK-MEL-2,JQ-1-vorinostat (2-1 mol-mol),1.8581618097986792
PC-14,selumetinib-GDC-0941 (4-1 mol-mol),1.0786711406515603
AsPC-1,6505803,-1.959385905579291
AsPC-1,6918328,0.3822733035015269
BC-3C,984333,4.266578154635455
KMH-2,3543504,3.885538325062561
AsPC-1,89928392,1.5669078555551634
SK-MEL-2,6184667,2.892199384908145
KYSE-510,4261,2.38505353909188
PLC/PRF/5,selumetinib-decitabine (4-1 mol-mol),5.478064987213685
AsPC-1,11152667,-0.9426796832875202
TC-71,46843906,1.6340199828461874
HuP-T3,11364421,1.6783982807514195
AsPC-1,2708,5.587707055847425
NUGC-3,2858523,3.144398220920389
BC-3C,49846579,2.0270080363293084
CML-T1,327653,2.5732071532781866
GSS,6184667,2.6692665720528663
PLC/PRF/5,5351362,1.2536475241143998
HEC-108,72193861,0.4949264975227585
BT 112,6438330,0.2152284023246567
PE/CA-PJ15,3552672,4.25665482583999
TC-71,11719255,3.682230222716305
PE/CA-PJ15,BRD-A02303741-navitoclax (2-1 mol-mol),3.651114903292107
KYSE-510,6914657,-4.206627725040442
HuP-T3,docetaxel-tanespimycin (2-1 mol-mol),1.3630986120545014
BC-3C,3025944,4.0265096879524425
D283 Med,16725315,3.6263864453470993
PC-14,409805,5.400742947036561
SK-MEL-2,10074640,3.96153005990111
KMH-2,54618305,4.158753389755641
HuP-T3,selumetinib-vorinostat (8-1 mol-mol),2.242647534898157
CML-T1,148198,-3.9003291277504526
CML-T1,5978,-4.3443825686600785
BT 112,44486219,4.929058970539822
GSS,25102847,2.294983786012222
TC-71,374536,1.285029194537173
BC-3C,SNX-2112-bortezomib (250-1 mol-mol),0.1825674084745871
REC-1,9444,2.9104997308545264
NUGC-3,24180125,1.117540206425308
KP-3,44507138,3.577234847384827
IMR-32,23725625,1.3692943803886752
SK-MEL-2,46199207,3.970946890203047
PLC/PRF/5,89928392,1.4476650930756756
SK-MEL-2,5978,4.555773696257843
PE/CA-PJ15,24821094,0.7369223016507568
GSS,3503,1.400103241305967
AsPC-1,10184653,1.884059851333118
HuP-T3,753704,5.56041062328625
KYSE-510,123631,3.5525905570051775
GSS,68056272,2.810162403713863
PLC/PRF/5,5460769,4.572267252029585
D283 Med,3543504,2.346861617384035
KMH-2,56946209,-4.458352530363758
KYSE-510,11257553,1.7122426688999433
REC-1,3552672,3.972703597128775
REC-1,10127622,4.851193058289671
IMR-32,1242560,3.4733172162405475
AsPC-1,216239,1.707935704723652
CML-T1,1242560,3.0102013740079783
PLC/PRF/5,2945648,3.30932906714191
CML-T1,216468,0.1350088901202253
IMR-32,216468,-0.6433507653432746
AsPC-1,1716436,2.9196038383716205
KYSE-510,5460769,1.9314900427321815
KYSE-510,5287969,-1.376793191469423
KMH-2,5335621,4.707137208906537
PLC/PRF/5,15983966,-3.900745627202261
D283 Med,71751553,4.245405525851178
BC-3C,676352,1.6463084262093086
KP-3,9936388,-3.794861235698215
KP-3,10127622,3.984264610718113
CML-T1,5470400,-2.3275269381266326
PC-14,56963564,-1.1093781360845574
KYSE-510,24785538,3.8929598671966903
BC-3C,5746,1.336712562734557
AsPC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.9679789776412068
BC-3C,387447,-4.766294881634265
HEC-108,46398810,3.0484074002567287
HEC-108,613753,3.395991597715239
GSS,11152667,-1.6427216501784565
BT 112,71466578,4.453393330882409
KYSE-510,4096211,1.7438447557773715
KMH-2,2729026,1.9828733907594425
GSS,navitoclax-PLX-4032 (1-1 mol-mol),-0.1809720865617626
REC-1,11238147,6.148625364557363
IMR-32,selumetinib-BRD-A02303741 (4-1 mol-mol),5.67541975977436
D283 Med,44607531,2.0088553908095954
BC-3C,serdemetan-SCH-529074 (1-1 mol-mol),2.334390800417499
TC-71,6505803,0.7879550085796516
D283 Med,44589607,0.7733689758035397
KMH-2,JQ-1-MK-0752 (1-1 mol-mol),0.9361910549949944
GSS,124202324,0.8676764714076153
PLC/PRF/5,5278396,3.7093458653546008
HEC-108,17759555,3.905037779906696
IMR-32,selumetinib-piperlongumine (8-1 mol-mol),2.3599682422063935
BT 112,crizotinib-PLX-4032 (2-1 mol-mol),1.4315306190333636
HuP-T3,navitoclax-pluripotin (1-1 mol-mol),0.368847097693027
D283 Med,9884685,0.4652080192462777
PLC/PRF/5,vorinostat-carboplatin (1-1 mol-mol),3.89698394043618
AsPC-1,24753719,4.618559637878285
PE/CA-PJ15,122327,4.1738841994986
AsPC-1,alisertib-navitoclax (2-1 mol-mol),1.2084192852647102
HuP-T3,44491742,4.372770131484514
PE/CA-PJ15,637858,2.2671736383658985
D283 Med,123631,1.7488376783176118
AsPC-1,25161177,4.641147259380914
D283 Med,24753719,3.1316348069328357
AsPC-1,445091,6.474898015897582
PLC/PRF/5,9936388,3.289212143502143
TC-71,25183872,-1.5500071356458365
PE/CA-PJ15,107970,2.9199181042545175
KP-3,navitoclax-sorafenib (1-1 mol-mol),3.3327970486975813
KP-3,11175137,4.186642684142347
BC-3C,216468,3.747621990650704
BT 112,54613361,-2.861738596856594
AsPC-1,2729026,3.0501658646319796
NUGC-3,16741245,5.13652858268846
PC-14,navitoclax-birinapant (1-1 mol-mol),-0.0924928169959921
PLC/PRF/5,327653,3.1034760000853994
PLC/PRF/5,carboplatin-etoposide (40-17 mol-mol),1.4655245766485818
IMR-32,136227924,2.2103917598606326
GSS,54618771,-0.6166501734641827
GSS,selumetinib-decitabine (4-1 mol-mol),3.139027234548702
TC-71,44137675,4.065441428743714
KYSE-510,serdemetan-SCH-529074 (1-1 mol-mol),2.5747008334120243
KMH-2,51037431,3.7952030815775166
BT 112,216468,1.2826036756590016
CML-T1,44491742,2.876043803936746
GSS,8515,3.1387042874632396
CML-T1,176870,2.5950096151434345
NUGC-3,20959075,-3.167914297854444
HuP-T3,53392493,2.0684681956337654
PE/CA-PJ15,445643,4.027920596276799
HEC-108,119607,5.2604571432303
BT 112,4788,5.347186098301908
BT 112,374536,1.8950859806063296
D283 Med,135984461,1.545115225409391
AsPC-1,10296883,4.32215490848641
HuP-T3,46398810,2.968900053185397
KMH-2,1641662,2.102070811011261
CML-T1,451668,-2.1837981176470738
TC-71,5311,1.3024726446901174
PLC/PRF/5,44462760,3.3803683788206977
SK-MEL-2,vorinostat-navitoclax (4-1 mol-mol),1.004224473149691
AsPC-1,navitoclax-pluripotin (1-1 mol-mol),0.1867529421630529
BC-3C,53392493,3.900517409737139
CML-T1,11455910,-0.3388293365451558
CML-T1,5291,-1.725219795873105
REC-1,15983966,3.4749561975260237
KMH-2,9936388,-5.258192279265897
AsPC-1,53392493,3.5744228182767164
PLC/PRF/5,11214940,4.147123429667128
REC-1,135398738,2.0417076153382316
SK-MEL-2,2742550,4.157489560725976
PE/CA-PJ15,5287620,-2.2543660755178827
BT 112,6917907,-5.932626557425448
D283 Med,carboplatin-UNC0638 (2-1 mol-mol),3.6189692606648016
PLC/PRF/5,25195348,3.2524515337445195
KYSE-510,135659046,4.68799289750423
D283 Med,5738263,2.4300934909040115
HuP-T3,12003241,-0.2833744856936582
D283 Med,9911830,1.6953738838285617
TC-71,45279963,3.880317889639905
AsPC-1,10302451,4.160835682979353
NUGC-3,vorinostat-navitoclax (4-1 mol-mol),1.4365952951135428
REC-1,4096211,5.082492134853834
IMR-32,3025944,4.24532382962554
BC-3C,3825829,3.767472456252349
PLC/PRF/5,1566236,1.8943301700866575
CML-T1,selumetinib-MK-2206 (8-1 mol-mol),2.7460107356112644
GSS,2945648,2.1096861600968104
NUGC-3,1566236,1.9302798040984224
BT 112,327653,2.6431646979441012
IMR-32,72193861,-1.3213295173964232
PLC/PRF/5,81146,4.433235641526054
KP-3,6610216,4.430226203729176
PLC/PRF/5,17755052,2.996247453993083
AsPC-1,5291,4.446798964395248
GSS,6918328,-2.4079984893551525
KMH-2,2113511,6.2177043075937695
BC-3C,10172275,3.9205906019111136
KYSE-510,16065773,3.775914680210675
AsPC-1,6917907,-5.50087073609159
SK-MEL-2,53232,2.229796867506251
CML-T1,4477,-0.6676342393752774
KP-3,46943432,0.0179698171752152
REC-1,42611257,4.975411256218309
KMH-2,tanespimycin-gemcitabine (1-1 mol-mol),-3.4451248256703804
NUGC-3,11625818,4.616569299046342
PE/CA-PJ15,9826308,0.508783393758027
NUGC-3,44185566,2.146767948185341
HuP-T3,5460769,4.291069487745317
CML-T1,selumetinib-PLX-4032 (8-1 mol-mol),3.463736211464864
CML-T1,15547703,2.6642294109203823
KYSE-510,navitoclax-gemcitabine (1-1 mol-mol),-3.1930550880186312
BC-3C,53232,2.555500536018932
PE/CA-PJ15,23725625,6.336602626198082
HEC-108,2874250,5.591629636654944
HEC-108,44819697,-1.05954599286061
CML-T1,49793307,-4.188413118061572
IMR-32,9803433,2.6929361698843888
CML-T1,54618305,-5.881736901302383
AsPC-1,5280436,2.0433035906644696
TC-71,16722836,1.6498789272200318
PC-14,10302451,-1.9208505295158915
KP-3,selumetinib-navitoclax (8-1 mol-mol),2.211509493209915
PC-14,16741245,4.805807368524508
PC-14,25105715,3.150741396456321
PE/CA-PJ15,148198,-2.65559177778782
AsPC-1,9936388,-0.8199656713038528
IMR-32,24785538,-0.3780514656797472
PLC/PRF/5,decitabine-navitoclax (2-1 mol-mol),4.238116685475049
D283 Med,25062766,1.4055870376887964
SK-MEL-2,selumetinib-piperlongumine (8-1 mol-mol),1.895997873157988
TC-71,vorinostat-navitoclax (4-1 mol-mol),0.9353830475743514
HEC-108,219104,3.940802724544765
D283 Med,54618305,4.176148849074149
PE/CA-PJ15,11977753,-2.687864175369831
REC-1,serdemetan-SCH-529074 (1-1 mol-mol),2.6925549668992197
GSS,sirolimus-bortezomib (250-1 mol-mol),-2.7575012848094147
KYSE-510,3543504,4.653323377824189
D283 Med,11485656,1.7629558217294734
GSS,selumetinib-MK-2206 (8-1 mol-mol),3.822381977395398
NUGC-3,46398810,2.7080446833635015
KYSE-510,984333,1.3919854553862656
CML-T1,6914657,-6.7918120052462685
CML-T1,24180719,2.7823494948279373
PLC/PRF/5,3854666,0.918467942921984
NUGC-3,24821094,1.772351348860867
IMR-32,104842,-8.37197946120253
BC-3C,3025986,-1.3921278968313844
GSS,44259,-0.5414437869532946
REC-1,445091,3.552814815749705
PLC/PRF/5,568763,0.4404230834482132
SK-MEL-2,selumetinib-GDC-0941 (4-1 mol-mol),1.2441784901384163
HuP-T3,24951314,1.4235135044150102
REC-1,656346,5.216170293018418
KYSE-510,11955716,-0.9587279982079464
D283 Med,JQ-1-vorinostat (2-1 mol-mol),0.6259651679916352
HEC-108,5978,-1.7034022834061815
PLC/PRF/5,5978,-2.9204939907176035
AsPC-1,25227462,2.9060868065293195
D283 Med,11719255,2.806098134518819
BT 112,1716436,2.062857445676959
NUGC-3,44137675,3.5909447273085937
SK-MEL-2,6610216,4.255505327986827
PC-14,3062316,-3.26358834718932
AsPC-1,10231331,1.7826677656602696
BC-3C,6918837,-2.2534670533654246
IMR-32,doxorubicin-navitoclax (2-1 mol-mol),-4.34165445158351
TC-71,4917,3.5240592308910985
HEC-108,vorinostat-navitoclax (4-1 mol-mol),0.2481940777627734
AsPC-1,9926054,1.8957621767397328
HuP-T3,676352,1.9029965224961456
KMH-2,702558,3.0708940474990736
PLC/PRF/5,5311281,4.973506080040096
PC-14,54626689,4.5901854787123515
PE/CA-PJ15,9825149,3.169297396053598
HuP-T3,JQ-1-navitoclax (2-1 mol-mol),2.3872748820971217
NUGC-3,11609586,2.2618125628096095
IMR-32,54596558,4.301887386980217
KMH-2,9915743,0.5597932998699471
PLC/PRF/5,25150857,3.5562533436822243
REC-1,2749,2.457349954560022
TC-71,5978,-3.781597668369261
TC-71,5280436,2.6301349748216567
HuP-T3,ISOX-bortezomib (250-1 mol-mol),0.144245152578182
CML-T1,24772860,-2.9357343941167713
KMH-2,151289,-0.4757556797265575
BC-3C,doxorubicin-navitoclax (2-1 mol-mol),0.6008258922691995
HEC-108,44589607,3.4353145741514557
BT 112,7251185,1.5687647885823757
TC-71,53392493,3.4401761092793537
HuP-T3,5291,4.150853397708747
PE/CA-PJ15,2871966,-1.907957584406415
D283 Med,327653,2.8736593168933786
CML-T1,46398810,1.457844995716712
BT 112,241158,4.111283984788845
KYSE-510,9933475,3.4716636451359917
SK-MEL-2,53392493,3.090478956198119
REC-1,24771867,5.565042494395041
REC-1,44241473,4.8692289567308675
KP-3,409805,5.570202879037171
PLC/PRF/5,46398810,3.3320955710706093
GSS,374536,1.1695844636083927
PLC/PRF/5,71751553,4.875285495081073
AsPC-1,44589607,3.181986375917279
CML-T1,vorinostat-carboplatin (1-1 mol-mol),1.2674452804454217
GSS,1242560,3.6494294615015255
KMH-2,12001922,1.6434388157498154
AsPC-1,25262965,-4.011117827244764
PC-14,4915,-5.791452728765355
TC-71,5470400,-2.003355424956553
IMR-32,984333,-2.9709158168640086
KMH-2,135999136,4.261603598420712
PLC/PRF/5,3825829,3.651094243261873
GSS,44241473,4.323404466734721
HEC-108,20959075,-3.040145887697204
BC-3C,568763,2.602903917393859
HEC-108,navitoclax-MST-312 (1-1 mol-mol),0.398713254172199
BT 112,66577038,3.1162446017420575
REC-1,168312962,1.9726902485289817
BT 112,navitoclax-PLX-4032 (1-1 mol-mol),3.450284426710319
CML-T1,5278396,2.8291940129393054
KYSE-510,56946209,-1.340935672276976
AsPC-1,46174525,4.390753346499015
PLC/PRF/5,4477,0.2676010622566162
TC-71,carboplatin-UNC0638 (2-1 mol-mol),5.64511651758471
AsPC-1,168312962,4.080126214508297
D283 Med,4917,2.940199279345652
HuP-T3,tanespimycin-gemcitabine (1-1 mol-mol),2.6296169541858694
AsPC-1,3634881,3.56845743908184
NUGC-3,11964036,1.6469196054576765
PLC/PRF/5,9915743,4.0648434850392
NUGC-3,docetaxel-tanespimycin (2-1 mol-mol),-6.103654705576909
D283 Med,23582824,-0.1827482787925018
CML-T1,25195348,1.1650045100950834
BT 112,23582824,0.9685063545248322
NUGC-3,71466578,3.5714167341999175
PE/CA-PJ15,216345,4.449220002696549
GSS,3025944,3.6552914132106062
BC-3C,9825149,3.579650735654113
BT 112,208908,1.6511587160909196
AsPC-1,5566,3.190935368909542
D283 Med,decitabine-navitoclax (2-1 mol-mol),-1.6592952462928667
PLC/PRF/5,53495165,1.709087743461689
PE/CA-PJ15,6450551,3.117610470620624
CML-T1,tretinoin-navitoclax (4-1 mol-mol),0.9331911225781374
CML-T1,400769,-1.2523952078832103
GSS,452548,-1.382256726894408
KMH-2,9926054,1.558336314725876
BT 112,11977753,-1.1582463708963373
D283 Med,11228183,0.836865512138477
KP-3,24951314,1.9737514152663609
REC-1,12003241,3.6312404592907614
HuP-T3,44185566,3.047929926499308
BC-3C,3543504,4.902111584052911
BT 112,72376,-2.818069890055989
HEC-108,10184653,1.654851711294291
PE/CA-PJ15,135411,0.500300489214103
TC-71,54618305,4.321118108161562
D283 Med,doxorubicin-navitoclax (2-1 mol-mol),-2.991531954647572
PLC/PRF/5,676352,1.8430994432339256
KMH-2,46907787,0.3409672144404854
PLC/PRF/5,56946209,-4.620975156515735
BC-3C,123631,2.112983855285536
TC-71,5746,-0.5333854543247218
AsPC-1,135440466,2.1679547773967314
KP-3,452548,0.6875214499833094
AsPC-1,5287969,-0.8371135357044818
AsPC-1,54613361,2.957295670472447
HEC-108,6914657,-4.042403483970356
KP-3,11178236,-3.5199262782907543
PE/CA-PJ15,SNX-2112-bortezomib (250-1 mol-mol),-4.513784898683675
KMH-2,156422,4.647817894933367
PC-14,1242560,4.349160506408389
AsPC-1,24753719,4.618559637878285
HEC-108,51039095,3.663645596248864
CML-T1,445455,4.626862894514658
BT 112,10385095,0.9487594139156588
AsPC-1,57330099,4.415374546363204
PE/CA-PJ15,136227924,2.633948596133963
PE/CA-PJ15,46199207,3.270686620801518
AsPC-1,selumetinib-navitoclax (8-1 mol-mol),0.9742361501395068
HuP-T3,11626560,2.4663043755994094
BT 112,4259181,0.804943209632055
HuP-T3,44819697,0.7007171788005963
HEC-108,452548,2.7369645386651307
REC-1,selumetinib-JQ-1 (4-1 mol-mol),5.213062841516755
TC-71,sirolimus-bortezomib (250-1 mol-mol),0.6072005287356511
PC-14,9840324,5.523880069172291
AsPC-1,carboplatin-UNC0638 (2-1 mol-mol),3.748908511395219
D283 Med,65064,2.891889878161975
KMH-2,11234052,3.795563896371719
PE/CA-PJ15,10385095,0.8645470546748426
CML-T1,638278,3.0153915179905098
GSS,3825829,2.772967132966308
KYSE-510,5311,1.9301104865134775
KMH-2,5287620,-1.6671599112607127
PLC/PRF/5,6914657,-2.1017539787920128
NUGC-3,9926054,1.9670154065403471
NUGC-3,124202324,2.1262185340944844
PLC/PRF/5,51037431,1.3031659688754045
CML-T1,67291369,-1.213032955096986
IMR-32,24951314,0.1603166716156078
PC-14,11404337,-0.86699452338107
PC-14,6252,2.490064475055688
AsPC-1,11497983,4.51017072011312
AsPC-1,71466380,6.178949844697013
BC-3C,56963564,0.7141210398353418
KYSE-510,9927531,4.748041591600806
SK-MEL-2,5311,1.803699116946934
KP-3,2858523,2.682785783367065
KP-3,6623618,2.3974496839813897
AsPC-1,11152667,-0.9426796832875202
SK-MEL-2,1641662,3.543782529063033
KP-3,selumetinib-UNC0638 (4-1 mol-mol),5.045746353952506
KP-3,654092,-2.1271165007576323
KMH-2,25150857,1.6846739388825889
SK-MEL-2,11626560,2.7990546336968296
REC-1,4917,3.1721395367741088
TC-71,46215462,1.5833433365477083
D283 Med,136227924,2.613464686393682
IMR-32,135398516,-0.2115694212354489
PC-14,6918328,-0.4686854814308683
GSS,123631,1.758180442524741
BC-3C,46843906,3.090586550972975
AsPC-1,tretinoin-carboplatin (2-1 mol-mol),4.763060903699729
TC-71,navitoclax-sorafenib (1-1 mol-mol),1.5647595938077117
BC-3C,5311281,3.658401877205808
KYSE-510,4477,0.2358431365105555
BC-3C,9956119,3.694807460400466
NUGC-3,51039095,3.3321368220613947
HEC-108,135411,0.6194051184569405
HEC-108,374536,1.892261126227868
KMH-2,6918837,-4.411426707410838
PC-14,46215462,0.6558574797092876
PE/CA-PJ15,46907787,3.628617033804344
BT 112,107985,-2.3005939746155244
NUGC-3,3543504,4.194029301033617
KP-3,49793307,-2.5564965350010467
TC-71,168313016,4.509628867413136
BC-3C,decitabine-navitoclax (2-1 mol-mol),2.93490674529882
BC-3C,11955716,1.6479367831422778
GSS,decitabine-navitoclax (2-1 mol-mol),-2.0881200752955005
AsPC-1,42642645,1.2436203489585118
KYSE-510,72193861,1.7949808752217784
KMH-2,navitoclax-sorafenib (1-1 mol-mol),-1.917288866212996
PE/CA-PJ15,3025944,4.079329167671241
KP-3,crizotinib-PLX-4032 (2-1 mol-mol),2.2756585160938796
PLC/PRF/5,4261,1.6016889241365653
BT 112,984333,1.584927202136717
PE/CA-PJ15,crizotinib-PLX-4032 (2-1 mol-mol),2.2605390959198113
REC-1,54618305,4.3771111696641185
SK-MEL-2,107970,2.2508906285434143
CML-T1,2749,0.3257235213594381
AsPC-1,5738263,4.8764899816054905
KP-3,5328940,1.36733478259693
PLC/PRF/5,11719255,4.3410704839610945
D283 Med,24771867,-2.2450737191486883
REC-1,5329102,4.264549452194595
CML-T1,23635314,-1.5423479854884166
TC-71,5460769,1.4458290097671247
PLC/PRF/5,56963564,2.023553713704896
TC-71,3634881,3.4737566346622413
AsPC-1,135999136,4.3448843965381965
GSS,doxorubicin-navitoclax (2-1 mol-mol),-4.0390749957959455
NUGC-3,11977753,-2.452099451027692
PLC/PRF/5,5287969,-1.0095386722365096
KYSE-510,2729026,3.215813928876562
BC-3C,11427553,3.105432988764133
PLC/PRF/5,969516,2.898782953505563
KP-3,44489367,4.890538998734305
IMR-32,11364421,-5.759515920313572
IMR-32,7251185,1.2286391948061073
REC-1,9840324,7.889263639418533
BT 112,24753719,4.155930680700891
BC-3C,25154868,5.292496325302527
KYSE-510,4521392,4.644324672931158
AsPC-1,219104,4.54762024266609
HEC-108,6852167,3.774395558261256
D283 Med,445643,3.9929703650481914
NUGC-3,3503,2.6827131035660847
NUGC-3,3815108,3.6827946568557666
AsPC-1,5282054,4.143624610165464
TC-71,676352,1.8734558249114632
BC-3C,11497983,4.618858366204936
TC-71,2729026,3.173974249036213
TC-71,JQ-1-carboplatin (1-1 mol-mol),2.9266133797401617
BC-3C,BRD-A02303741-navitoclax (2-1 mol-mol),3.441976003114225
GSS,tanespimycin-gemcitabine (1-1 mol-mol),-4.662877476911163
BT 112,3552672,1.4281271446672807
KMH-2,252682,7.011847260914495
KMH-2,16722836,1.2656098893857526
PLC/PRF/5,5113032,4.602885946759123
HEC-108,11626560,2.4526082617686793
NUGC-3,969516,2.587643924086733
KP-3,23635314,-2.586840709278856
TC-71,126941,-4.390169700884511
BC-3C,3689413,4.931170730107947
KMH-2,374536,2.08598760334219
BC-3C,piperlongumine-MST-312 (1-1 mol-mol),3.519247086570859
PE/CA-PJ15,52947716,2.90442121100954
AsPC-1,5287620,-2.2438477065180233
REC-1,24964624,5.51443016806739
TC-71,71466380,3.590258349269878
KYSE-510,5746,-0.4226764828539959
KYSE-510,26596,-0.7866712659714874
PC-14,25150857,3.220593885644357
KP-3,25062766,2.7557599627308274
KMH-2,4096211,0.0747534248684018
PC-14,44185566,3.23113420718539
HEC-108,selumetinib-MK-2206 (8-1 mol-mol),4.526627272212327
CML-T1,9926054,1.696565612874625
KMH-2,446155,2.2710682869847636
KYSE-510,7251185,3.784852902433824
REC-1,54626689,4.088202914478188
D283 Med,24772860,-2.7962047950668345
PC-14,9866186,0.4772395714988762
KMH-2,5329102,1.4498015385739376
KYSE-510,46191454,2.257194870840102
KP-3,9911830,3.156441375051414
HuP-T3,9887053,4.07990532641299
PE/CA-PJ15,16720766,1.2705022351166626
BT 112,selumetinib-GDC-0941 (4-1 mol-mol),3.393388864496841
GSS,tanespimycin-bortezomib (250-1 mol-mol),-1.8015851395784044
GSS,16720766,-0.067599912891946
AsPC-1,25150857,2.720712035994173
GSS,11485656,1.8292349527382337
PE/CA-PJ15,16736978,1.610051692476406
NUGC-3,613753,3.2700993438306165
NUGC-3,JQ-1-vorinostat (2-1 mol-mol),1.2649474821125353
BC-3C,73707371,5.58385522692904
HuP-T3,4477,0.7500067469313434
HuP-T3,984333,1.5721860041126483
TC-71,10427712,3.866806580084858
BC-3C,44632017,1.5198320107004044
GSS,16736978,0.4010815939480577
HEC-108,9929138,6.458847770997077
PE/CA-PJ15,9935249,2.936045396377626
CML-T1,3854666,0.73725489161191
TC-71,16659841,3.6341000678057984
HuP-T3,selumetinib-GDC-0941 (4-1 mol-mol),0.9673243203252392
KP-3,5329102,1.659425566170689
PE/CA-PJ15,54613361,0.0258798813529389
KP-3,126941,-2.255953466035363
SK-MEL-2,4917,3.6880216374353103
BC-3C,4578,4.131277354187527
TC-71,9935249,1.560837001432667
BC-3C,3062316,1.5676324316475545
KMH-2,3825829,2.5333469127311004
KMH-2,SNX-2112-bortezomib (250-1 mol-mol),-2.245664195883502
PLC/PRF/5,148124,-0.1119871124056631
CML-T1,selumetinib-JQ-1 (4-1 mol-mol),0.8733678884698052
PE/CA-PJ15,42611257,3.846620621313575
D283 Med,49766530,-3.2280701678526853
BT 112,5278396,3.7905260034746218
CML-T1,2945648,2.7633194270668877
BT 112,51037431,5.205147276612667
KP-3,9926054,1.9542215923866435
D283 Med,11427553,4.872458207858214
PC-14,9823820,1.8036222521667309
IMR-32,262093,1.1917781979548805
D283 Med,5328940,1.7071399155082068
HuP-T3,17755052,3.4304742988115366
PC-14,5738263,2.3868626596390903
KMH-2,alisertib-navitoclax (2-1 mol-mol),-1.958595821130802
TC-71,11964036,2.454873118708816
KMH-2,100016,3.8705403745512017
CML-T1,16736978,1.2014198902848654
IMR-32,89928392,0.2481087555075495
PC-14,11167602,2.3645338141956924
KP-3,42642645,1.348436123185398
TC-71,5566,3.20295083434214
HuP-T3,71680916,4.329506074723249
GSS,11238147,0.1933233682121613
TC-71,6610216,4.613001823007589
TC-71,54143018,1.1352840364804255
HuP-T3,25062766,2.4453672011464023
PE/CA-PJ15,46224516,3.629361812570019
CML-T1,72376,-3.431780344099396
PLC/PRF/5,119607,3.986666468022108
KYSE-510,2746,3.665067942472177
BC-3C,25262965,-3.8901170672484287
GSS,60168763,3.119293424460154
TC-71,11640390,1.366989766110467
PLC/PRF/5,7326481,1.761922703473697
D283 Med,1239801,3.514118708957111
D283 Med,55508,1.738146449836156
PC-14,11455910,0.0459407670906722
REC-1,6610216,3.8618283441811054
PC-14,11222830,1.8160665948878003
IMR-32,24772860,-2.5862445017450924
TC-71,navitoclax-pluripotin (1-1 mol-mol),0.2159994807368008
GSS,52912189,0.1030947036583431
D283 Med,2945648,2.7267209315034946
PE/CA-PJ15,piperlongumine-MST-312 (1-1 mol-mol),1.379887967820859
D283 Med,44489675,3.5231335030624855
KYSE-510,16038120,1.5396171885369814
AsPC-1,25105715,4.199758530142014
D283 Med,71466445,1.8844109066317911
HuP-T3,25105715,3.756943800954468
KYSE-510,60700,-0.877100474062993
PE/CA-PJ15,11222830,1.5034258070513389
IMR-32,11404337,-2.700681379951113
TC-71,5282054,4.513222113551348
AsPC-1,16065773,2.935886834183449
GSS,55283,0.429469885955291
IMR-32,11964036,1.001472098412633
AsPC-1,15953870,5.362858272792295
D283 Med,374536,-5.802881326036661
HEC-108,3062316,2.505322411201139
KYSE-510,6450551,3.3903624171303974
PE/CA-PJ15,24978538,3.991703826733128
BT 112,44137675,3.190081046640756
BC-3C,9823820,5.674036146232755
BT 112,2729026,1.695580673596315
KYSE-510,5566,3.062070031231825
PC-14,5278396,3.0631112652211296
AsPC-1,176870,5.289710540069244
TC-71,4096211,0.9381734467713232
HEC-108,44259,1.4684609831763502
IMR-32,71680916,3.8817614477933393
PC-14,135411,0.053480983141028
D283 Med,11222830,1.8597449067047809
IMR-32,11214940,-0.4483259226189699
GSS,135984461,1.9439618887139551
KMH-2,136227924,2.758064098306969
KMH-2,44487061,4.455067778773301
PC-14,4477,-0.0975301875063986
PE/CA-PJ15,6184667,1.987560151741866
BC-3C,7251185,3.579262680582759
HuP-T3,11609586,3.0975126346448056
BC-3C,71751553,4.284434035767574
GSS,9915743,0.3423445319525382
D283 Med,67291369,-1.3976379586601873
KP-3,6918837,-2.1662531046783777
PE/CA-PJ15,selumetinib-piperlongumine (8-1 mol-mol),4.644191554187911
GSS,3025986,-1.4255338119821197
KMH-2,3503,1.3006105599305138
PC-14,SNX-2112-bortezomib (250-1 mol-mol),-3.312261812996962
BT 112,11404337,-0.2767075951827175
PLC/PRF/5,11455910,0.2914890015755099
KMH-2,126941,-3.9779310000787382
D283 Med,7251185,1.5816987638690432
HEC-108,selumetinib-UNC0638 (4-1 mol-mol),4.806918156541826
CML-T1,66577038,2.0285847507138017
KP-3,5281321,-0.7568226828261236
D283 Med,9956119,3.549058379846889
AsPC-1,11364421,-1.021042778985214
GSS,4378219,1.891542644264269
CML-T1,374536,2.401691970017444
D283 Med,23939,4.340055640528423
HEC-108,doxorubicin-navitoclax (2-1 mol-mol),-1.1181452203598452
KP-3,3025944,4.126836183023836
PC-14,1239801,1.7160946167393711
BC-3C,46224516,3.187622593777834
AsPC-1,73707398,2.3690176063372888
PE/CA-PJ15,10127622,7.137745593026455
AsPC-1,11977753,1.3763157806720072
KYSE-510,6505803,-1.66043256037682
PLC/PRF/5,9549297,2.658886097046531
GSS,6450551,1.69313168732471
PC-14,54618305,4.281679623383799
NUGC-3,navitoclax-gemcitabine (1-1 mol-mol),-2.939896172994061
TC-71,984333,-0.8208115650132628
IMR-32,409805,3.9011051007010216
D283 Med,168312962,2.205429971467616
BT 112,selumetinib-BRD-A02303741 (4-1 mol-mol),5.118428363435484
GSS,322968,3.8962537574421887
KMH-2,36462,-0.642209166172259
CML-T1,10074640,0.1978471501959747
BC-3C,6918638,1.5868731043226476
AsPC-1,8515,4.986545700595871
PE/CA-PJ15,44819697,0.4241094034222136
KP-3,15983966,-3.1742686275598544
KP-3,11612883,2.777490098134625
D283 Med,31703,-2.9030613182863205
PLC/PRF/5,135875424,4.546560112708509
AsPC-1,selumetinib-decitabine (4-1 mol-mol),2.5650434324640847
SK-MEL-2,9927531,5.603550958927875
AsPC-1,400769,-0.2711365707281618
PC-14,51037431,1.133811841560157
BT 112,5746,-0.397041971069554
CML-T1,10231331,3.71504818577299
AsPC-1,637858,2.8111542457272605
PC-14,3815108,3.796609713170094
GSS,135398516,0.827078887371846
SK-MEL-2,11178236,-2.757521949601896
PLC/PRF/5,24821094,3.729693325550022
PE/CA-PJ15,100016,6.230779358531284
CML-T1,24180125,2.207667320892802
GSS,carboplatin-etoposide (40-17 mol-mol),1.4962173940697636
HEC-108,5311,1.8736355088080991
IMR-32,4261,0.7810755123130659
D283 Med,23725625,2.5008033134469647
CML-T1,9868037,1.2045012402986977
KYSE-510,49867930,4.450646674680186
CML-T1,23725625,2.2812581172519124
HuP-T3,navitoclax-MST-312 (1-1 mol-mol),0.8342028342455182
TC-71,5328940,1.352756102270782
KYSE-510,100016,5.186546688011686
KYSE-510,11507802,1.398152842707577
PC-14,613000,2.367652889107365
GSS,72193861,0.1311412597901036
PC-14,54678924,3.486960640257901
GSS,11364421,-4.4383593468023985
GSS,71304818,1.491544835885914
KYSE-510,3025986,0.0395031914690791
AsPC-1,44137675,4.002233175780649
BC-3C,6852167,1.631200387252669
CML-T1,60750,-4.308471121020489
BT 112,11494412,1.153463963183282
SK-MEL-2,322968,2.8493986496250474
KP-3,24856436,1.0476355516063085
BC-3C,16065773,3.1193941236579006
PLC/PRF/5,5281321,-2.3237962668790524
PE/CA-PJ15,57519531,3.7236545137960073
PC-14,44607530,-2.8516012431883366
BT 112,10302451,3.727610987508193
IMR-32,11222830,1.426317231301014
HEC-108,73707398,1.5484357778063762
AsPC-1,44493528,4.313387127964929
PLC/PRF/5,753704,4.749989409543222
CML-T1,54649381,3.615747973120369
GSS,9911463,2.6255650357234797
NUGC-3,46224516,1.8558841772024808
TC-71,11228183,1.8462977673852523
HuP-T3,55508,4.397520768584908
GSS,46224516,1.3799999744435634
CML-T1,5311281,3.0916675116608863
D283 Med,9933475,1.5513206335845269
AsPC-1,selumetinib-vorinostat (8-1 mol-mol),2.1619817893004805
D283 Med,25126798,4.439280321419275
AsPC-1,3825829,4.335500071907528
BT 112,6610216,4.1837874586497765
KP-3,selumetinib-MK-2206 (8-1 mol-mol),3.711369070858268
KP-3,5738263,3.1756712094586823
KYSE-510,5291,3.7283829332929694
IMR-32,1641662,1.7712869149432415
BT 112,JQ-1-vorinostat (2-1 mol-mol),1.5924494369146067
PE/CA-PJ15,71466380,5.688383705062217
BC-3C,carboplatin-etoposide (40-17 mol-mol),4.077066103223801
HuP-T3,613753,3.2946831222357233
D283 Med,56649450,1.3695223630329627
PLC/PRF/5,176870,5.095439310905841
HEC-108,4261,2.7308504637450683
PE/CA-PJ15,327653,3.705959138945344
KMH-2,67156097,-2.3710292392349124
PC-14,49793307,-2.2897588093070005
D283 Med,72734382,2.7546451144628756
KMH-2,65064,3.079648002703383
REC-1,9929138,7.294165808460384
D283 Med,9887053,1.695110985326941
BT 112,navitoclax-gemcitabine (1-1 mol-mol),-4.253008173611593
KMH-2,445455,4.873752175923701
KMH-2,135984461,4.570908568849745
BT 112,24901704,4.366815856328311
PC-14,24901704,2.3587345537063538
D283 Med,54618771,1.215604089870786
REC-1,24180719,5.326289522106428
D283 Med,25105715,3.463494794398442
IMR-32,44543605,0.2129283546045009
GSS,selumetinib-tretinoin (2-1 mol-mol),3.3105434884618004
HuP-T3,44489675,3.6946366435409352
AsPC-1,5287969,-0.8371135357044818
REC-1,4259181,2.258839706285654
IMR-32,3385,1.493252466930647
KP-3,53232,0.96343310852112
KMH-2,44241473,4.307492980589522
AsPC-1,49766530,-1.5554439905221051
IMR-32,16065773,1.7255717075384394
KYSE-510,24797083,1.059863665861496
AsPC-1,44819697,-0.3025066533854976
NUGC-3,135421197,1.602671962705462
IMR-32,6610216,4.098372993728488
BC-3C,3465537,3.2940431181911447
NUGC-3,49850262,4.988289822198244
IMR-32,9903786,1.34691800492683
KMH-2,5280436,3.092917027837839
NUGC-3,50905018,4.486580141535201
KMH-2,24771867,-0.8834131311064513
KP-3,52947716,1.3547543214080018
KMH-2,5281321,-2.394829115643839
PE/CA-PJ15,6918736,-2.1464031856297443
PE/CA-PJ15,10184653,1.386804330820947
NUGC-3,16065773,3.113968799257308
D283 Med,52912189,0.6805327994585112
GSS,15547703,2.250066090824681
BT 112,60700,-2.8896776101219515
KP-3,219104,2.974540129333194
PLC/PRF/5,9927531,3.33785239114395
REC-1,31703,-0.2190696100824472
HEC-108,54143018,-0.2958313294856644
SK-MEL-2,11404337,0.550817025493175
D283 Med,navitoclax-pluripotin (1-1 mol-mol),-1.8329751159945813
SK-MEL-2,44589607,3.250793209659342
TC-71,3384730,2.326453076754431
GSS,16722836,0.3148107226350502
BC-3C,2871966,1.8287855033643137
D283 Med,53232,2.450854354928572
KP-3,ISOX-bortezomib (250-1 mol-mol),0.9487064821537566
PC-14,71466578,4.3442351704394895
CML-T1,126941,-3.100237153288417
CML-T1,3384730,0.9879066704986152
GSS,navitoclax-gemcitabine (1-1 mol-mol),-3.626196900838238
KP-3,400769,-0.6333745035148951
KYSE-510,426756,4.45434823672058
PC-14,9911463,4.053685719227892
PC-14,6505803,-1.6585666949761726
AsPC-1,5566,3.190935368909542
PC-14,42642645,-0.2758248149200779
HEC-108,262093,2.510970460452122
BC-3C,969516,4.144958741683994
PC-14,16722836,1.4200790699310284
HEC-108,6918736,-2.1205057865818633
BT 112,6505803,0.1257905254161033
PC-14,52947716,0.2660247014884829
BT 112,11234052,4.430633213786369
BC-3C,44486219,4.157281936397457
PE/CA-PJ15,24771867,2.507049112145433
IMR-32,3503,0.7804460572009453
PLC/PRF/5,11427553,3.8294720054647993
IMR-32,227681,1.8110872641064517
AsPC-1,23582824,1.2589428940506815
KMH-2,54619238,4.6045100189893935
AsPC-1,387447,-4.291846387154746
PLC/PRF/5,25062766,3.212389060885976
GSS,10385095,0.9297454334410128
GSS,24772860,-2.5384701521759356
AsPC-1,navitoclax-sorafenib (1-1 mol-mol),1.6576308864505285
CML-T1,57519531,1.0516100309241616
BC-3C,11964036,1.3598279937776576
BC-3C,11647372,1.153527088627874
IMR-32,11507802,0.0852464454148725
NUGC-3,25150857,2.153979012889042
SK-MEL-2,23582824,1.813428901186736
GSS,3081361,2.453543752321006
HuP-T3,439501,-2.469428626730465
HEC-108,44489367,4.45975641268053
GSS,119607,3.92147410526368
AsPC-1,6450551,4.162604073037061
BT 112,49793307,-3.616736826753609
SK-MEL-2,3689413,2.4030655110444767
KP-3,68056272,4.287326902713343
BC-3C,56946209,-2.8151362419503485
CML-T1,1716436,3.108020123675437
HEC-108,11485656,3.338600175698492
PC-14,8515,3.8030363012759327
CML-T1,409805,3.5817002644537683
CML-T1,12001922,1.44047939392769
PE/CA-PJ15,11955716,-2.713956440083192
BT 112,17755052,2.3447671065006106
PC-14,24951314,0.973112962639724
PE/CA-PJ15,9907093,4.416525401831105
BT 112,piperlongumine-MST-312 (1-1 mol-mol),1.6765220415179445
HEC-108,168312962,-2.000701767765318
HEC-108,241158,3.683911292843857
CML-T1,5328940,-0.6883003462747955
KMH-2,44185566,0.96665135195286
PE/CA-PJ15,46926350,-4.278267218938167
PE/CA-PJ15,44566777,-0.036067971292337
PE/CA-PJ15,19582717,5.341691439105365
D283 Med,6852167,1.541783481002512
TC-71,4578,4.310668355424637
AsPC-1,1750826,-1.5700020776253725
PC-14,441298,3.020679167194442
HEC-108,navitoclax-sorafenib (1-1 mol-mol),2.4263859453349914
REC-1,25126798,6.245895265924279
KP-3,doxorubicin-navitoclax (2-1 mol-mol),0.4547511598111908
PLC/PRF/5,71466578,4.839047115265132
GSS,11625818,3.942435738537663
PE/CA-PJ15,9444,4.387009695223505
HEC-108,3025986,-0.5174612953614975
PC-14,448949,0.9447027216168168
IMR-32,23582824,-1.110740611943506
GSS,11640390,0.9227080300401443
KMH-2,104842,-3.8663712291757975
KMH-2,135875424,3.335950960073661
GSS,2733487,6.3934213127777255
REC-1,navitoclax-sorafenib (1-1 mol-mol),2.823908857478378
BT 112,49766530,0.144276899282749
AsPC-1,322968,4.827920048367381
PE/CA-PJ15,135999136,4.2175976064097265
NUGC-3,44819697,-0.0239587829276347
HuP-T3,1566236,2.433067651410228
KYSE-510,16741245,3.769516433315235
CML-T1,441298,0.5187670078326817
PLC/PRF/5,46926350,-4.214679057159525
GSS,16038120,-0.7412730559850733
BC-3C,4378219,3.95059564857708
AsPC-1,vorinostat-carboplatin (1-1 mol-mol),3.776760089642386
D283 Med,44486219,3.429631651942111
AsPC-1,selumetinib-navitoclax (8-1 mol-mol),0.9742361501395068
AsPC-1,11977753,1.3763157806720072
KYSE-510,52912189,5.071927062590809
KYSE-510,11396600,3.570057014705878
IMR-32,navitoclax-pluripotin (1-1 mol-mol),-2.6314478848073
SK-MEL-2,54678924,3.009288234241988
REC-1,54619267,3.743801530940776
AsPC-1,carboplatin-UNC0638 (2-1 mol-mol),3.748908511395219
AsPC-1,54618771,1.0442216511349782
HuP-T3,JQ-1-carboplatin (1-1 mol-mol),1.982980925186552
AsPC-1,16065773,2.935886834183449
AsPC-1,selumetinib-piperlongumine (8-1 mol-mol),2.3106029653407276
HuP-T3,5329102,2.4996480668272527
TC-71,5351362,1.329728669627052
GSS,9967941,2.614265782822018
IMR-32,6918638,-2.6640844779638244
GSS,BRD-K27188169-navitoclax (2-1 mol-mol),-1.2560950768783368
HuP-T3,tretinoin-carboplatin (2-1 mol-mol),5.021357813866161
BT 112,3634881,1.0045650301958045
BT 112,375860,-0.4292821848483891
IMR-32,44491742,3.818890533402266
D283 Med,2874250,4.322597187496923
KMH-2,navitoclax-gemcitabine (1-1 mol-mol),-2.789315361251211
SK-MEL-2,25105715,3.7306135827212046
AsPC-1,56649450,2.958633157592254
KMH-2,25262965,-1.7181390897064877
HEC-108,9936388,-4.887528080420867
D283 Med,56973724,2.3235035869013703
GSS,5311281,1.2419425699352236
PE/CA-PJ15,89928392,2.0830072880843407
KMH-2,400769,-1.5896546527981914
PE/CA-PJ15,24772860,-3.9275354144637222
HuP-T3,vorinostat-navitoclax (4-1 mol-mol),1.7749149652569187
GSS,5291,2.87065380365479
IMR-32,46926350,-5.503879322272109
REC-1,3503,1.8711858712785363
AsPC-1,11427553,3.0222816384498237
REC-1,9903786,4.191167368609226
KMH-2,71466380,4.597594303242699
HuP-T3,46943432,3.2592232125577665
KYSE-510,JQ-1-carboplatin (1-1 mol-mol),4.538673492010493
SK-MEL-2,54143018,4.314913110704269
PC-14,216345,3.76636528013032
BC-3C,6918328,0.8732873094384801
AsPC-1,44491742,4.429887143828186
D283 Med,6610355,3.4554564076272496
BC-3C,448949,1.687223152011255
KP-3,322968,3.1686208941787797
PLC/PRF/5,400769,-1.7576715065134367
PE/CA-PJ15,9926054,1.7631963091393454
BC-3C,644241,2.777421268835519
D283 Med,10184653,1.6755426612344793
D283 Med,11175137,1.7894441907886798
PE/CA-PJ15,56949517,4.259049323571045
BT 112,vorinostat-navitoclax (4-1 mol-mol),2.6221867944276993
BT 112,119607,5.928336850661068
BC-3C,9926054,1.793966289929591
AsPC-1,11396600,3.3240147605355506
KYSE-510,53392493,3.7562177843122977
HuP-T3,10127622,4.169685865232827
NUGC-3,71466380,4.346170468954436
TC-71,10302451,3.884014223654917
BT 112,3503,0.8637202569317721
BT 112,salermide-PLX-4032 (12-1 mol-mol),5.150071894755857
CML-T1,73707386,2.9358077283853974
KP-3,9911463,3.5465517511972173
REC-1,216239,2.4300236285527177
BC-3C,4788,5.956584973275199
KMH-2,11404337,-1.9075326301634037
HEC-108,6184667,5.152766799175181
PC-14,4788,5.215846047111057
SK-MEL-2,serdemetan-SCH-529074 (1-1 mol-mol),2.355751476848307
KYSE-510,selumetinib-JQ-1 (4-1 mol-mol),4.587608539341743
HuP-T3,46926350,-3.9956296104835447
AsPC-1,46199207,3.695579616421397
HEC-108,2749,4.864852970303599
GSS,navitoclax-MST-312 (1-1 mol-mol),-0.2533682401544452
BC-3C,10127622,4.306015198392758
PC-14,135440466,0.8720299056367994
AsPC-1,16219061,4.6595447221902955
D283 Med,387447,-5.573112310264525
HEC-108,JQ-1-vorinostat (2-1 mol-mol),2.7336649081261437
SK-MEL-2,613753,3.2709653678821575
PLC/PRF/5,2742550,3.829662269991737
PLC/PRF/5,65064,5.741872177609147
KYSE-510,11167602,2.041208237103879
IMR-32,11396600,2.686072598374917
HEC-108,9868037,3.1019775097215554
PC-14,57519531,1.535196812994606
GSS,9907093,3.5083738260565487
HEC-108,16741245,3.4879989323714713
D283 Med,10427712,4.834864727067545
HEC-108,9926054,2.177226179063823
REC-1,135440466,3.3571915295721526
PLC/PRF/5,54678924,1.0507140357404905
BT 112,219104,3.367056596744358
PC-14,11317348,1.2633354719410963
BT 112,24772860,-3.2237648858189742
KP-3,25126798,4.021431904538916
AsPC-1,16722836,2.2980478994816425
HuP-T3,9884685,1.9355517940144655
AsPC-1,5351362,2.4874401689371033
KP-3,25102847,2.719985343062399
BT 112,46398810,1.9166680275447008
PLC/PRF/5,2858523,3.03040423113715
CML-T1,selumetinib-decitabine (4-1 mol-mol),-0.3389481007221296
IMR-32,135440466,2.9886330484777255
TC-71,89183176,3.1153090342937797
KYSE-510,60750,-3.975504396592846
PLC/PRF/5,3025986,0.547369214316244
PE/CA-PJ15,11175137,2.227719156737245
HuP-T3,241158,3.8412641522091144
REC-1,54143018,3.927414869926896
AsPC-1,selumetinib-decitabine (4-1 mol-mol),2.5650434324640847
TC-71,9866186,0.2622855577556232
REC-1,9935249,3.294492382049569
HuP-T3,9911830,2.533690069517969
HuP-T3,crizotinib-PLX-4032 (2-1 mol-mol),2.5650363225974315
KYSE-510,135398516,4.442272056885084
CML-T1,navitoclax-PLX-4032 (1-1 mol-mol),0.956704604832818
TC-71,54618164,3.730396690506125
TC-71,135999136,1.4901332353785983
TC-71,3503,1.4490765792885063
D283 Med,4705,3.1008912872866325
PLC/PRF/5,54765302,2.9347018025139966
REC-1,9868037,0.961521370423606
HuP-T3,10184653,2.026243337908569
CML-T1,BRD-K27188169-navitoclax (2-1 mol-mol),1.24494098413804
IMR-32,9933475,1.664146606717292
HEC-108,BRD-A02303741-carboplatin (1-1 mol-mol),4.399669755507875
SK-MEL-2,10385095,1.309860426299206
REC-1,selumetinib-UNC0638 (4-1 mol-mol),5.204842830109013
AsPC-1,448949,1.7535133746232512
NUGC-3,216345,4.452169108182355
NUGC-3,ISOX-bortezomib (250-1 mol-mol),0.6956388241450759
BT 112,1317464,4.14615022758794
KMH-2,57519531,1.3356837866594973
HuP-T3,9956119,4.370077084995815
CML-T1,119607,4.0157878157192375
HEC-108,375860,-0.0015834583996186
REC-1,2708,6.648601387442783
CML-T1,6852167,0.9836314645814764
REC-1,11626560,3.077771804962775
BT 112,426756,4.127837359215836
GSS,219104,2.9834486272792615
GSS,66577038,1.695947220430622
IMR-32,navitoclax-PLX-4032 (1-1 mol-mol),-1.3315361566246946
KYSE-510,107985,-3.785009433750071
IMR-32,navitoclax-birinapant (1-1 mol-mol),-1.1241497489501564
PE/CA-PJ15,54618771,-1.2856394778285385
AsPC-1,5351362,2.4874401689371033
AsPC-1,12003241,0.1897400127907629
D283 Med,16065773,1.947977492056464
PE/CA-PJ15,11455910,0.2163871462693647
PE/CA-PJ15,445091,4.246266958830633
PLC/PRF/5,navitoclax-gemcitabine (1-1 mol-mol),-1.341258540963254
IMR-32,126941,-1.4673521484458831
BC-3C,44137675,3.579747900384603
HuP-T3,9936388,0.6940852338085793
PE/CA-PJ15,navitoclax-piperlongumine (1-1 mol-mol),4.044139806704131
IMR-32,613753,2.453441833731902
KYSE-510,44566777,3.0683648989929853
AsPC-1,6918638,0.7071735542476161
HEC-108,selumetinib-GDC-0941 (4-1 mol-mol),4.231361891065658
HuP-T3,56649450,4.499318873015619
KYSE-510,2742550,4.37690819597459
KMH-2,5738263,2.6573720905812275
GSS,159324,1.2139166709223652
CML-T1,124202324,0.7419542279604492
AsPC-1,57330099,4.415374546363204
BT 112,439501,-2.896282798681624
PLC/PRF/5,6918638,0.9074037907911854
PLC/PRF/5,alisertib-navitoclax (2-1 mol-mol),1.415470761114316
KP-3,11964036,1.3831682790065782
IMR-32,11625818,4.166928026781259
REC-1,2828334,6.171020558945514
D283 Med,2828334,5.77841146939239
HuP-T3,selumetinib-piperlongumine (8-1 mol-mol),4.093853736240695
AsPC-1,9935249,3.639166614114404
CML-T1,9967941,3.2676581028704503
PLC/PRF/5,5311,1.9214987721762755
CML-T1,10427712,1.89618534848285
BC-3C,613000,2.9604866266312575
NUGC-3,44241473,5.180110957285132
AsPC-1,vorinostat-carboplatin (1-1 mol-mol),3.776760089642386
PE/CA-PJ15,9866186,-0.0637155066173063
PC-14,46199207,3.3573036569250005
PE/CA-PJ15,54143018,0.7108830901806709
KYSE-510,44607531,2.072702677022034
PE/CA-PJ15,53301938,6.132050382123197
D283 Med,selumetinib-piperlongumine (8-1 mol-mol),2.4396148018972585
KMH-2,24753719,2.762394243468006
HuP-T3,168312962,3.781886601468438
AsPC-1,5460769,5.795061807453513
D283 Med,25227462,-4.9287589290971905
REC-1,9952709,1.1972813100462671
GSS,135411,0.6455113716410611
KP-3,6505803,-1.05905255098836
REC-1,89183176,6.320609171745764
IMR-32,9967941,1.4368622499720558
BT 112,72734382,4.824193200647447
NUGC-3,3854666,1.9021354568285025
KP-3,3825829,4.167375675761747
PLC/PRF/5,2708,5.513863316789198
TC-71,54613361,-1.656462687635457
CML-T1,3385,2.6066574492649184
AsPC-1,11234052,4.540853045838434
KP-3,vorinostat-navitoclax (4-1 mol-mol),1.6931046422688103
BT 112,5978,-4.255189500155859
PLC/PRF/5,BRD-A02303741-carboplatin (1-1 mol-mol),4.494422386751145
REC-1,171352865,4.0553194235264565
BC-3C,56949517,4.254420920221526
TC-71,46926350,-5.737308373443815
AsPC-1,327653,4.351823995090995
PLC/PRF/5,16741245,2.646739533184288
CML-T1,11178236,-2.7580162479970634
NUGC-3,12003241,-0.6366922027749422
AsPC-1,44462760,4.701078704400346
PC-14,56946209,-3.897840273037845
REC-1,3634881,1.64098323028159
REC-1,11964036,2.2027300169841957
KYSE-510,71304818,2.047465121764238
AsPC-1,36462,3.6552458214160506
SK-MEL-2,5287969,-0.7648343703299985
BC-3C,6917907,-5.589366083135022
GSS,BRD-A02303741-navitoclax (2-1 mol-mol),0.6566023707805214
AsPC-1,60700,1.1964352024151823
D283 Med,selumetinib-GDC-0941 (4-1 mol-mol),1.1541990578163812
KMH-2,969516,1.6744989896078368
AsPC-1,119607,5.550900919397946
GSS,11427553,0.5121763596725512
PLC/PRF/5,246676,4.431557533323378
KMH-2,15983966,-5.543246989488695
AsPC-1,107985,-4.227741895863185
REC-1,136227924,3.1866861789415855
D283 Med,100016,3.728925578699804
PC-14,11485656,2.0369141609233656
D283 Med,11507802,0.4939974977002742
SK-MEL-2,25227462,1.768371088261411
PLC/PRF/5,JQ-1-MK-0752 (1-1 mol-mol),4.269386275433074
NUGC-3,BRD-K55473186,4.21023555012659
BT 112,9915743,1.837502115717176
KMH-2,44507138,1.688756154948792
TC-71,vorinostat-carboplatin (1-1 mol-mol),3.239179125834509
KP-3,11364421,-2.308711634729733
TC-71,25227462,-0.9932173447986576
TC-71,24748573,1.6436402547184223
PE/CA-PJ15,vorinostat-carboplatin (1-1 mol-mol),4.177227596511851
HEC-108,656346,1.215673304181218
IMR-32,serdemetan-SCH-529074 (1-1 mol-mol),0.926663072745395
AsPC-1,24180719,3.701309063973522
PC-14,445643,4.0648720096321656
KMH-2,36314,1.7071309844277265
D283 Med,10410894,2.0006248450880912
HEC-108,66577038,3.3902057561836436
KP-3,docetaxel-tanespimycin (2-1 mol-mol),-4.050413146410149
PC-14,24772860,-3.422596924284342
PLC/PRF/5,100016,6.529147023700783
HEC-108,24951314,2.044375448042514
KP-3,54619238,4.3217818182091365
CML-T1,selumetinib-navitoclax (8-1 mol-mol),1.8946920670328231
AsPC-1,2871966,-0.1237405253519755
PE/CA-PJ15,16219061,3.234867207662873
PE/CA-PJ15,15547703,2.735293811596617
KYSE-510,17755052,1.7348619727916808
HEC-108,44484440,3.2684255567443
BC-3C,25062766,1.6710230233636385
BC-3C,alisertib-navitoclax (2-1 mol-mol),0.0203147572137617
BT 112,9887053,4.183653051540166
REC-1,11222830,3.69502429393256
CML-T1,6505803,-0.3633146304142068
SK-MEL-2,5566,2.990439672942584
REC-1,135411,0.3102978372083019
GSS,168313016,4.309710891894579
SK-MEL-2,selumetinib-decitabine (4-1 mol-mol),2.4848629414986254
AsPC-1,71466380,6.178949844697013
PLC/PRF/5,selumetinib-PLX-4032 (8-1 mol-mol),4.795232185146686
GSS,5287620,-2.945655379522424
GSS,89183176,3.1772874298873637
CML-T1,68056272,2.531220488236934
PE/CA-PJ15,2708,4.901414773558016
PC-14,3025944,4.10204120238025
KP-3,24753719,4.638034647169119
PC-14,3038522,3.8372175290130466
CML-T1,448949,0.9677195275785144
D283 Med,11609586,0.9542779203239456
HEC-108,72376,-2.7240450345568905
HEC-108,2828334,6.315620913516899
TC-71,9884685,0.722756540979205
BT 112,selumetinib-decitabine (4-1 mol-mol),6.418283242663844
GSS,25062766,0.8127654419231318
PE/CA-PJ15,45279963,3.892578403317123
GSS,9877608,3.923769598981982
PLC/PRF/5,24901704,3.537906280189079
PLC/PRF/5,9840324,5.315584084816236
PE/CA-PJ15,4096211,1.866846334114683
KYSE-510,23725625,4.715421775465591
TC-71,9907093,3.95285667829606
BT 112,11719255,0.9914291642812176
BT 112,16065773,1.6561708801047088
PLC/PRF/5,9911463,3.7898292588985862
AsPC-1,2742550,5.133078791264603
PLC/PRF/5,216239,1.5548464077629884
REC-1,445643,4.336315651295407
PLC/PRF/5,1716436,3.800525149446647
NUGC-3,vorinostat-carboplatin (1-1 mol-mol),2.9821090106646357
IMR-32,5470400,-3.4210582731065955
SK-MEL-2,9926054,1.8796163413954976
D283 Med,24748573,1.2146097740205386
BC-3C,6918736,0.7591451180553966
KP-3,11609586,2.647562513890928
PC-14,piperlongumine-MST-312 (1-1 mol-mol),2.990616335790466
KMH-2,9887053,3.2360475812117757
IMR-32,piperlongumine-MST-312 (1-1 mol-mol),0.8546727889236155
AsPC-1,9915743,1.396378280260739
TC-71,decitabine-navitoclax (2-1 mol-mol),3.2381013752442627
KP-3,135398516,3.623149887917262
PLC/PRF/5,5282054,3.814337875756489
REC-1,10184653,3.8754614074646407
D283 Med,navitoclax-piperlongumine (1-1 mol-mol),0.4568546586164775
KP-3,25150857,1.525204608043172
TC-71,387447,-4.777747319829986
KMH-2,387447,-5.191236757244743
AsPC-1,selumetinib-UNC0638 (4-1 mol-mol),1.8710456800697877
BC-3C,6610355,3.6817504369732954
REC-1,5566,3.0953320771208275
D283 Med,71304818,2.1992785048974577
GSS,49766530,0.909441474448473
CML-T1,24771867,0.0964586614823225
D283 Med,44185566,1.0704577587111352
HEC-108,9903786,3.9980769668892706
SK-MEL-2,6918837,-3.006204204027818
PLC/PRF/5,44491742,4.0953370325315355
PC-14,159324,4.972641562462416
NUGC-3,60750,-5.010839564198659
GSS,36462,-1.7824773633563245
PLC/PRF/5,11238147,3.247680309531719
PLC/PRF/5,selumetinib-MK-2206 (8-1 mol-mol),4.054432582656026
PE/CA-PJ15,135398516,1.9338219503271263
KYSE-510,73707438,3.7607996234815033
KYSE-510,navitoclax-pluripotin (1-1 mol-mol),0.1465400022186781
GSS,46943432,0.9758869456663198
IMR-32,16219061,1.0601014449898798
PC-14,doxorubicin-navitoclax (2-1 mol-mol),-1.022256177422171
KP-3,44632017,1.0979422072818712
PLC/PRF/5,71680916,5.3073053858239465
CML-T1,613753,3.0468922998366357
KMH-2,12003241,-0.520398442259763
TC-71,11507802,1.127861032971443
SK-MEL-2,4261,1.376400806242365
HEC-108,100016,6.393272881400893
AsPC-1,5278396,3.912005463923024
GSS,168313047,1.7159785692429452
KYSE-510,400769,-0.7683841777891469
PC-14,2746,2.459398202696394
TC-71,613000,2.44388555037588
TC-71,136227924,2.205314859996721
D283 Med,81146,5.645785388190545
AsPC-1,702558,5.7476960936684565
KMH-2,46199207,1.948919632524886
PE/CA-PJ15,erlotinib-PLX-4032 (2-1 mol-mol),1.314829540676128
CML-T1,53232,4.305570613336498
CML-T1,11507802,-0.1369004319183971
KMH-2,16720766,0.9709420836572418
CML-T1,44137675,3.6793288779986377
KMH-2,5351362,0.6914206308923384
NUGC-3,6252,-0.3860598061779524
KYSE-510,262093,2.791157701495768
PC-14,46398810,3.04872906643706
D283 Med,44607530,0.9211029721085632
PC-14,25126798,3.0644071921081193
AsPC-1,3825829,4.335500071907528
PLC/PRF/5,6505803,-1.356651808905463
AsPC-1,sirolimus-bortezomib (250-1 mol-mol),0.6140845395504789
PE/CA-PJ15,24753719,4.1461682769332615
PC-14,4259181,0.4148318229863006
GSS,2858523,2.3372908019576757
KMH-2,262093,2.330746095077634
KP-3,135421197,0.5862918255078794
BT 112,25262965,-1.8877634388627147
REC-1,11507802,2.8362664340225336
IMR-32,6918837,-6.741541684047562
HuP-T3,46907787,1.2763139172323097
BC-3C,9967941,4.638852639793287
PC-14,4378219,5.64918445258186
GSS,65628,5.281644335437836
NUGC-3,1641662,3.460569122898765
AsPC-1,439501,-1.6009280184427317
KYSE-510,71466445,4.893287749594832
D283 Med,11396600,2.9109671183024983
TC-71,49766530,1.0136455106007916
KP-3,168312962,3.7073929511460704
BC-3C,11404337,0.8699913882296267
AsPC-1,123631,3.3144447888973048
REC-1,9907093,4.061850457187021
D283 Med,selumetinib-UNC0638 (4-1 mol-mol),5.192185535679209
KYSE-510,72376,-1.2766832319349315
CML-T1,9927531,3.1672020542525674
PE/CA-PJ15,25062766,2.574410153179034
AsPC-1,2858523,3.256128469853813
HuP-T3,24785538,1.540895569713237
GSS,navitoclax-piperlongumine (1-1 mol-mol),-0.5925401962479443
CML-T1,9866186,-1.0355523545849354
KYSE-510,6436223,-5.284979818343056
REC-1,168313047,5.738652550951113
PE/CA-PJ15,5291,4.05816854700883
KYSE-510,2842253,6.152087021572915
D283 Med,15547703,2.9787798550877476
BT 112,16659841,3.2885249851469065
CML-T1,JQ-1-MK-0752 (1-1 mol-mol),0.6034690158877323
D283 Med,2113511,4.840177237246556
SK-MEL-2,tanespimycin-bortezomib (250-1 mol-mol),2.677378887587516
AsPC-1,JQ-1-vorinostat (2-1 mol-mol),1.708029438891557
REC-1,selumetinib-decitabine (4-1 mol-mol),5.032870950205346
AsPC-1,135875424,4.124114476494282
CML-T1,11228183,0.9343365693589996
IMR-32,2126,3.4955940947973065
BT 112,5280436,1.7556445184150695
PE/CA-PJ15,11640390,3.767424083733669
HEC-108,65628,4.442011228839073
PLC/PRF/5,67156097,-0.8108981865979858
KYSE-510,44486219,4.37734743550197
AsPC-1,3854666,3.565227366628202
PE/CA-PJ15,44607530,1.5447595133665166
HEC-108,11178236,-4.583978166396032
PLC/PRF/5,44493528,4.794092403972537
HuP-T3,25227462,0.1487181406442073
SK-MEL-2,16038120,2.2105555441084133
NUGC-3,11364421,-3.400744350526742
REC-1,salermide-PLX-4032 (12-1 mol-mol),4.957710312224808
GSS,46199207,2.3572985611496287
PE/CA-PJ15,60750,-4.289743147111487
KMH-2,17755052,1.783758106889838
NUGC-3,serdemetan-SCH-529074 (1-1 mol-mol),1.754139694439504
AsPC-1,89928392,1.5669078555551634
TC-71,462382,0.4149928134036834
PC-14,24856436,-0.4978882217078796
PC-14,7326481,3.0182937737030944
TC-71,24797083,1.232623936916102
SK-MEL-2,216345,4.726017609039073
CML-T1,3038522,2.3382153755761372
PC-14,66577038,3.5004555474754824
BC-3C,49867926,3.809350010737912
CML-T1,4917,2.5218741140394476
NUGC-3,3634881,3.177268724990775
HEC-108,25126798,3.8368047255927937
NUGC-3,16038120,2.6245420982025816
KMH-2,73707398,0.2398101632779203
PC-14,151289,1.4486982071000016
KMH-2,46943432,1.9293526492233928
HuP-T3,tanespimycin-bortezomib (250-1 mol-mol),0.6963202387947334
PE/CA-PJ15,6918837,-2.413311422436222
HEC-108,49793307,-2.56694084675293
GSS,decitabine-carboplatin (1-1 mol-mol),-0.8811348373618481
TC-71,44632017,1.0673213947174678
AsPC-1,119607,5.550900919397946
D283 Med,11178236,-4.81725298730488
BC-3C,45279963,3.761205673207426
NUGC-3,2828334,6.108747233724881
AsPC-1,16736978,1.4850226649426823
PC-14,46174525,4.355295994323497
PLC/PRF/5,navitoclax-MST-312 (1-1 mol-mol),0.9747662899983116
GSS,9840324,5.307721461711452
SK-MEL-2,navitoclax-MST-312 (1-1 mol-mol),1.1625570837116823
BC-3C,54618771,1.3234339265863326
HuP-T3,46174525,5.4457837824532245
NUGC-3,6914657,-2.3384109733700544
AsPC-1,136227924,3.2025742465891938
NUGC-3,9887053,3.9156704737457937
KMH-2,20959075,-4.058687349563306
HEC-108,10074640,3.0709446672134946
TC-71,24964624,2.362801870971703
NUGC-3,5281321,-0.178271661952803
TC-71,216468,0.1450477397287882
KYSE-510,44589607,3.626954580990843
TC-71,252682,6.42326397149765
PC-14,4096211,1.790962002826893
AsPC-1,9956119,2.16125044927063
IMR-32,10410894,1.878163995814545
AsPC-1,5280436,2.0433035906644696
HuP-T3,11707110,2.782188957571083
GSS,44202524,1.3101331174979725
KMH-2,23725625,3.2494896570291383
D283 Med,119182,-3.5504334050643314
PC-14,176870,-4.905616033041748
REC-1,65064,4.890612829121044
GSS,6918736,-1.6132498898132115
KYSE-510,25062766,2.506191564689318
PC-14,5282054,4.090465058158363
PLC/PRF/5,sirolimus-bortezomib (250-1 mol-mol),0.3197220965800605
HuP-T3,6505803,1.3238670991795596
KP-3,216345,4.239964571319956
AsPC-1,JQ-1-navitoclax (2-1 mol-mol),1.1906328907742711
SK-MEL-2,9956119,4.152729077258935
KYSE-510,135999136,4.6232522957296736
AsPC-1,216468,5.354333542051531
PLC/PRF/5,25126798,3.952499057215827
AsPC-1,25262965,-4.011117827244764
PC-14,9915743,-2.4249555987147615
PE/CA-PJ15,54618164,4.606818581386584
HuP-T3,4261,3.8165819220848767
PC-14,107970,3.287444237855521
KMH-2,vorinostat-navitoclax (4-1 mol-mol),0.5827126499633882
PE/CA-PJ15,439501,-2.069757641280327
GSS,erlotinib-PLX-4032 (2-1 mol-mol),1.8182317316573875
IMR-32,4917,3.5381089144621787
TC-71,crizotinib-PLX-4032 (2-1 mol-mol),1.431607760903271
PE/CA-PJ15,16725315,5.2914205961984235
REC-1,44491742,3.8136752597353953
REC-1,10427712,4.273957814608531
KP-3,JQ-1-navitoclax (2-1 mol-mol),-0.7188723962167386
AsPC-1,65064,5.237570806440869
CML-T1,3025944,4.207605674746215
SK-MEL-2,19582717,3.5846085030570394
SK-MEL-2,selumetinib-JQ-1 (4-1 mol-mol),0.1209546449517723
NUGC-3,46907787,3.024654204411081
D283 Med,alisertib-navitoclax (2-1 mol-mol),-3.1585358120838825
KMH-2,6610355,4.256977158989411
AsPC-1,selumetinib-tretinoin (2-1 mol-mol),1.7169571239818917
BC-3C,24748573,3.605839229824761
BC-3C,sirolimus-bortezomib (250-1 mol-mol),0.3697062841938496
KYSE-510,676352,2.9581607277450064
KMH-2,44819697,-3.5125705811438217
AsPC-1,9825149,2.485133390345911
PC-14,6610355,4.737749939026015
PC-14,crizotinib-PLX-4032 (2-1 mol-mol),2.280079390306755
AsPC-1,44819697,-0.3025066533854976
HuP-T3,2113511,6.036487802507154
D283 Med,246676,4.416806480399498
REC-1,3676137,5.3966770598151586
BC-3C,446155,1.7418360688812062
TC-71,15547703,3.212227755273037
KYSE-510,16720766,-0.3841009173062561
TC-71,56946209,-5.577977083490354
GSS,26596,-1.5813697443428234
PE/CA-PJ15,5281672,6.160455651983477
PE/CA-PJ15,7326481,2.629394046938682
KMH-2,44484440,3.223340167755633
NUGC-3,selumetinib-JQ-1 (4-1 mol-mol),2.244150108489299
SK-MEL-2,11222830,3.608357188274662
KMH-2,11609586,2.0637953316848896
PC-14,9926054,2.1919524814380846
PC-14,19582717,3.344872206545546
KP-3,24964624,3.0611588104793057
CML-T1,46907787,-0.5465083296094366
D283 Med,erlotinib-PLX-4032 (2-1 mol-mol),2.6364358466676627
KYSE-510,57519531,1.791080935951746
PC-14,5329102,2.2211830308707925
AsPC-1,16736978,1.4850226649426823
TC-71,24856436,0.4727719167356995
AsPC-1,1566236,2.844580785967763
KP-3,sirolimus-bortezomib (250-1 mol-mol),1.5261353801171291
TC-71,6918878,1.6710139941964712
PLC/PRF/5,4705,2.7931521546735243
PLC/PRF/5,5329102,2.84272571753026
BC-3C,vorinostat-carboplatin (1-1 mol-mol),4.315073110421908
BC-3C,12003241,-1.7584420473179934
KP-3,54454,0.8356021258126708
GSS,11404337,-1.198572034455594
CML-T1,56946209,-4.816302217893272
AsPC-1,9967941,3.911764573168509
PC-14,54613361,-0.3915773914647401
D283 Med,446155,1.3640842146375642
KMH-2,675434,4.380536236973683
CML-T1,46199207,2.0991647549590304
KMH-2,984333,-2.1870876003258717
PLC/PRF/5,11625818,4.770542355306057
PE/CA-PJ15,2749,1.3392553924109478
KMH-2,123631,2.0681789518379197
KP-3,11455910,1.1515388808863225
KMH-2,navitoclax-pluripotin (1-1 mol-mol),-0.3743173331291292
TC-71,5311037,3.8517651952027054
PC-14,6610216,4.542252614030989
BC-3C,11707110,4.379207198592553
PLC/PRF/5,salermide-PLX-4032 (12-1 mol-mol),5.269359450734018
IMR-32,6252,-1.642189538874569
D283 Med,66577038,3.783588364889245
HCC33,6918837,-4.242062614847813
NUGC-3,16722836,2.185251938422943
REC-1,46199207,3.314311267175405
PE/CA-PJ15,5351362,1.0110502710399616
PE/CA-PJ15,44507138,2.9434296092809595
CML-T1,11238147,1.550777100551064
PC-14,613753,3.517699490649258
PLC/PRF/5,11964036,3.2757834354758644
PC-14,100016,6.551425062945198
TC-71,135875424,2.7755794314588105
BC-3C,2949965,2.717226154893051
CML-T1,54686904,3.622967709931094
PLC/PRF/5,tretinoin-carboplatin (2-1 mol-mol),6.193807354279354
IMR-32,7326481,2.516321049859165
PLC/PRF/5,6610355,4.9958220868397385
GSS,2828334,5.287360195823853
NUGC-3,3062316,0.4436217261967663
AsPC-1,11955716,-2.13511164723979
KYSE-510,2733487,8.353370026459457
SK-MEL-2,selumetinib-BRD-A02303741 (4-1 mol-mol),2.3814029113977537
KP-3,6918328,0.9299376475581184
KMH-2,49850262,2.963335221123529
BC-3C,selumetinib-GDC-0941 (4-1 mol-mol),1.2071985367174134
D283 Med,crizotinib-PLX-4032 (2-1 mol-mol),3.638694658116099
AsPC-1,5282054,4.143624610165464
SK-MEL-2,6917907,-5.896607687827428
BC-3C,72199292,1.594102685781091
BC-3C,11364421,-5.524796888339065
NUGC-3,5311,1.42208672171305
HEC-108,322968,3.0271522101080532
HEC-108,151289,0.8721533950647946
D283 Med,5460769,1.125938178392905
D283 Med,11213558,0.9641513863181852
HuP-T3,2708,5.229598766149438
NUGC-3,44589607,2.6525929732225237
PC-14,sirolimus-bortezomib (250-1 mol-mol),1.4531465186128956
TC-71,11626560,0.9836468203220784
TC-71,44607531,1.5990146464695802
CML-T1,24856436,-1.6072060020086385
BC-3C,11178236,-2.339652742887502
TC-71,selumetinib-MK-2206 (8-1 mol-mol),4.348580076522246
KYSE-510,54649381,3.815475443460375
PLC/PRF/5,9907093,4.354611533483454
GSS,9887053,2.681738072239393
NUGC-3,452548,-1.9764357021257897
PLC/PRF/5,3081361,3.086333404889058
SK-MEL-2,2746,3.33396317139844
HuP-T3,navitoclax-sorafenib (1-1 mol-mol),3.5500030348393667
AsPC-1,10231331,1.7826677656602696
D283 Med,4477,-0.1925528209177479
GSS,126941,-4.241220322683792
KP-3,31703,0.3868565544209454
BC-3C,71466578,4.679961867778745
KP-3,10184653,1.0237143575145715
SK-MEL-2,2858523,3.2161838291456233
PLC/PRF/5,53325874,4.28354134086109
AsPC-1,11214940,2.3233429785878443
NUGC-3,656346,1.0594804198297751
IMR-32,5351362,0.4512859894379911
HEC-108,54619267,5.275779209173027
NUGC-3,11222830,1.8549890730351544
AsPC-1,19582717,4.191920632274723
D283 Med,11626560,0.0898695348441468
D283 Med,445091,3.8628212220629825
TC-71,6918837,-5.188856131279658
D283 Med,24180719,4.216892125950757
PLC/PRF/5,doxorubicin-navitoclax (2-1 mol-mol),-1.399019694447614
BC-3C,1716436,3.821199681154137
KMH-2,44632017,0.1133386123282452
HuP-T3,60700,1.2793809884126126
BT 112,tretinoin-carboplatin (2-1 mol-mol),4.36566401221058
IMR-32,selumetinib-PLX-4032 (8-1 mol-mol),4.7827928345241215
KP-3,25195348,4.163904143890383
GSS,6505803,-2.9961696629002956
HuP-T3,11404337,1.0495167124251128
IMR-32,5746,-4.3837551231683065
KP-3,56946209,-3.2276461969239834
IMR-32,25062766,1.6201321793642758
HuP-T3,126941,-4.07371973001698
TC-71,23582824,0.0752115300647183
D283 Med,navitoclax-MST-312 (1-1 mol-mol),0.7013282040570831
GSS,53232,2.096335164114523
CML-T1,3689413,-2.671933251411637
KMH-2,3385,4.061281204012652
BT 112,216239,1.682447495531753
NUGC-3,107970,2.2870652507466156
D283 Med,44493528,4.1397828788754465
KYSE-510,36314,-6.003655405920266
BT 112,2749,-0.764976916755987
D283 Med,89928392,0.7177145922675237
HuP-T3,448949,2.1685596620814565
HEC-108,12001922,1.836445664605824
AsPC-1,9926054,1.8957621767397328
IMR-32,5284616,-6.144247602010548
CML-T1,24901704,0.2948239854297986
AsPC-1,53325874,4.506725704395743
KMH-2,24951314,-0.1974890208476558
PE/CA-PJ15,11719255,3.5553759448209084
PC-14,107985,-3.662594404968572
HuP-T3,6918328,0.6989696425214073
CML-T1,9915743,1.9836361869709076
PC-14,6918736,-5.3643030965094916
PLC/PRF/5,702558,7.4077142434616015
HCC33,15983966,-5.907390927070333
HEC-108,136227924,3.134071919213167
CML-T1,6184667,4.239961832830672
KP-3,JQ-1-carboplatin (1-1 mol-mol),5.58247855672367
BC-3C,5287969,-1.8820282399432504
IMR-32,9444,3.8139284665700184
CML-T1,6917907,-6.247910968385368
PC-14,60750,0.123161460916901
D283 Med,44462760,4.193275636143645
KMH-2,1242560,1.2847001062875232
PE/CA-PJ15,216468,1.1366663027821788
AsPC-1,24748573,4.519934140177759
D283 Med,11238147,1.1761560661302457
TC-71,3025944,4.552970780141328
D283 Med,54618164,3.747562396348618
IMR-32,6450551,0.3087760037732445
KYSE-510,3136844,4.134498854805466
D283 Med,5479543,3.66909557584616
KYSE-510,16659841,4.392503191998635
BT 112,24785538,-0.31795448088545
GSS,5470400,-3.3910125393711485
D283 Med,11317348,2.3932264978402613
BC-3C,54619267,6.3681930610745745
HuP-T3,72376,-1.771653200109272
PLC/PRF/5,36462,0.8167490272691379
GSS,65064,5.190227160248983
KP-3,9887053,4.887376712089991
SK-MEL-2,969516,4.129726264744313
PC-14,navitoclax-pluripotin (1-1 mol-mol),-2.898024229695615
AsPC-1,72193861,3.428817244246792
GSS,10077130,2.723954697995756
BC-3C,11609586,3.199183222803346
REC-1,5280436,6.299859839186282
HuP-T3,36462,3.380707637397105
KMH-2,49793307,-4.005365392804202
PC-14,1750826,-0.15538351601615
TC-71,15953870,4.21580973131526
IMR-32,11228183,-1.3665196095298395
PLC/PRF/5,6852167,3.832431058074985
PC-14,44632017,1.2382575385480483
BC-3C,11612883,4.394109171636409
D283 Med,135928012,2.2283751237398906
GSS,216468,3.587291231973774
TC-71,2708,3.815322018076648
REC-1,JQ-1-MK-0752 (1-1 mol-mol),3.97873368586236
BC-3C,24951314,2.4124665900328623
CML-T1,151289,0.34759640697574
HEC-108,6917907,-4.71711933146506
PLC/PRF/5,135440466,3.5831224448238777
HuP-T3,11977753,3.281021154274905
PE/CA-PJ15,3543504,4.175307132679089
HEC-108,57519531,4.18371886542851
PE/CA-PJ15,7251185,3.2473108983237164
KYSE-510,15953870,3.73241111430141
KP-3,6852167,3.3293836315268805
PE/CA-PJ15,54619267,4.016762427349269
PLC/PRF/5,52912189,4.965456169467795
REC-1,2126,3.851450658410572
REC-1,219104,3.576061161986938
D283 Med,227681,2.8388924362301378
BC-3C,11152667,-0.9624710260076396
CML-T1,3825829,3.084807192466588
KMH-2,crizotinib-PLX-4032 (2-1 mol-mol),1.743016765908143
KMH-2,135421197,1.1476668863331456
HuP-T3,selumetinib-JQ-1 (4-1 mol-mol),1.2883856318712232
D283 Med,702558,2.919468662006613
KP-3,16038120,0.6576831184951375
KP-3,16720766,5.493699052054533
BT 112,11507802,1.1612523205296417
KMH-2,3136844,4.953174257927024
HuP-T3,selumetinib-tretinoin (2-1 mol-mol),3.9566869559335585
AsPC-1,9956119,2.16125044927063
CML-T1,2733487,8.178067655910914
PC-14,36462,2.3416403863743125
SK-MEL-2,9549297,3.977778608545143
BC-3C,3503,2.269463251105971
REC-1,11404337,-2.3807065169464336
CML-T1,12003241,-4.650247315633356
PLC/PRF/5,11609586,3.3948252909809575
HuP-T3,11238147,3.6375005285241033
PE/CA-PJ15,54626689,4.686002745759547
SK-MEL-2,5738263,4.141005306837072
KMH-2,24180125,2.3529996714086066
KP-3,439501,-2.4441073658124837
BC-3C,53245473,3.740645377425694
KP-3,1750826,-2.891676476044356
PE/CA-PJ15,24856436,-0.9774495657955756
AsPC-1,11719255,5.644609733763846
PC-14,12001922,2.282227019704268
PE/CA-PJ15,24951314,2.5074808192251252
KYSE-510,10074640,3.7190415212131542
KP-3,2828334,6.180015821773138
AsPC-1,navitoclax-gemcitabine (1-1 mol-mol),1.0785149117899562
HuP-T3,11234052,4.425621489915021
GSS,49793307,-4.424092542115905
HuP-T3,4521392,4.351966444408677
REC-1,25154868,4.640862968305209
NUGC-3,54618305,4.228237436999806
CML-T1,2874250,4.926765314452629
IMR-32,2708,-0.4057818743536672
CML-T1,11485656,1.9899616795432975
SK-MEL-2,4259181,1.4036951416401309
TC-71,6918736,-2.3194226015717376
REC-1,10074640,4.06593247218381
KYSE-510,104842,-4.695507922922084
AsPC-1,ISOX-bortezomib (250-1 mol-mol),1.1160066277256155
SK-MEL-2,24951314,1.1637791949954526
HEC-108,docetaxel-tanespimycin (2-1 mol-mol),-4.808010092677581
KYSE-510,46398810,3.4858247241567275
TC-71,5291,3.8087808310668168
PE/CA-PJ15,3384730,5.08056647864703
PC-14,3689413,2.901459905806189
PLC/PRF/5,46191454,1.9722624400079265
BT 112,969516,2.869310026352302
GSS,44185566,0.9973447888480624
BC-3C,2729026,3.0300305524792837
CML-T1,159324,0.3275039904336689
GSS,25195348,3.174876743921555
REC-1,17759555,6.872158537406996
PE/CA-PJ15,25126798,3.7492188324293543
KP-3,1242560,4.052837619574442
AsPC-1,9952709,5.897814669584309
REC-1,selumetinib-MK-2206 (8-1 mol-mol),4.739772098068011
CML-T1,46174525,3.020182372643586
IMR-32,11626560,-0.7723742635876396
AsPC-1,navitoclax-piperlongumine (1-1 mol-mol),1.083172716520978
PLC/PRF/5,374536,1.498952017518494
PC-14,5351362,1.7010534547277063
PLC/PRF/5,25227462,2.130477616893528
GSS,selumetinib-JQ-1 (4-1 mol-mol),-3.114554328810234
AsPC-1,24951314,2.0738112971970275
AsPC-1,11404337,0.3809720735493328
HuP-T3,25161177,3.646148401953212
KMH-2,9911830,2.2989781797044313
PC-14,9907093,4.14725283853085
IMR-32,71304818,2.8081992413927765
D283 Med,148198,-7.782574988452476
BT 112,2828334,5.978817648129075
CML-T1,6252,-3.9112690302721265
CML-T1,11214940,-0.4703282723698588
BT 112,54618164,3.5492837733522205
IMR-32,selumetinib-vorinostat (8-1 mol-mol),0.9204615438259656
PLC/PRF/5,387447,-4.9533047793677145
SK-MEL-2,4477,0.6174311430568699
HEC-108,65064,5.34082663858378
HuP-T3,selumetinib-UNC0638 (4-1 mol-mol),3.11768337000848
D283 Med,441298,3.3392911841728767
NUGC-3,44632017,0.9802259992014344
PE/CA-PJ15,387447,-4.5457624697994
TC-71,54619267,3.8129753958106942
D283 Med,25195348,2.687944983140332
BC-3C,23582824,1.1247883478043128
SK-MEL-2,24964624,3.210375357246789
KMH-2,4521392,3.848949710187479
KP-3,241158,4.0882665535753375
D283 Med,4261,0.5418403862812319
TC-71,5738263,3.4936243097577515
KP-3,2945648,-0.541885973592653
AsPC-1,11612883,5.278069767960674
GSS,60700,-1.326265621706629
PC-14,123631,-5.454121984956304
GSS,selumetinib-PLX-4032 (8-1 mol-mol),4.247741541635056
HEC-108,navitoclax-pluripotin (1-1 mol-mol),-0.960955516945734
HuP-T3,4705,2.7233440783632608
KMH-2,11238147,1.9401814426833337
AsPC-1,54626689,5.229882111208764
TC-71,11647372,3.616323379066039
IMR-32,11455910,-0.0063621760742968
GSS,10090485,4.381468783348597
AsPC-1,6917907,-5.50087073609159
PLC/PRF/5,24797083,-0.0446112434402059
AsPC-1,4521392,4.0696198883268275
AsPC-1,6450551,4.162604073037061
REC-1,71304818,3.5702343060949744
KYSE-510,doxorubicin-navitoclax (2-1 mol-mol),-1.5357208431417035
HuP-T3,2871966,0.5817483683031975
BC-3C,navitoclax-pluripotin (1-1 mol-mol),-0.7719833868582072
PC-14,452548,-0.0582862590511638
D283 Med,11364421,-5.590051926548293
PC-14,44607531,-3.5118481148163982
REC-1,25102847,2.749185219775311
CML-T1,46943432,2.522264418529326
KMH-2,serdemetan-SCH-529074 (1-1 mol-mol),1.597675127922174
IMR-32,24771867,-4.867128838340709
HEC-108,17755052,3.4677210523800936
KYSE-510,54626689,4.821893470864067
D283 Med,72376,-2.8932553569848385
KMH-2,4477,-1.02526806933475
NUGC-3,5978,-2.398677595645576
GSS,54619267,2.7958803295410593
NUGC-3,73707398,0.756281056203992
AsPC-1,24180719,3.701309063973522
D283 Med,36462,-0.7003958685437419
REC-1,5738263,3.8957465012071353
TC-71,445091,4.214055444465804
CML-T1,753704,4.085313154725238
HEC-108,11222830,1.779874343530328
GSS,6610216,2.9495192814585542
GSS,11455910,-0.448056775545068
KYSE-510,5282054,4.836737923523606
CML-T1,24964624,2.008023563128915
REC-1,53392493,3.37260858409881
GSS,445091,4.758950555442641
CML-T1,tanespimycin-gemcitabine (1-1 mol-mol),-3.893519256585349
BT 112,9866186,-0.3818998278365069
IMR-32,11317348,-1.2393985957377731
AsPC-1,11175137,3.2351214827225956
REC-1,374536,2.3703708600058446
KP-3,10074640,3.2800025366089183
KYSE-510,36462,1.8586989227994473
IMR-32,25183872,-1.851562247626712
PE/CA-PJ15,3825829,4.163765164448535
HEC-108,11404337,0.7883165010808656
KP-3,5282054,3.4267608952562756
PE/CA-PJ15,52912189,3.3034022538106025
PC-14,15983966,-5.390386977647823
CML-T1,9823820,1.5491308586448294
KP-3,24772860,-1.376396591458844
HEC-108,638278,3.526450795936247
AsPC-1,4705,5.582464580618905
GSS,6914657,-7.21102439834126
BC-3C,vorinostat-navitoclax (4-1 mol-mol),0.5439164551713076
HEC-108,54619238,5.029653380643683
BT 112,36314,2.3721535443352013
KP-3,71304818,2.7861228498307185
AsPC-1,5329102,1.9734309343360383
KYSE-510,445091,4.768466236369798
CML-T1,56963564,-0.6939066710243597
AsPC-1,44607531,1.5574724897590664
PC-14,selumetinib-piperlongumine (8-1 mol-mol),1.8405265821093273
GSS,72734382,2.1407125654622727
BC-3C,4096211,3.63543753891695
GSS,vorinostat-navitoclax (4-1 mol-mol),-0.4818824118554694
KYSE-510,5113032,4.3101037435440706
PC-14,1566236,4.058624946663528
KMH-2,216345,2.413590189878599
D283 Med,5978,-3.0503373024803557
SK-MEL-2,71304818,3.914661065987117
HEC-108,46191454,0.932122354999318
AsPC-1,11427553,3.0222816384498237
SK-MEL-2,navitoclax-piperlongumine (1-1 mol-mol),2.7599618684552283
D283 Med,241158,3.4452599332241616
IMR-32,10184653,1.6276135333454234
HEC-108,alisertib-navitoclax (2-1 mol-mol),-0.2691749995476873
REC-1,25262965,3.368960294136847
D283 Med,tretinoin-carboplatin (2-1 mol-mol),0.0098310122185737
HuP-T3,54613361,5.307179038572215
TC-71,9911463,4.31174852976799
REC-1,676352,3.0460469545928124
AsPC-1,71680916,4.418583351869457
AsPC-1,6852167,3.622461858977091
BC-3C,17755052,1.14235035927198
SK-MEL-2,tretinoin-carboplatin (2-1 mol-mol),4.856655744975525
GSS,445643,3.3082918681513176
D283 Med,1716436,2.988422279265608
IMR-32,107985,-5.071647837163832
GSS,24901704,2.40588669762839
BC-3C,3038522,2.9049367165059996
REC-1,448949,3.078603121406269
TC-71,613753,4.41622551033192
HEC-108,168313016,6.1351198054698575
KMH-2,6450551,0.9471042683627704
HEC-108,ISOX-bortezomib (250-1 mol-mol),0.3460694218807578
PC-14,3081361,-2.434323823830516
PE/CA-PJ15,60700,-1.6744601529140877
BC-3C,44607530,1.4567685757046984
PE/CA-PJ15,53495165,-0.1488380586894688
KMH-2,44543605,2.718585220539699
KP-3,navitoclax-pluripotin (1-1 mol-mol),-0.4015323398432444
AsPC-1,16038120,0.5677006157285766
IMR-32,JQ-1-navitoclax (2-1 mol-mol),-1.0620754123447265
CML-T1,72193861,-0.1877801569331633
BT 112,4917,2.125230450219151
BC-3C,613753,4.727926918354313
AsPC-1,44566777,0.4941234322675649
REC-1,637858,3.5079007609087527
PE/CA-PJ15,219104,4.253811608091339
SK-MEL-2,11455910,1.0662653811839238
GSS,135928012,4.989265033759339
KMH-2,11214940,0.9300275380390216
KYSE-510,54619267,4.590728681781791
AsPC-1,11494412,3.580103428724827
HuP-T3,5287620,-3.5836939395445913
TC-71,60750,-4.593698832173344
D283 Med,60700,-2.552297119661109
HEC-108,15953870,3.7106591750651736
AsPC-1,107985,-4.227741895863185
D283 Med,46943432,1.9673056187100668
AsPC-1,11214940,2.3233429785878443
GSS,54649381,3.288447109658824
PC-14,4521392,4.078954262243556
IMR-32,387447,-5.0534644538912445
PLC/PRF/5,10410894,2.4947660839905628
BT 112,119182,-1.0754477765372774
SK-MEL-2,salermide-PLX-4032 (12-1 mol-mol),5.301884495923358
AsPC-1,2858523,3.256128469853813
BC-3C,3854666,3.3854560486679053
KYSE-510,66577038,3.1736474048070265
AsPC-1,17755052,1.5687054045124371
HEC-108,navitoclax-birinapant (1-1 mol-mol),1.0122779025542474
REC-1,46215462,6.2160192270590855
BC-3C,11657048,4.346079831085061
PC-14,9952709,3.5197745889529983
PLC/PRF/5,89183176,4.666883803859375
PC-14,89928392,2.519472731436531
PLC/PRF/5,2828334,6.020626353199215
AsPC-1,6918837,-2.7365580441764155
BT 112,11427553,3.7884247720646873
KMH-2,5311,0.2262898573021068
NUGC-3,4477,1.183646396237434
CML-T1,BRD-K03911514,3.1384749532861234
HEC-108,439501,-2.3418750446111347
KP-3,tanespimycin-bortezomib (250-1 mol-mol),-0.1312023090499479
BC-3C,36462,3.334767376058825
GSS,9884685,-0.174857877617277
IMR-32,46215462,1.4477881036573337
AsPC-1,navitoclax-sorafenib (1-1 mol-mol),1.6576308864505285
SK-MEL-2,44819697,0.2501364117398791
CML-T1,3543504,3.744639287704583
KP-3,375860,0.992773842660452
KMH-2,3854666,0.5486625704198924
GSS,24978538,-1.5122970633419512
D283 Med,9915743,1.368920834577302
PE/CA-PJ15,176870,3.0085115802075437
HEC-108,9967941,3.882245660335456
CML-T1,42642645,-1.8637300463446456
PC-14,6184667,3.393270938692378
D283 Med,9444,3.79519909230311
PC-14,erlotinib-PLX-4032 (2-1 mol-mol),-4.924011614622907
AsPC-1,navitoclax-birinapant (1-1 mol-mol),2.1190799837985597
PE/CA-PJ15,46215462,1.5654927399329872
GSS,11396600,2.8148513524153005
AsPC-1,6438330,3.2823568933486196
PE/CA-PJ15,8515,2.421663775633471
BT 112,52947716,-1.8173903777090337
TC-71,10184653,1.63881346723094
NUGC-3,9907093,4.314575624060918
BC-3C,25102847,1.7891523882828315
CML-T1,11612883,2.4336919382311253
HuP-T3,16065773,2.155269900494742
PLC/PRF/5,54618305,4.300403954013755
D283 Med,135411,-1.9342059509823124
BT 112,6914657,-2.2779536161879044
D283 Med,1566236,1.5114731538286772
KP-3,60700,0.3100676828218605
HEC-108,navitoclax-gemcitabine (1-1 mol-mol),-1.2713189320537277
KMH-2,44492757,4.466240512188941
KMH-2,piperlongumine-MST-312 (1-1 mol-mol),1.4395715644832294
PC-14,docetaxel-tanespimycin (2-1 mol-mol),-4.510003946272339
KYSE-510,selumetinib-piperlongumine (8-1 mol-mol),5.136196563384513
PLC/PRF/5,9825149,4.36756752436876
TC-71,72734382,4.726887981964321
TC-71,alisertib-navitoclax (2-1 mol-mol),0.6213751729290982
HEC-108,441298,2.5312141311049214
PLC/PRF/5,24772860,-2.245537876529176
PE/CA-PJ15,11647372,1.6267530000250203
GSS,5329102,1.6374169130423133
KYSE-510,2871966,1.2276227645338869
BT 112,5287969,-2.475133352382641
D283 Med,12001922,1.043249882837814
KP-3,4788,5.674879620376492
AsPC-1,969516,2.9281765712067447
AsPC-1,984333,1.2969820633088274
HEC-108,selumetinib-PLX-4032 (8-1 mol-mol),6.183444970425624
GSS,3543504,3.582813867551697
GSS,tretinoin-carboplatin (2-1 mol-mol),3.965450858632381
D283 Med,selumetinib-decitabine (4-1 mol-mol),-0.3297766379520341
KP-3,49850262,5.166256753861956
KYSE-510,135984461,4.447866088850815
BT 112,2708,2.9934356963189304
KYSE-510,107970,2.515593278152379
PC-14,6918289,3.065230294140497
HEC-108,9911830,3.642303707567872
HuP-T3,9907093,4.467626530245781
SK-MEL-2,11964036,2.999902032518692
TC-71,54626689,4.535760169083424
HuP-T3,42642645,1.566786855324099
NUGC-3,9935249,3.7836037686670543
BC-3C,16741245,5.994114232400852
BC-3C,73707398,1.995912944947898
NUGC-3,5351362,2.3998202397935517
HuP-T3,227681,2.514870644267688
D283 Med,16741245,4.294298413876073
IMR-32,10127622,4.674924788333881
CML-T1,16720766,-1.7114419714530344
HEC-108,107970,2.8725679938480817
HuP-T3,24964624,2.5347495437600753
SK-MEL-2,107985,-2.782254692074657
CML-T1,16722836,0.8135653137043857
PLC/PRF/5,322968,3.129909828851233
PC-14,5328940,-3.455221746073052
NUGC-3,11427553,3.55230265735769
NUGC-3,89928392,1.506533892150173
BT 112,44819697,0.0659575190296443
BT 112,6918638,0.7933014260092189
REC-1,56649450,3.786726508072347
NUGC-3,15983966,-0.2175788949536013
NUGC-3,10074640,3.1124061974154693
PC-14,156422,2.966030422722191
PLC/PRF/5,3634881,3.8966048906867377
IMR-32,46199207,3.428381150868246
PLC/PRF/5,navitoclax-PLX-4032 (1-1 mol-mol),2.9534370312869136
CML-T1,5280436,4.11670865979611
KMH-2,11625818,3.5304248739726565
PLC/PRF/5,445455,5.084671915642631
KYSE-510,1242560,3.713283949748194
PC-14,BRD-K27188169-navitoclax (2-1 mol-mol),0.9936418350863891
KYSE-510,docetaxel-tanespimycin (2-1 mol-mol),-2.787390286484636
CML-T1,36462,-1.7431711247812498
BC-3C,11238147,1.5908088252686547
PE/CA-PJ15,1566236,2.6409505588349353
PE/CA-PJ15,409805,3.811497133930035
GSS,135875424,3.760188013536636
BC-3C,4259181,1.463523509527546
D283 Med,11455910,0.6480749902472364
BC-3C,11625818,4.760582131984097
KP-3,136227924,3.03068470875373
GSS,4521392,3.129722533601952
PC-14,12003241,-2.6584563263219203
AsPC-1,11485656,3.206693439346989
D283 Med,753704,2.8717556024543067
BT 112,5282054,3.2552997941378226
SK-MEL-2,10127622,2.552103790334664
NUGC-3,107985,-4.895591423275197
HEC-108,44486219,4.957991177382761
PE/CA-PJ15,9952709,3.102814524192607
KMH-2,439501,-2.384989575251817
KYSE-510,1641662,2.98393507886217
IMR-32,44819697,-4.568070897071165
AsPC-1,262093,3.2992304028365926
HuP-T3,7251185,1.9415241444855404
KP-3,44259,2.0024502475067414
PE/CA-PJ15,10410894,3.434134302968134
NUGC-3,5328940,2.69864856623051
BT 112,4096211,1.2803456710080927
PLC/PRF/5,1641662,3.5340023013862383
D283 Med,10302451,2.6795990859409695
IMR-32,selumetinib-decitabine (4-1 mol-mol),1.3491995050988332
D283 Med,selumetinib-vorinostat (8-1 mol-mol),2.011575118738352
TC-71,44462760,4.674927257780393
CML-T1,9935249,2.5956918222650507
IMR-32,9926054,1.7425604419011955
D283 Med,9840324,6.111683507272441
BC-3C,10302451,3.564024501759527
HEC-108,135999136,4.441314867436916
BT 112,12003241,0.1954695576836523
KMH-2,119182,-1.5017162048939945
PE/CA-PJ15,36462,-0.1372192920508844
CML-T1,4788,4.608482830288328
HEC-108,SNX-2112-bortezomib (250-1 mol-mol),-0.4374113289550588
TC-71,3038522,2.335402608004976
GSS,10127622,3.6627114061753505
AsPC-1,148198,-3.729188282050714
BC-3C,5113032,4.519613170924636
HuP-T3,104842,-2.1883971380944054
KP-3,2729026,1.3395123265794755
NUGC-3,676352,2.4035556904738216
IMR-32,9911463,2.6287307610589172
IMR-32,10113978,1.6572935339982182
CML-T1,71466380,3.6658800118854673
BC-3C,54626689,4.469550899506127
